[go: up one dir, main page]

WO2013017770A1 - Device for culturing nerve cells, and uses thereof - Google Patents

Device for culturing nerve cells, and uses thereof Download PDF

Info

Publication number
WO2013017770A1
WO2013017770A1 PCT/FR2012/051688 FR2012051688W WO2013017770A1 WO 2013017770 A1 WO2013017770 A1 WO 2013017770A1 FR 2012051688 W FR2012051688 W FR 2012051688W WO 2013017770 A1 WO2013017770 A1 WO 2013017770A1
Authority
WO
WIPO (PCT)
Prior art keywords
adhesion
neuronal cells
neurexin
cell
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2012/051688
Other languages
French (fr)
Inventor
Olivier THOUMINE
Katalin CZÖNDÖR
Mikaël GARCIA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CYTOO
Centre National de la Recherche Scientifique CNRS
Universite Victor Segalen Bordeaux 2
Original Assignee
CYTOO
Centre National de la Recherche Scientifique CNRS
Universite Victor Segalen Bordeaux 2
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CYTOO, Centre National de la Recherche Scientifique CNRS, Universite Victor Segalen Bordeaux 2 filed Critical CYTOO
Publication of WO2013017770A1 publication Critical patent/WO2013017770A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/08Chemical, biochemical or biological means, e.g. plasma jet, co-culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0619Neurons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/30Synthetic polymers
    • C12N2533/32Polylysine, polyornithine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/50Proteins

Definitions

  • the present invention relates to a support (1) for culturing neuronal cells, to the use of this support for cell culture, in screening methods and in qualitative and / or quantitative methods of analyzing growth. neuronal and synaptogenesis.
  • the present invention also relates to a method of manufacturing said support.
  • the present invention finds application, particularly in the field of research and pharmacy.
  • references in brackets ([]) refer to the list of references at the end of the text.
  • the general approach is to delineate adhesive areas in an environment covered with a release agent (cytotropic), on which the cell can not adhere, thus confining cell extension.
  • cytotropic a release agent
  • One of the first methods described relates to a device comprising circular adhesive islands 400 to 2000 ⁇ 2 in diameter made by evaporation of palladium through a mask on an underlying non-adhesive surface (Ireland, GW, Dopping-Hepenstal, PJ, Jordan, PW &O'Neill, CH Limitation of Substrate Size Cytoskeletal Organisms and Behavior of Swiss 3T3 Fibroblasts Cell Biol Int Rep 13, 781-90 (1989) [5]).
  • microcontact printing of self-assembled alkanethiolate monolayers on a metal substrate was used (Chen, CS, Mrksich, M., Huang, S., Whitesides, GM & Ingber). , DE Micropatterned surfaces for control of cell shape, position, and function, Biotechnol Prog 14, 356-63 (1998) [8]).
  • Another recently implemented technique consists in carrying out a covalent coupling of adhesion proteins directly on a surface via a UV-activated crosslinking chemical agent (Fink, J., Thery, M., Azioune, A., Dupont , R., Chatelain, F., Bornens, M. & Piel, M. Comparative study and improvement of current cell micro-patterning techniques, Lab Chip 7, 672-80 (2007) [14]).
  • Micro-structured systems comprising parallel adhesive lines separated by non-adhesive grooves have also been used to promote directional growth of axons (Yamagata, M., Weiner, JA, Dulac, C., Roth, KA & Sanes, JR Labeled).
  • axons Yamagata, M., Weiner, JA, Dulac, C., Roth, KA & Sanes, JR Labeled.
  • retinotectal system markers for retinorecipient sublaminae and the retinal ganglion cell subsets that innervate them Mol Cell Neurosci 33, 296-310 (2006).
  • Micropatterned ECM substrates reveal complementary contribution of low and high affinity ligands to neurite outgrowth Cytoskeleton (Hoboken) (201 1) [19]).
  • Another group used the micro-contact printing method to make rectangular islands of 2- 5 ⁇ separated by 5-10 ⁇ , and deposited ephrin neuronal proteins involved in axon guidance and reorientation of the growth cone (von Philipsborn, A. C, Lang, S., Bernard, A., Loeschinger, J. , David, C., Lehnert, D., Bastmeyer, M. & Bonhoeffer, F. Microcontact printing of axon guidance molecules for generation of graded patterns Nat Protoc 1, 1322-8 (2006).
  • micro fluidic devices associated with a culture substrate for separating two populations of different neurons directing axonal growth along pre-determined lines and establishing synaptic contacts between the two types.
  • neurons Tumithalogen-Jones, M., Rhee, SW, Cribbs, DH, Cotman, CW & Jeon, NL
  • a microfluidic culture platform for CNS axonal injury, regeneration and transport Nat Methods 2, 599-605 ( 2005). [22], Paul, D., Saias, L., Pedinotti, J.
  • NrCAM coupling to the cytoskeleton is dependent on multiple protein domains and partitioning into lipid rafts, Mol Biol Cell 15, 4695-709 (2004) [26]). This is a limitation all the stronger as regards the study of the formation of specialized contacts allowing the communication between neurons, the "synapses", which constitutes a fundamental question of neurobiology.
  • Synaptogenesis is a complex and multi-stage process at the level of axon / dendrite contacts, initiated by adhesion proteins and followed by recruitment of scaffold molecules and functional channel receptors (Bresler, T., Ramati, Y.
  • Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons.
  • Sudhof TC Neuroligins and Neural Link Synaptic Function to Cognitive Disease. Nature 455, 903-1 (2008).
  • micro-wells a technique using non-neuronal neuroligin-1-expressing cells isolated in micro-wells was used to stimulate pre-synaptic differentiation in contact-forming axons (Shi, P., Scott MA, Ghosh B., Wan D., Wissner-Gross Z., Mazitschek R., Haggarty SJ, Fatih M. Synapse microarray identification of small molecules that enhance synaptogenesis Nat Nat 2, 510 (201 1) [70]), but these micro -wells have diameters of 30 ⁇ , far from the physiological size of real synapses, of the order of 1 ⁇ , and the hemi-synapses are always randomly formed inside these wells.
  • neurons may not differentiate properly in response to strong geometric limitations imposed by the adhesive microenvironment, not being able to extend their arborization of axons and dendrites. Hence the need to find the optimal geometry and coating conditions to grow primary neurons on these substrates, trying to stay as close as possible to their physiological environment.
  • neuronal cells can be cultured to analyze the physiological properties of neuronal cells, including their axonal and dendritic development as well as the formation of synapses, and to test the effect of compounds on these processes.
  • a simple device that can be easily implemented and thus reducing costs and improve the culture of neuronal cells and their uses. Description of the invention
  • the present invention is specifically intended to meet these needs by providing a support (1) for culturing neuronal cells (c) comprising a substrate (3) on a surface (5) of which islet islands (7) of adhesion of said neuronal cells, said islands (7) having a diameter of 100 nm to 3 microns and being spaced between them from 1 to 10 microns.
  • the present invention also relates to the use of the support (1) for culturing neuronal cells, in a method of quantitative and / or qualitative analysis of neuronal cells and in a screening method.
  • neuronal cells are understood to mean any cells originating from the nervous system of a mammal, bird, batrachian, or mollusc, and / or any cell derived from a neuronal cell line. It may be, for example, neuronal cells isolated from the nervous system, for example from the brain or spinal cord, rodents, for example from rats or mice, chickens, amphibians, for example Xenopus, molluscs such as Aplysia, embryonic or newborn stages, which may be located in the hippocampus, cortex, striatum, dorsal root ganglia (DRG). They may also be cells selected from the SH-SY5Y neuroblastoma line, the PC12 line, the cortical neuronal cell line (HCN-1), or the B104 neuroblastoma line.
  • the support (1) can be of any form known to those skilled in the art, it can be for example square, rectangular or circular.
  • the substrate (3) can be any solid substrate known to those skilled in the art. It may be for example a transparent or opaque substrate. It may be a substrate made of glass, quartz, silicon or a material of the polymer type, for example plastics, for example polycarbonate, polystyrene, polyethylene or PTFE, covered or not with a thin layer of another polymeric metal material, for example gold or metal oxides such as S102, ⁇ 2, NTO "indium tin oxide", or crosslinked gels, for example polydimethylsiloxane (PDMS) or polyacrylamide.
  • plastics for example polycarbonate, polystyrene, polyethylene or PTFE
  • a thin layer of another polymeric metal material for example gold or metal oxides such as S102, ⁇ 2, NTO "indium tin oxide", or crosslinked gels, for example polydimethylsiloxane (PDMS) or polyacrylamide.
  • PDMS polydimethylsiloxane
  • the thickness of the substrate (3) may be from 0.1 mm to 3 mm, from 0.1 mm to 0.290 mm, from 0.120 mm to 0.250 mm, from 0.150 mm to 0.170 mm.
  • the thickness of the substrate when it is between 150 ⁇ and 170 ⁇ , it can be used directly in an optical reading device, for example an epifluorescence microscope using a high numerical aperture oil immersion objective, allowing the illumination in total internal reflection (evanescent waves) and thus the visualization of the adhesive contact with a depth of field of a hundred nanometers.
  • the surface (5) can be any surface known to those skilled in the art on which molecules, for example chemical substances and / or proteins can be arranged. This may be for example a flat surface, a rough surface, a surface comprising depressions, for example wells or channels.
  • the islands (7) can be arranged on the surface in such a way that they form a network, for example a hexagonal or square network. According to the invention, the islands can be located equidistant from each other or in variable intervals.
  • the surface between the islands (7) can be a cytophobic surface (9).
  • the surface can be made cytophobic because of the presence of a compound chosen from polyethylene glycol, polyethylene oxide, polyvinyl acetate, poly (2-hydroxyethyl methacrylate, polyacrylamide, poly (N-vinyl-2-pyrrolidone), poly (N-isopropyl acrylamide), silicones, for example polydimethylsiloxane (PDMS), silanes, for example perfluorinated silanes, anionic polymers, phosphoryl choline polymers, albumin, casein, hyaluronic acid, liposaccharides, glycoproteins, phospholipids or a combination thereof.
  • the application of the cytophobic compounds can be carried out by any method known to those skilled in the art, for example by liquid phase deposition, spin coating, dipping, spraying, or chemical vapor deposition, for example by plasma or controlled atmosphere or a combination of both.
  • it may be The method described in the following document Bhushan, Bharat Hansford, Arthur Lee, Kang Kug "Surface modification of silicon and polydimethylsiloxane surfaces with vapor-phase-deposited ultrathin fluorosilane films for biomedical nanodevices", Journal of Vacuum Science & Technology A: Vacuum, Surfaces, and Films, Jul 2006, 24 (4), 1 197 - 1202 [63].
  • adhesion proteins means an adhesion protein derived from a neuronal cell membrane or a physiological membrane supporting a neuronal cell derived from non-neuronal cells, for example non-neuronal cells.
  • neurons selected from glial cells, astrocytes, oligodendrocytes, ependymocytes, satellite cells, Schwann cells, microglial cells, or embryonic stem cells of said cells.
  • a membrane adhesion protein of neuronal cells for example immunoglobulin-like adhesion molecules (IgCAM), for example L1 molecules, neural-type adhesion molecules (NrCAM).
  • IgCAM immunoglobulin-like adhesion molecules
  • NrCAM neural-type adhesion molecules
  • transaxonal glycoprotein 1 TAG-1
  • cadherins for example N-cadherin
  • proto-cadherins neurexins, for example neurexins 1, 2 or 3, neurexins of the ⁇ or ⁇ forms, neurexins with or without alternative splicing sites in position 4, neuroligins, for example neuroligins 1, 2, 3, or 4, with or without an alternative splicing site at the A or B positions, and the leucine-rich domain transmembrane proteins ( "Leucine-Rich Repeat Transmembrane Protein”) eg LRRTM 1, 2, 3 or 4.
  • leucine-rich domain transmembrane proteins "Leucine-Rich Repeat Transmembrane Protein"
  • the adhesion proteins may also be, for example, Synaptic Cell Adhesion Molecule (SynCAM) adhesion molecules 1, 2, 3, or 4.
  • SynCAM Synaptic Cell Adhesion Molecule
  • It may be a recombinant protein, for example a protein consisting of an N-terminal extracellular domain of adhesion proteins Membranes of neuronal cells, for example the aforementioned proteins, fused, for example, in its C-terminal part to a label.
  • the label when the adhesion protein is a recombinant protein comprising a C-terminal label, the label may be chosen from the following labels: the green fluorescent protein ("green fluorescent protein” (EGFP)), the protein red fluorescent protein (RFP), polyhistidine sequences (6-10 His), haemagglutinin label (HA), myc tag, Glutathione S-transferase (GST), or a constant fragment of antibody (Fc).
  • EGFP green fluorescent protein
  • RFP protein red fluorescent protein
  • HA haemagglutinin label
  • GST Glutathione S-transferase
  • Fc constant fragment of antibody
  • the recombinant proteins can be obtained by any method known to those skilled in the art. It may be, for example, the methods described in the document Isabelle Collin cvc, Genetic engineering, "transgenic animals", edition Essentials milans, 1999 [64], the Handbook of Biochemistry and Molecular Biology, Fourth Edition 201 1 - Editor (s): Roger L. Lundblad, Lundblad Biotechnology, Chapel Hill, North Carolina, USA; Fiona Macdonald, CRC Press, Boca Raton, Florida, USA [65], or the Practical Handbook of Biochemistry and Molecular Biology Gerald D. Fasman CRC Press, 1989 - 601 pages [66]; or the Recombinant DNA Principles and Methodologies, Editor (s): James Greene, Catholic University, Washington DC, USA CRC Press, 1998 [67].
  • the adhesion protein is chosen from neurexins, neuroligins, IgCAMs, N-cadherin, synCAMs, Leucine-rich domain transmembrane proteins ("Leucine-Rich Repeat Transmembrane” (LRRTM)) or a mixture of these.
  • the adhesion protein is selected from neurexins, neuroligins, N-cadherin and / or a mixture thereof.
  • the adhesion protein used in the device of the invention induces growth of axons and / or dendrites and / or synaptogenesis.
  • the adhesion protein can be attached directly to the surface (5) or via an intermediate binder attached to said surface (5).
  • the direct attachment of the adhesion protein on the surface (5) can be carried out by any method known to those skilled in the art, for example by adsorption, by chemical, electrochemical or thermal grafting.
  • the intermediate binder may be chosen from a reactive chemical species which makes it possible to establish a covalent bond, for example benzophenone, an acidic, amine or thiol function, silanes, for example trichlorosilane alkyls, and / or non-covalent bond, for example nickel-nitrile triacetic acid (NTA), a protein, for example biotin, streptavidin, glutathione, an antibody for example anti-Fc, anti-GFP, anti-RFP, anti-HA, anti -myc, anti-His, anti-GST, a charged species for example poly-D-lysine or poly-ornithine, a polysaccharide.
  • a reactive chemical species which makes it possible to establish a covalent bond
  • benzophenone an acidic, amine or thiol function
  • silanes for example trichlorosilane alkyls
  • non-covalent bond for example nickel-nitrile triacetic acid (NTA
  • the fixing of the binder on the surface (5) can be carried out by any method known to those skilled in the art, for example by soaking the surface in a solution comprising said binder.
  • the fixing method may be for example a method comprising a step of soaking the surface (5) in an antibody solution and rinsing in a liquid medium.
  • the application of the cytophobic compounds can be carried out by any method known to those skilled in the art, for example by deposition in the liquid phase, for example by spinning, dipping, spraying, or chemical vapor deposition, by example by plasma or controlled atmosphere) or a combination of both.
  • the binder is polylysine, it allows optimal attachment of neurons and extension of neurites.
  • the adhesion protein when it is a recombinant protein, it can interact with the surface (5) and / or with a binder fixed on the surface (5) thus making it possible to increase the amount of adhesion proteins fixed .
  • the binder when the binder is an antibody, it may be specific for the adhesion protein.
  • the protein when the protein is a recombinant protein as defined above, the antibody may be specific for the label of said recombinant protein.
  • the binder when the binder is an antibody, its site of interaction with the adhesive protein may be such as to allow the ectodomain of the adhesive protein to be oriented in such a way that the reactive part is available for cell adhesion. .
  • the islands (7) can be deposited on the surface (5) by a method chosen from photolithography, dip-pen nanolithography, beam lithography, ink jet printing, printing. by microswitch.
  • the islands (7) have a diameter of 0.2 to 2.5 ⁇ , of 0.2 to 2 ⁇ , of 0.3 to 150 ⁇ .
  • the spacing between the islands is 0.5 to 10 ⁇ , 1 to 9 ⁇ , 3 to 7 ⁇ .
  • the diameter of the islets makes it possible to fix the neuronal cells and makes it possible to form points of attachment between, for example, the cell body, the axons or the dendrites and the immobilized adhesion protein on the islets.
  • the subject of the present invention is also a process for producing a neuronal cell culture support (1) comprising a step of depositing on a surface (5) an islet substrate (7) of neuronal cell adhesion. , said islands (7) having a diameter of 0.2 to 2.5 ⁇ , 0.2 to 2 ⁇ , of 0.3 to 150 ⁇ and being spaced between them from 0.5 to 10 ⁇ , 1 to 9 ⁇ , 3 to 7 ⁇ .
  • the neuronal cells are as defined above.
  • the substrate used in the process of the invention corresponds to the substrate defined above.
  • the adhesion proteins used in the method of the invention correspond to the proteins defined above.
  • the method may further comprise a step of coating a cytophobic compound.
  • the step of coating the cytophobic compound can be carried out prior to the deposition step of the adhesion islands.
  • the cytophobic compound used in the process is as defined above.
  • the method may comprise a step of coating the surface (5) with a binder.
  • the step of coating the surface (5) with a binder may be carried out prior to the step of depositing the adhesion islands.
  • the binder used in the process is as defined above.
  • the present invention also relates to the use of the support (1) for the culture of neuronal cells.
  • the present invention also relates to the use of the support
  • the support of the present invention can be advantageously used to analyze the effects of chemical molecules on the growth of neurites, for example on the number, the size, the geometry, the connections.
  • the carrier of the present invention can be advantageously used to study the effects of chemical molecules on the formation, structure, development and migration of the axonal growth cone.
  • the carrier of the present invention may be advantageously used to analyze the effects of chemical molecules on, for example, the formation, number, structure and / or function of pre-synaptic or postsynaptic hemispynapses.
  • the subject of the present invention is also the use of the support (1) in a method of quantitative and / or qualitative analysis of neuronal cell synaptogenesis.
  • the carrier of the present invention may be advantageously used to study, for example, the formation, number, structure and / or function of pre-synaptic or postsynaptic hemispynapses.
  • the carrier of the present invention can be advantageously used to analyze and quantify the effects of chemical molecules on, for example, synaptogenesis of neuronal cells.
  • the present invention also relates to the use of the support (1) in screening methods.
  • the device of the invention advantageously allows to cultivate neuronal cells and maintain these cells in culture for a time sufficient to allow their development.
  • the device of the invention allows the development of synapses.
  • the adhesion proteins attached to the islets advantageously retain their adhesive functions, allowing, for example and advantageously the expression of endogenous counter-receptors in neurons, for example N-cadherin endogenous in axons and dendrites, endogenous neuroligins in dendrites, and endogenous neurexins in axons.
  • FIG. 1 shows a culture medium (1) comprising a substrate (3), a cytophobic surface (5), and adhesive islands (7).
  • Figure 2A shows a culture medium comprising a hexagonal array of micro-islets coated with neurexin-1-Fc on a surface elsewhere cytophobe.
  • the grafting of neurexin-1 ⁇ -Fc on the islets initially coated with polylysine was provided by an anti-Fc antibody.
  • Neurons expressing neuroligin-1 develop post-synaptic compartments specifically on these islets.
  • the sectional diagram of an individual post-synapse formed on an island of neurexin-covered is shown on the right.
  • FIG. 2B shows a culture support comprising a hexagonal network of micro-islets covered with neurexin-1 ⁇ -Fc on a surface elsewhere cytophobe.
  • Figure 2C is a two-fold magnified diagram of a portion of the culture medium showing dendrites of neurons expressing neuroligin-1 developing post-synaptic compartments specifically on these islands.
  • Figure 2D is a roughly 10-fold enlarged sectional diagram of an individual post-synapse formed on a neurexin-coated island.
  • Figure 3 shows fluorescence images of dissociated hippocampal neurons from embryonic rats in culture on micro-islet substrates coated with neurexin-1 ⁇ -Fc. The neurons were deposited on these substrates, transfected after 4 days with neuroligin-1-HA or EGFP, and cultured in total for 8 days.
  • A Image of a neuron expressing neuroligin-1-HA immuno-labeled with an anti-HA antibody.
  • (b) Image of a neuron transfected with EGFP. The islets were coated with an anti-huFc antibody conjugated to the fluorophore Cy5 (aHuFc-Cy5), for a display of the islets (corresponding images on the right).
  • FIG. 4 represents fluorescence images of axons and dendrites as a function of the support used.
  • Figure 4 (a) shows photographs of a neuron expressing neuroligin-1-HA, developing on the substrate coated with neurexin-1 ⁇ -Fc. The transfected neuron was visualized by immunostaining of the HA epitope with primary anti-HA antibodies and secondary antibodies conjugated to Alexa488 fluorophore. In particular, this photograph represents the structured morphology of rat hippocampal neurons (DIV 8) grown on micro-islet substrates.
  • Figure 4 (b) shows photographs of a neuron expressing EGFP, developing on a substrate coated with neurexin-1 ⁇ -Fc.
  • FIG. 5 represents fluorescence images of dendrites and explains the method for quantifying the enrichment factors of neuroligin-1 and PSD-95 synaptic proteins at the micro-pattern or islet level.
  • the image in (a) represents a dendritic region of a neuron expressing neuroligin-1-HA and PSD-95: EGFP grown on a substrate coated with ⁇ ⁇ -Fc.
  • the corresponding image in (b) represents the islands previously coated with ahuFc-Cy5 fluorescent antibodies.
  • the image in (c) represents the detected islets (dashed circles), which are then transferred to the PSD-95: EGFP image. Islets that are not covered with dendrites (solid circles) have been eliminated from quantification.
  • the image in (d) represents the outlines of the remaining islets (dashed circles), transferred to the PSD-95: EGFP image, where the neurite contour is determined by a threshold function (in gray).
  • the enrichment index is calculated by measuring the fluorescence intensity in each island (circles), and divided by the average intensity measured from dendritic zones located outside the micro-patterns (gray).
  • Panel 6 shows the results of the quantification of synaptic protein enrichment factors at the level of micro-patterns.
  • Panel (a) shows photographs of cells showing the recruitment of Neuroligin-1 (high) and PSD-95: EGFP (medium) at micro-patterns covered with neurexin-1 ⁇ -Fc (low).
  • Panels (b) and (c) are graphs depicting enrichment of postsynaptic proteins (endogenous neuroligins-1-HA; PSD-95: EGFP or PSD-95).
  • the abscissa corresponds to the enrichment index which is a dimensionless number normalized to 1, dividing by the level of fluorescence at the level of the islets by a reference level on control regions.
  • Enrichment was quantitatively determined on the islets using 3 different cultures of hippocampal neurons following the procedure described in Figure 5.
  • the cumulative distribution of the enrichment index of neuroligins-1-HA (in b) or PSD-95: EGFP and endogenous PSD-95 (in c) is shown on the graphs.
  • the enrichment index was calculated for each protein under the following conditions: substrates coated with neurexin-1 ⁇ -Fc and neurons expressing neuroligin-1-HA (Nrx-Fc + Nlgn-1 (solid line curve); substrates covered with human Fc and neurons expressing neuroligin-1-HA (huFc + Nlgn-1 (curve spaced lines) or substrates covered with neurexin-1 ⁇ -Fc and over-expressing neurons EGFP (Nrx-Fc + EGFP (curve in dotted line).
  • An enrichment index value of 1 indicates that there is no particular recruitment of the protein under study.
  • Figure 7 shows photographs taken over time of neuronal cells expressing neuroligin-1 and PSD-95: EGFP, in culture on a substrate whose islets are covered with neurexin-1 ⁇ -Fc.
  • this figure represents the changes of dendritic filopodia, visualized by the fluorescence signal of PSD-95: EGFP.
  • These figures show the contacts between the peripheral part of the dendritic filopodia enriched in PSD-95 (arrows), with islets covered with neurexin-1 ⁇ -Fc (dashed circles), precursor events of the formation of hemi-post-synapses .
  • FIG 8 shows photographs of transient calcium fluxes induced by glutamate decapping.
  • Hippocampal rat neurons (DIV 7) developing on the substrate coated with neurexin-1 ⁇ -Fc (a) and expressing neuroligin-1-HA and PSD-95: mCherry (b) were labeled with the indicator Calcium Fluo-4, to observe intracellular calcium changes (c) and were incubated in a solution containing caged glutamate (4-methoxy-7-nitroindolinyl-caged 1-glutamate).
  • the bi-photon laser beam for decapping is focused in the vicinity of an island (arrow). It is noted that the increase of the Fluo-4 signal from the location of the stripping propagates through the dendrites over time (Panel c).
  • Panel (d) represents a graph showing different calcium responses, normalized to a reference level (ordinate) versus time in seconds (abscissa). These responses were measured at the island closest to the location of glutamate decapping (black curve), or on neighboring islands (dashed lines), as shown in PSD-95: mCherry ( islands 1, 2 and 3 respectively).
  • Figure 9 shows fluorescence images of dissociated hippocampal neurons from embryonic rats in culture on micro-islet substrates coated with N-cadherin-Fc (top panels: N-cadherin-Fc substrate) or the molecule witness Fc (bottom panels: Substrate Hu-Fc).
  • the neurons were deposited on these substrates and cultured for 8 days.
  • the left panels show images of neurons labeled with the phalloidin molecule.
  • Bodipy for coloring the actin filaments.
  • the images corresponding to right show the islets coated with anti-huFc antibody conjugated to fluorophore Cy5 (aHuFc-Cy5).
  • the corresponding images on the right show the islets coated with an anti-human Fc antibody conjugated to the Cy5 fluorophore (anti-Human Fc Cy5).
  • Figure 9c shows the higher magnification image of a colored growth cone for actin filaments with the phalloidin-Bodipy molecule, which shows the actin accumulation at the adhesions with N-coated islets.
  • cadherin-Fc (arrows and circles).
  • the right panel represents the corresponding image of islets of N-cadherin-Fc.
  • 9 d represents a culture support comprising a hexagonal network of micro-islets covered with N-cadherin-Fc on a surface elsewhere cytophobe. The grafting of the N-cadherin-Fc molecule on the islets initially coated with polylysine was provided by an anti-Fc antibody.
  • the central diagram represents a 2-fold diagram of a portion of the culture medium showing axons and dendrites of neurons developing on the support and forming specific contacts at the islet level.
  • the diagram on the right represents a roughly 10-fold enlarged section of an individual adhesive contact formed on an island of N-cadherin coated. Note the difference between the horizontal and vertical scales.
  • Figures 10a and b show fluorescence images of dissociated hippocampal neurons from embryonic rats in culture on micro-islet substrates coated with N-cadherin-Fc (N-cadherin-Fc substrate).
  • the neurons were deposited on these substrates, transfected after 4 days with red fluorescent protein (RFP) (a) or N-cadherin-RFP (b), and cultured in total for 8 days.
  • RFP red fluorescent protein
  • b N-cadherin-RFP
  • Figure 10 (c) is a bar graph depicting on the ordinate the enrichment index of RFP and N-cadherin-RFP on N-cadherin-Fc coated islets.
  • Figure 11a shows a culture medium comprising a hexagonal array of micro-islets coated with 6His-neuroligin-1 on a surface elsewhere cytophobe.
  • Figure 11b shows a two-fold magnification diagram of a portion of the culture medium showing axons and dendrites of neurons developing on the support and forming specific island-level contacts.
  • Figure 11 represents a roughly 10-fold enlarged sectional diagram of an individual pre-synapse formed on an island of neuroligin-coated graft onto islands initially coated with polylysine via anti-Histidine antibodies.
  • synaptic vesicles are also represented and the term CASK stands for calcium / calmodulin-dependent serine protein kinase.
  • Figure 11 represents a fluorescence image of a culture support on which the islets are coated with an anti-6His antibody conjugated to the fluorophore Cy5 and on which 6His-neuroligin-1 was fixed.
  • Figure 1 1 e represents a fluorescence image of the axon of a neuron transfected with neurexin-1 ⁇ -GFP.
  • the clear spots correspond to the accumulation of neurexin-1 ⁇ -GFP at the level of the islets covered with 6His-neuroligin-1 and show the growth of the axons.
  • FIG. 12a shows a culture support comprising a hexagonal network of micro-islets coated with adhesion molecules synaptic 1 fused to the Fc fragment (SynCAM-1-Fc) and grafted onto the islets initially coated with polylysine via an anti-Fc antibody on a surface elsewhere cytophobe.
  • Figure 12b is a two-fold magnification diagram of a portion of the culture medium showing axons and dendrites of neurons developing on the support and forming specific island-level contacts, in particular, they form pre-synaptic compartments. specifically on these islets.
  • Figure 12c shows a roughly 10-fold enlarged sectional diagram of a presynapse formed on a SynCAM-1-Fc coated island.
  • Figure 12d is a fluorescence photograph of a culture medium showing the islets coated with a Cy5 fluorophore-conjugated anti-Fc antibody to which SynCAM-1-Fc proteins (clear dots in the photograph) have been attached.
  • Figure 12e shows a fluorescent image of the immunofluorescence staining of the endogenous SynCAMI receptor after deposition and culture for 8 days of dissociated hippocampal neurons from embryonic, untransfected rats on the culture device.
  • Figure 12f shows a fluorescence image of the immunofluorescence staining of presynaptic vesicles (synapsin) after culture on the dissociated hippocampal neuron device, from embryonic rats.
  • the matrices of hydrophilic islands of 0.5 to 2 ⁇ and separated from 3 to 6 ⁇ in a cytophobic environment were obtained from CYTOO on glass slides of 2x2cm 2 and 170 ⁇ thick (custom products, CYTOOchips Custom, catalog number 10-950-00).
  • the substrates were then treated with Poly (L-lysine) PLL (40 g / ml, Sigma P2636- 1G) which was adsorbed on the hydrophilic points.
  • the substrates were then dried and stored at 4 ° C.
  • This plasmid was subcloned between the HindIII / XhoI sites in the pcDNAhygro (+) vector.
  • HEK293 cells (5 ⁇ 10 6 cells) were electroporated (Biorad Pulser Xcell) with 30 to 50 g of this plasmid and then cultured in DMEM High glucose medium (DMEMNA0500, Midimed) containing 10% fetal calf serum (SVFBRE500, Midimed), 1 mM MEM Sodium pyruvate (1 1360039, Fisher Scientific), 1% GlutaMAX (Trade Mark) supplement I (35050038, Fisher Scientific) without antibiotic for 36 h, then supplemented with 0.5 mg / mL.
  • DMEM High glucose medium DMEMNA0500, Midimed
  • MEM Sodium pyruvate (1 1360039, Fisher Scientific
  • GlutaMAX Trade Mark
  • hygromycin B (10687-010, Fisher Scientific) to select a stable clone expressing neurexin-1 ⁇ -Fc (10 days).
  • the cells were cultured on supports coated with Poly-L-lysine hydrobromide (1 mg / ml, P2636-1G, Sigma-Aldrich) for 3 months in Medium AIM V (registered trademark) (31035-025, Fisher Scientific) supplemented with 0.5 mg / mL of hygromycin B. 60 mL of conditioned medium was taken twice a week and then frozen at -20 ° C.
  • the plasmid encoding the SynCAM-1-Fc protein has been generously provided by T. Biederer (Yale University, USA) and is described in the reference (Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D. ., Liu,
  • SynCAM synaptic adhesion molecule that drives synapse assembly
  • the SynCAM-1-Fc molecule was produced from this gene according to the method described above for neurexin-1-Fc, according to the protocol described in Breillat, C., Thoumine O., Choquet, D. Characterization of SynCAM surface SynCAM derived ligand with high homophilic binding affinity, Biochem Biophys Res Commun, 359, 655-659 (2007) [71].
  • the recombinant adhesion proteins were purchased from the manufacturer R & D Systems: N-cadherin-Fc (6626-NC-050), neurexin1-Fc (4485-NX-050), neurexin-1 ⁇ -Fc (5268-NX-050), Neuroligin-1-6His (4340-NL-050), Neuroligin-2-6His (5645-NL-050), and LRRTM-1-6His (4897-LR-050), LRRTM- 3-6His (4898-LR-050), LRRTM-4-6His (5377-LR-050), SynCAM1-Fc (3519-S4), SynCAM2-Fc (4290-S4),
  • SynCAM3-Fc (3678-S4), SynCAM4-Fc (4164-S4).
  • Each coverslip obtained was inverted over 200 ⁇ l of this antibody solution on parafilm (Dutscher, 090998) previously sterilized for 1 h with a UV lamp (365 nm) under a laminar flow hood (TELSTAR, AV-100). and incubated for 4 to 5 hours at 23 ° C to ensure uniform antibody distribution on the micro-patterns.
  • the substrates were thoroughly washed with borate buffer, and then incubated at 4 ° C overnight with 100 ⁇ l of purified neurexin-i-Fc, purified N-cadherin-Fc (R & D Systems, 1388-NC-050) or human Fc (Jackson Immunoresearch, P / N 009-000-008) used as a control, all the proteins being diluted to 0.04 mg / ml in the borate buffer. These protein solutions were previously centrifuged for 10 minutes at 14,000 rpm at 4 ° C.
  • the substrates were thoroughly washed with borate buffer, and then incubated at 4 ° C overnight, ie 16 hours with 100 ⁇ l of SynCAM-1 solutions.
  • Fc or 6His-neuroligin-1 purified and diluted to 0.04 mg / ml in buffer borate. These protein solutions were previously centrifuged for 10 minutes at 14,000 rpm at 4 ° C.
  • the substrates were placed in a 6-well plate, washed 3 times with 1 ml of borate buffer and once with 1 ml of minimal essential medium (MEM) (21430-020, Gibco / Invitrogen) supplemented with % horse serum (16050-122, Gibco / Invitrogen) and left in 2.5 ml MEM supplemented with 10% horse serum for 1 to 2 hours in an incubator at 37 ° C and 5% CO2 (Heraeus , HERACell 150).
  • MEM minimal essential medium
  • Neurons dissociated from the hippocampus from E18 rat embryos were spread on substrates (100,000 cells / substrate). After 4-5 hours, the substrates were thoroughly washed with Neurobasal (NB) medium (Gibco, 12348-017) supplemented with B27 (Gibco, 17504-044) and L-Glutamine (Glu200100, MidiMed) at 37 ° C. to remove unbound cells, then incubated in 2.5 ml of this same medium for 8 to 10 days. After 3 days the neurons were transfected with the plasmids encoding Neuroligin-1-HA (provided by P. Scheiffele), PSD-95: EGFP (provided by S.
  • NB Neurobasal
  • B27 Gibco, 17504-044
  • L-Glutamine Glu200100, MidiMed
  • the neurons were transfected with plasmids encoding Neurexin-i-GFP (provided by M. Missler), N-cadherin-RFP (provided by RM Mege) or vectors for red fluorescent protein (RFP) (Qiagen).
  • Neurexin-i-GFP provided by M. Missler
  • N-cadherin-RFP provided by RM Mege
  • RFP red fluorescent protein
  • the neurons were stained with anti-HA rat antibody diluted 1: 400 in phosphate buffered saline (PBS) (Roche, 11867423001) followed by Alexa568 conjugated goat anti-rat antibody (Invitrogen A1 1077; 2 mg / ml) diluted 1: 800 in PBS for 30 min at 23 ° C.
  • PBS phosphate buffered saline
  • Alexa568 conjugated goat anti-rat antibody Invitrogen A1 1077; 2 mg / ml
  • the cells were fixed and permeabilized in 0.1% Triton X 100 (T9284, Sigma) in PBS for 5 min. Nonspecific binding was blocked with 1 ml of PBS containing 1% BSA.
  • the neurons were labeled with anti-PSD-95 mouse antibody (Neuromab 75-028, 1: 400) followed by Alexa568 fluorophore-conjugated goat anti-mouse antibodies (2 mg / ml dilution 1: 800, Invitrogen A1 1004).
  • actin filaments the cells were fixed and permeabilized in 0.1% Triton X 100 (T9284, Sigma) in PBS for 5 min. Nonspecific binding was blocked with 1 ml of PBS containing 1% BSA, and then the neurons were treated with phallicidin-Bodipy (trademark) FL (Molecular Probes, Invitrogen, B607) diluted 1: 100 in PBS.
  • Immunostaining was also performed with anti-synapsin mouse antibodies (Synaptic Systems 106001, 1: 400), or anti-SynCAM-1 rabbit antibodies (Novus NB 300-186, 1: 400) followed by antibodies. Fluorescent side effects for labeling synapsin or endogenous SynCAM-1 adhesion molecules according to the method described above.
  • Immunolabels were visualized on a Leica DM R-type right epifluorescence microscope (Leica Microsystems, Wetzlar, Germany) equipped with a 63x / 1, 32 NA objective and a Chroma Technology filter set (Bellows Falls, VT, USA) for EGFP: excitation: S490 / 20 nm, emission: S528 / 38 nm, dichroic: 86100bs; TRITC or RFP: excitation: S555 / 28 nm, emission: S617 / 73, dichroic: 101848; the Cy5: excitation: S635 / 20, emission: S685 / 40 nm, dichroic: 101848.
  • the images were acquired with a CCD camera (HQ Coolsnap, Roper Scientific, Evry, France), using the software Metamorph (Universal Imaging Corp. .)
  • the enrichment factors of Neuroligin-1 and PSD-95 were measured on 3 dendritic regions randomly selected on each neuron and were calculated using an automatic program written in the Metamorph (Universal Imaging Corp) software, and a procedure explained in Figure 5.
  • the RFP and N-cadherin-RFP enrichment factors were measured on 3 axonal regions randomly selected on each neuron and were calculated according to the procedure explained in Figure 5.
  • the observation chamber was placed on a confocal scanning laser microscope (TCS SP5, Leica) thermostated at 37 ° C and equipped with a bi-photon pulsed laser (Mai Tai Spectra-Physics) set at 750 nm.
  • TCS SP5, Leica confocal scanning laser microscope
  • a bi-photon pulsed laser Main Tai Spectra-Physics set at 750 nm.
  • an area of 100 x 100 m was scanned at 700 Hz by an Argon laser at 488 nm and the fluorescence was collected between 500 and 530 nm by a photomultiplier, using an HCX PL APO CS oil lens.
  • the fluorescence intensity values of fluo-4 at a given location were normalized to the average fluorescence intensity obtained before the bi-photon light pulse.
  • the hippocampal primary neurons (DIV7) cultured on neurexin-1 ⁇ -Fc covering the micro-motifs and expressing Nlgn-1 WT and PSD-95: EGFP were placed in an open chamber containing a 1: 1 mixture of a solution. of Tyrode and NB conditioned medium. The cells were then observed on a Leica 6000 DMI inverted microscope (Leica Microsystems, Wetzlar, Germany), equipped with a CCD camera (Coolsnap HQ2, Roper Scientific, Evry, France) and a thermostatic box (Life Imaging Services, Basel, Switzerland) providing 37 ° C and 5% CO 2 .
  • Transmembrane adhesion proteins, neurexins, and neuroligins are key players in synapse formation (Sudhof, TC Neuroligins and neurexins link synaptic function to cognitive disease, Nature 455, 903-1 1 (2008) [36]). These molecules form a link between the pre- and postsynaptic membranes by a high affinity recognition between their ectodomains (Craig, AM & Kang, Y. Neurexineuroligin signaling in synapse development, Curr Opin Neurobiol 17, 43-52 (2007). [41]).
  • neuroligin and neurexin When present on the surface of heterologous cells or microspheres, neuroligin and neurexin have the ability to generate pre- and post-synapses, respectively.
  • functional in contact with primary neurons (Graf, ER, Zhang, X., Jin, SX, Linhoff, MW & Craig, AM Neurexins induce differentiation of GABA and glutamate postsynaptic special izations via neuroligins Cell 1 19, 1013-26 (2004) [34], Heine, M., Thoumine, O., Mondin, M., Tessier, B., Giannone, G. & Choquet, D. Activity-independent and subunit-specific recruitment of functional AMPA receptors.
  • the present example via the use of the culture support of the invention has advantageously allowed to cultivate neuronal cells and a spatial control of the formation of synapses at a resolution micrometric, due to the adhesion properties of the synaptogenic neurexin / neuroligin complex ( Figures 1 and 2).
  • the rat hippocampal neuron culture on substrates with islets coated with purified neurexin was performed and the cells obtained are shown in Figures 3 and 4.
  • the islet substrates have a regular network of chemically activated islets (1, 5). ⁇ of diameter, separated by 5 ⁇ ), surrounded by a non-adhesive bottom.
  • the islets were coated with a recombinant neurexin-1 ⁇ fused with the constant fragment of human IgG, Fc ( ⁇ ⁇ -Fc), or pure Fc used as a control molecule.
  • the coupling was done via a secondary anti-Fc antibody labeled with the Cy5 fluorophore, advantageously allowing both the good orientation of the adhesive ectodomain and the visualization of the fluorescence of the micro-islets.
  • Dissociated hippocampal neurons were placed on these substrates and allowed their development for 7 to 10 days.
  • the neurons were transfected after 4 days with neuroligin-1 (Nlgn-1), or green fluorescent protein (EGFP) as a control.
  • neuroligin-1 Neuroligin-1
  • EGFP green fluorescent protein
  • Dendritic spine-like structures have been observed showing an accumulation of neuroligin-1 in the peripheral part of the filopodia attached to the micro-pattern coated with neurexin-1 ⁇ -Fc ( Figure 3c). Also, in order to better understand the dynamics of synapse formation, this system was combined with video microscopy to live imaging the fluorescence of PSD-95: EGFP.
  • One of the advantages of using the culture substrate of the invention comprising islets with respect to random observations of synapse formation is that the position where synapse formation is expected is controlled.
  • One point that is not yet clear in the literature is whether the Synapses are formed between the axonal filopodia contacting the dendrites, or between the dendritic filopodia contacting the axons.
  • This step is also a study of the function of the postsynaptic assemblies on the device of the invention covered with neurexin.
  • This example also relates to the study of the growth of neurites and the formation of pre-synapses by the neuronal cells in culture on the substrate of the invention.
  • the device of the invention allows via the use of different immobilized adhesion proteins at the islet level, the selective study of different synaptic systems, or proteins involved in the growth of axons and dendrites.
  • N-cadherin-Fc when N-cadherin-Fc was deposited, significant growth of neurites was observed in directions related to islet disposition, accompanied by adhesion and specific migration of growth cones. which was not the case for substrates coated with the control molecule Fc (FIG. 9).
  • cells transfected with N-cadherin-RFP, but not cells transfected with the RFP control protein showed local accumulation of N-cadherin-RFP on the N-cadherin-Fc coated islands ( Figure 10).
  • This example also relates to the study of axonal growth and the formation of pre-synapses by neuronal cells in culture using the device of the invention as well as the study of the formation of pre-synapses by the cells. neurons in contact with the substrate of the invention coated with Neuroligin-1 or SynCAM-1.
  • the device of the invention also makes it possible, via the use of different immobilized adhesion proteins at the level of the islets, the study selective of different synaptic systems, or proteins involved in the growth of axons and dendrites. For example, when the 6His-Neuroligin-1 molecule was deposited on the islets, significant growth of axons was observed in directions related to islet disposition, as well as accumulation of neurexin-GFP in the axons of the islets. transfected neurons ( Figure 1 1).
  • the device of the invention makes it possible to study the formation of synapses and synaptic function with a high production of statistical and reproducible data.
  • the device of the invention can be widely used with other synaptogenic molecules, such as neuroligins, for example to induce the formation of pre-synapses and / or with newly identified proteins such as LRRTMs and TrkCs (Sudhof , TC Neuroligins and neurexins link synaptic function to cognitive disease, Nature 455, 903-1 (2008) [36], Linhoff, MW, Lauren, J., Cassidy, RM, Dobie, FA, Takahashi, H., Nygaard. , HB, Airaksinen, MS, Slingermatter, SM & Craig, Neuron 61, Neuron 61,
  • the device of the invention can be used in processes in which molecules are screened to study their effect on synaptic differentiation. It also allows the detection of new therapeutic targets for pathologies such as autism, schizophrenia, and X-linked mental retardation in humans, pathologies in which mutations of the genes encoding neuroligins and neurexins appear to be involved (Jamain, S., Quach, H., Betancur, C., Rastam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C. & Bourgeron, T.
  • Cells and culture substrates are obtained according to the method described in Examples 1 and 2 above.
  • N-cadherin-Fc BD Transduction Laboratories (trademark), ref. 610921) are placed in the presence of peptides competing with cadherin interactions, for example containing the HAV sequences.
  • (1 mM) (Williams, EJ, Williams, G., Gour, B., Blaschuk, O. & Doherty, P. INP, a novel N-cadherin antagonist targeted to amino acids that flank the HAV motif.) Mol Cell Neurosci 15, 456-64 (2000) [49], Williams, E., Williams, G., Gour, BJ, Blaschuk, OW & Doherty, P.
  • a novel family of cyclic peptide antagonists suggests that N-cadherin specificity is determined. by amino acids that flank the HAV motif, J Biol Chem 275, 4007-12 (2000). [50]), adhesive protein fragments derived from cadherins, for example the EC1-EC2 domains (Perret, E., Benoliel, AM , Nassoy, P., Stones, A., Delmas, V., Thiery, JP, Bongrand, P. & Feracci, H. Fast dissociation kinetics between individual Ec adherin fragments revealed by flow chamber analysis. Embo J 21, 2537-46 (2002).
  • RNAi-based approach identified molecules required for glutamatergic and GABAergic synapse development Neuron 53, 217-32 (2007) [53]) or catenins (Bard, L., Boscher , C, Lambert, M., Mege, RM, Choquet, D. & Thoumine, O. A molecular clutch between the actin flow and N-cadherin adhesion drives growth cone migration J Neurosci 28, 5879-90 (2008). 25]) or mutated cadherin molecules (in the extracellular domains to prevent interactions with cadherin counter-receptors, or in intracellular domains to prevent binding with intracellular partners). The effect of these compounds on the development of neurites and synapses after 8 days of culture will be examined and quantified as explained in Figures 5 and 6.
  • the neuronal cells cultured on micro-patterned substrates coated with neurexin-1-Fc are placed in the presence of recombinant neurexin proteins (Scheiffele, P., Fan, J., Choih, J., Fetter, R Serafini, T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons Cell 101, 657-69 (2000) [35], Dean, C, Scholl, FG, Choih, J., DeMaria, S. , Berger, J., Isacoff, E. & Scheiffele, P.
  • neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons Cell 101, 657-69 (2000) [35], Dean, C, Scholl, FG, Choih, J., DeMaria, S., Berger, J., Isacoff, E. & Scheiffele, P.
  • SynCAM Synaptic adhesion molecule that drives synapse assembly
  • Peptides and proteins are used at concentrations 10 times greater than the dissociation constants of the targeted interactions, ie typically 1 ⁇ for cadherin interactions, 10 nM for neurexin / neuroligin interactions, and 5 ⁇ for intracellular level of pre- and post-synaptic scaffolds.
  • the siRNAs are used at concentrations of 0.5-2 g / carrier using the Lipofectamine 2000 transfection agent, as recommended by the supplier (Invitrogen).
  • peptides and proteins were used at concentrations 10 times higher than the dissociation constants of the targeted interactions, ie 100 nM for interactions between
  • the substrates are seeded with neurons derived from knockout mice for certain genes, for example, neurexins (Missler, M., Zhang, W., Rohlmann, A., Kattenstroth, G., Hammer, RE, Gottmann , K. & Sudhof, TC Alpha-neurexins couple
  • Neuroligins determines synapse maturation and function, Neuron 51, 741-54 (2006).
  • IgCAMs Kamiguchi, H., Hlavin, ML & Lemmon, V.
  • Cytoskeleton (Hoboken) (201 1). 20. von Philipsborn, A. C, Lang, S., Bernard, A., Loeschinger, J., David, C., Lehnert, D., Bastmeyer, M. & Bonhoeffer, F. Microcontact printing of axon guidance molecules for generation of graded patterns. Nat. Protoc, 1322-8 (2006).

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

The present invention relates to a device for culturing nerve cells on substrates, consisting of micrometric islands covered with neural cell adhesion molecules, on an evenly cytophobic base. Said system is coupled with a method for the qualitative and/or quantitative analysis of neurite growth and the synaptogenesis of said nerve cells. The invention further relates to a method for screening for compounds involved in said processes.

Description

DISPOSITIF DE CULTURE DE CELLULES NEURONALES ET  DEVICE FOR CULTURING NEURONAL CELLS AND

UTILISATIONS  USES

DESCRIPTION DESCRIPTION

Domaine technique Technical area

La présente invention se rapporte à un support (1 ) de culture de cellules neuronales, à l'utilisation de ce support pour la culture de cellules, dans des procédés de criblage et dans des méthodes d'analyse qualitatives et/ou quantitatives de la croissance neuronale et de la synaptogénèse. La présente invention a également pour objet un procédé de fabrication dudit support.  The present invention relates to a support (1) for culturing neuronal cells, to the use of this support for cell culture, in screening methods and in qualitative and / or quantitative methods of analyzing growth. neuronal and synaptogenesis. The present invention also relates to a method of manufacturing said support.

La présente invention trouve une application, notamment dans le domaine de la recherche et de la pharmacie.  The present invention finds application, particularly in the field of research and pharmacy.

Dans la description ci-dessous, les références entre crochets ([ ]) renvoient à la liste des références présentées à la fin du texte.  In the description below, references in brackets ([]) refer to the list of references at the end of the text.

Etat de la technique State of the art

Des procédés permettant de cultiver des cellules vivantes sur des substrats avec micro-motifs sont pas nouveaux. Par un contrôle géométrique précis des zones adhésives déterminant les possibilités d'extension cellulaires, plusieurs études ont révélé que la forme des cellules en culture affecte considérablement la prolifération, la différenciation et la polarité cellulaires (Folkman, J. & Moscona, A. Rôle of cell shape in growth control. Nature 273, 345-9 (1978). [1 ] Watt, F. M., Methods for culturing living cells on substrates with micro-motifs are not new. By precise geometric control of the adhesive zones determining the possibilities of cell extension, several studies have revealed that the shape of cells in culture considerably affects cellular proliferation, differentiation and polarity (Folkman, J. & Moscona, A. Rôle of cell shape in growth control Nature 273, 345-9 (1978) [1] Watt, FM,

Jordan, P. W. & O'Neill, C. H. Cell shape controls terminal differentiation of human epidermal keratinocytes. Proc Natl Acad Sci U S A 85, 5576-80 (1988). [2] Thery, M., Racine, V., Pépin, A., Piel, M., Chen, Y., Sibarita, J. B. & Bornens, M. The extracellular matrix guides the orientation of the cell division axis. Nat Cell Biol 7, 947-53 (2005). [3] Thery, M., Racine, V., Piel,Jordan, P.W. & O'Neill, C.H. Cell shape controls terminal differentiation of human epidermal keratinocytes. Proc Natl Acad Sci U S A 85, 5576-80 (1988). [2] Thery, M., Racine, V., Pepin, A., Piel, M., Chen, Y., Sibarita, J. B. & Bornens, M. The extracellular matrix guides the orientation of the cell division axis. Nat Cell Biol 7, 947-53 (2005). [3] Thery, M., Racine, V., Piel,

M., Pépin, A., Dimitrov, A., Chen, Y., Sibarita, J. B. & Bornens, M. Anisotropy of cell adhesive microenvironment governs cell internai organization and orientation of polarity. Proc Natl Acad Sci U S A 103, 19771 -6 (2006).[4]). M., Pepin, A., Dimitrov, A., Chen, Y., Sibarita, JB & Bornens, M. Anisotropy of cell adhesive microenvironment governs the internai organization and orientation of polarity. Proc Natl Acad Sci USA 103, 19771 -6 (2006) [4]).

L'approche générale consiste à délimiter des zones adhésives dans un environnement recouvert d'un agent anti-adhésif (cytotophobe), sur lequel la cellule ne peut pas adhérer, confinant ainsi l'extension cellulaire. Un des premiers procédés décrits concerne un dispositif comprenant des îlots adhésifs circulaires de 400 à 2000 μιτι2 de diamètre réalisés par évaporation de palladium à travers un masque sur une surface sous- jacente non-adhésive (Ireland, G. W., Dopping-Hepenstal, P. J., Jordan, P. W. & O'Neill, C. H. Limitation of substratum size alters cytoskeletal organization and behaviour of Swiss 3T3 fibroblasts. Cell Biol Int Rep 13, 781 -90 (1989). [5]). Des techniques actuelles plus simples, par exemple des méthodes d'impression à jet d'encre, consistent à déposer des gouttelettes microscopiques d'adhésif de type polylysine sur un substrat non-adhésif comme un revêtement de polyéthylène glycol, mais la résolution est faible, i.e. de l'ordre de 100-200 μιτι (Sanjana, N. E. & Fuller, S. B. A fast flexible ink-jet printing method for patterning dissociated neurons in culture. J Neurosci Methods 136, 151 -63 (2004). [6] Yamagata, M., Weiner, J. A., Dulac, C, Roth, K. A. & Sanes, J. R. Labeled lines in the retinotectal System: markers for retinorecipient sublaminae and the retinal ganglion cell subsets that innervate them. Mol Cell Neurosci 33, 296-310 (2006). [7]). The general approach is to delineate adhesive areas in an environment covered with a release agent (cytotropic), on which the cell can not adhere, thus confining cell extension. One of the first methods described relates to a device comprising circular adhesive islands 400 to 2000 μιτι 2 in diameter made by evaporation of palladium through a mask on an underlying non-adhesive surface (Ireland, GW, Dopping-Hepenstal, PJ, Jordan, PW &O'Neill, CH Limitation of Substrate Size Cytoskeletal Organisms and Behavior of Swiss 3T3 Fibroblasts Cell Biol Int Rep 13, 781-90 (1989) [5]). Current simpler techniques, such as inkjet printing methods, include depositing microscopic droplets of polylysine-type adhesive onto a non-adhesive substrate such as a polyethylene glycol coating, but the resolution is low, ie of the order of 100-200 μιτι (Sanjana, NE & Fuller, SB A fast flexible ink-jet printing method for neurons in culture dissociated patterning J Neurosci Methods 136, 151 -63 (2004). [6] Yamagata, M., Weiner, JA, Dulac, C, Roth, KA & Sanes, JR Labeled lines in the retinotectal System: markers for retinorecipient sublaminae and the retinal ganglion cell subsets that innervate them Mol Cell Neurosci 33, 296-310 (2006) [7]).

Pour définir des micro-structures plus petites, l'impression par microcontact de monocouches auto-assemblées d'alkanethiolates sur un substrat métallique, a été utilisée (Chen, C. S., Mrksich, M., Huang, S., Whitesides, G. M. & Ingber, D. E. Micropatterned surfaces for control of cell shape, position, and function. Biotechnol Prog 14, 356-63 (1998). [8]). D'autres solutions micro-lithographiques permettant l'impression de protéines d'adhésion sur des lamelles en verre silanisées ont été développées, utilisant des tampons en élastomère micro-fabriqués à partir d'un masque de chrome (Rozkiewicz, D. I., Kraan, Y., Werten, M. W., de Wolf, F. A., Subramaniam, V., Ravoo, B. J. & Reinhoudt, D. N. Covalent microcontact printing of proteins for cell patterning. Chemistry 12, 6290-7 (2006). [9], Shi, P., Shen, K. & Kam, L. C. Local présentation of L1 and N- cadherin in multicomponent, microscale patterns differentially direct neuron function in vitro. Dev Neurobiol 67 , 1765-76 (2007). [10], Ladoux, B., Anon, E., Lambert, M., Rabodzey, A., Hersen, P., Buguin, A., Silberzan, P. & Mege, R. M. Strength dependence of cadherin-mediated adhésions. Biophys J 98, 534-42 (2010). [1 1 ]), ou une impression directe du substrat de verre ou de PDMS par rayons UV profonds passant à travers un masque en chrome (Azioune, A., Carpi, N., Tseng, Q., Thery, M. & Piel, M. Protein micropatterns: A direct printing protocol using deep UVs. Methods Cell Biol 97, 133-46 (2010). [12], Azioune, A., Carpi, N., Fink, J., Chehimi, M. M., Cuvelier, D. & Piel, M. Robust method for high-throughput surface patterning of deformable substrates. Langmuir 27, 7349-52 (2010). [13]). Une autre technique mise en œuvre récemment consiste à réaliser un couplage covalent de protéines d'adhésion directement sur une surface via un agent chimique réticulant, activé par un faisceau UV (Fink, J., Thery, M., Azioune, A., Dupont, R., Châtelain, F., Bornens, M. & Piel, M. Comparative study and improvement of current cell micro-patterning techniques. Lab Chip 7, 672-80 (2007). [14]). Une approche très récente appelée micro-photo-impression, utilisant un laser bi-photon commandé par ordinateur permettant de réaliser la photo-ablation à l'échelle micrométrique d'un film anti-adhésif de poly-vinyl-alcool, a été envisagée (Doyle, A. D., Wang, F. W., Matsumoto, K. & Yamada, K. M. One- dimensional topography underlies three-dimensional fibrillar cell migration. J Cell Biol 184, 481 -90 (2009). [15]) afin de réaliser de nombreuses géométries différentes. Toutefois, ces méthodes sont difficiles à mettre en œuvre, et impliquent une expertise qui limite souvent leur utilisation à un nombre réduit de laboratoires de recherche fondamentale. To define smaller microstructures, microcontact printing of self-assembled alkanethiolate monolayers on a metal substrate was used (Chen, CS, Mrksich, M., Huang, S., Whitesides, GM & Ingber). , DE Micropatterned surfaces for control of cell shape, position, and function, Biotechnol Prog 14, 356-63 (1998) [8]). Other micro-lithographic solutions allowing the printing of adhesion proteins on silanized glass coverslips have been developed, using micro-manufactured elastomeric pads from a chrome mask (Rozkiewicz, DI, Kraan, Y., Werten, MW, Wolf, FA, Subramaniam, V., Ravoo, BJ & Reinhoudt, DN Covalent microcontact printing of proteins for cell patterning Chemistry 12, 6290-7 (2006). [9], Shi, P., Shen, K. & Kam, LC Local presentation of L1 and N-cadherin in multicomponent, microscale patterns differentially direct neuron function in vitro Dev Neurobiol 67, 1765-76 (2007) [10], Ladoux, B., Anon, E., Lambert, M., Rabodzey, A., Hersen, P., Buguin, A., Silberzan, P. & Mege, RM Strength dependence of cadherin-mediated adhesions Biophys J 98, 534-42 (2010). [1 1]), or a direct printing of the glass substrate or PDMS by deep UV rays going to through a chromium mask (Azioune, A., Carpi, N., Tseng, Q., Thery, M. & Piel, M. Protein micropatterns: A direct printing protocol using deep UVs., Cell Biol 97, 133-46 ( 2010). [12], Azioune, A., Carpi, N., Fink, J ., Chehimi, MM, Cuvelier, D. & Piel, M. Robust method for high-throughput surface patterning of deformable substrates. Langmuir 27, 7349-52 (2010). [13]). Another recently implemented technique consists in carrying out a covalent coupling of adhesion proteins directly on a surface via a UV-activated crosslinking chemical agent (Fink, J., Thery, M., Azioune, A., Dupont , R., Chatelain, F., Bornens, M. & Piel, M. Comparative study and improvement of current cell micro-patterning techniques, Lab Chip 7, 672-80 (2007) [14]). A very recent approach called micro-photo-printing, using a computer-controlled bi-photon laser to perform micrometric photo-ablation of a poly-vinyl-alcohol release film, was considered ( Doyle, AD, Wang, FW, Matsumoto, K. & Yamada, KM One-dimensional topography underlies three-dimensional fibrillar cell migration J Cell Biol 184, 481-90 (2009). [15]) to achieve many geometries different. However, these methods are difficult to implement, and involve expertise that often limits their use to a small number of basic research laboratories.

Dans le domaine de la neurobiologie cellulaire, des îlots adhésifs assez étendus (50-100 μιτι) ont été utilisés afin d'isoler individuellement les neurones primaires en culture et de générer des synapses formées par le neurone sur lui-même (autapses) (Allen, T. G. Préparation and maintenance of single-cell micro-island cultures of basai forebrain neurons. Nat Protoc , 2543-50 (2006). [16], Wilson, N. R., Ty, M. T., Ingber, D. E., Sur, M. & Liu, G. Synaptic reorganization in scaled networks of controlled size. J Neurosci 27, 13581 -9 (2007). [17]). Des systèmes micro-structurés comprenant des lignes adhésives parallèles séparées par des rainures non-adhésives ont aussi été utilisées pour susciter la croissance directionnelle des axones (Yamagata, M., Weiner, J. A., Dulac, C, Roth, K. A. & Sanes, J. R. Labeled lines in the retinotectal System: markers for retinorecipient sublaminae and the retinal ganglion cell subsets that innervate them. Mol Cell Neurosci 33, 296-310 (2006). [7], Wilson, N. R., Ty, M. T., Ingber, D. E., Sur, M. & Liu, G. Synaptic reorganization in scaled networks of controlled size. J Neurosci 27, 13581 -9 (2007). [17], Ruardij, T. G., Goedbloed, M. H. & Rutten, W. L. Adhésion and patterning of cortical neurons on polyethylenimine- and fluorocarbon-coated surfaces. IEEE Trans Biomed Eng 47, 1593-9 (2000). [18]). Un article récent a utilisé une technique d'impression par micro-contact à base d'un microscope à force atomique pour créer des zones adhésives de 7-10 μιτι espacés de 10-20 m et déposer des protéines de la matrice extracellulaire (fibronectine ou laminine) permettant de contrôler de façon différentielle la croissance des neurones (Fereol, S., Fodil, R., Barnat, M., Georget, V., Milbreta, U. & Nothias, F. Micropatterned ECM substrates reveal complementary contribution of low and high affinity ligands to neurite outgrowth. Cytoskeleton (Hoboken) (201 1 ). [19]). Un autre groupe a utilisé la méthode de micro-impression par contact pour réaliser des îlots rectangulaires de 2- 5 μηη séparés de 5-10 μητι, et a déposé des protéines neuronales ephrines impliquées dans le guidage axonal et la réorientation du cône de croissance ( von Philipsborn, A. C, Lang, S., Bernard, A., Loeschinger, J., David, C, Lehnert, D., Bastmeyer, M. & Bonhoeffer, F. Microcontact printing of axon guidance molécules for génération of graded patterns. Nat Protoc 1 , 1322-8 (2006). [20], von Philipsborn, A. C, Lang, S., Loeschinger, J., Bernard, A., David, C, Lehnert, D., Bonhoeffer, F. & Bastmeyer, M. Growth cone navigation in substrate-bound ephrin gradients. Development 133, 2487-95 (2006). [21 ]). In the field of cellular neurobiology, fairly large adhesive islands (50-100 μιτι) were used to individually isolate primary neurons in culture and to generate synapses formed by the neuron on itself (autapses) (Allen , TG Preparation and maintenance of single-cell micro-island cultures of basal forebrain neurons Nat Protoc, 2543-50 (2006). [16], Wilson, NR, Ty, MT, Ingber, DE, On, M. & Liu , G. Synaptic Reorganization in Scaled Networks of Controlled J Neurosci 27, 13581-9 (2007) [17]). Micro-structured systems comprising parallel adhesive lines separated by non-adhesive grooves have also been used to promote directional growth of axons (Yamagata, M., Weiner, JA, Dulac, C., Roth, KA & Sanes, JR Labeled). in the retinotectal system: markers for retinorecipient sublaminae and the retinal ganglion cell subsets that innervate them Mol Cell Neurosci 33, 296-310 (2006). [7], Wilson, NR, Ty, MT, Ingber, DE, On, M. & Liu, G. Synaptic Reorganization in Scaled Networks of Controlled J Neurosci 27, 13581 -9 (2007). [17], Ruardij, TG, Goedbloed, MH & Rutten, WL Adhesion and Patterning of Cortical Neurons on Polyethylenimine and fluorocarbon-coated surfaces IEEE Trans Biomed Eng 47, 1593-9 (2000) [18]). A recent article has used a micro-contact printing technique based on an atomic force microscope to create adhesive zones of 7-10 μιτι spaced 10-20 m apart and to deposit proteins from the extracellular matrix (fibronectin or laminin) for differentially controlling the growth of neurons (Fereol, S., Fodil, R., Barnat, M., Georget, V., Milbreta, U. & Nothias, F. Micropatterned ECM substrates reveal complementary contribution of low and high affinity ligands to neurite outgrowth Cytoskeleton (Hoboken) (201 1) [19]). Another group used the micro-contact printing method to make rectangular islands of 2- 5 μηη separated by 5-10 μητι, and deposited ephrin neuronal proteins involved in axon guidance and reorientation of the growth cone (von Philipsborn, A. C, Lang, S., Bernard, A., Loeschinger, J. , David, C., Lehnert, D., Bastmeyer, M. & Bonhoeffer, F. Microcontact printing of axon guidance molecules for generation of graded patterns Nat Protoc 1, 1322-8 (2006). [20], von Philipsborn, A C, Lang, S., Loeschinger, J., Bernard, A., David, C., Lehnert, D., Bonhoeffer, F. & Bastmeyer, M. Growth cone navigation in substrate-bound ephrin gradients, Development 133, 2487 -95 (2006) [21]).

D'autres approches ont également été utilisées, des dispositifs micro fluidiques associés à un substrat de culture permettant de séparer deux populations de neurones différents, de diriger la croissance axonale suivant des lignes pré-déterminées et d'établir des contacts synaptiques entre les deux types de neurones (Taylor, A. M., Blurton-Jones, M., Rhee, S. W., Cribbs, D. H., Cotman, C. W. & Jeon, N. L. A microfluidic culture platform for CNS axonal injury, régénération and transport. Nat Methods 2, 599-605 (2005). [22], Paul, D., Saias, L., Pedinotti, J. C, Chabert, M., Magnifico, S., Pallandre, A., De Lambert, B., Houdayer, C, Brugg, B., Peyrin, J. M. & Viovy, J. L. A "dry and wet hybrid" lithography technique for multilevel replication templates: Applications to microfluidic neuron culture and two-phase global mixing. Biomicrofluidics 5, 24102 (201 1 ). [23]). Ce système est commercialisé par la compagnie Millipore (AXIS device, réf. AX15010). Une amélioration de ce système initial avec un canal micro- fluidique perpendiculaire central permet des stimulations avec des agents chimiques susceptibles d'engendrer une réponse physiologique des neurones (Taylor, A. M. & Jeon, N. L. Micro-scale and microfluidic devices for neurobiology. Curr Opin Neurobiol 20, 640-7 (2010). [24]).  Other approaches have also been used, micro fluidic devices associated with a culture substrate for separating two populations of different neurons, directing axonal growth along pre-determined lines and establishing synaptic contacts between the two types. of neurons (Taylor, AM, Blurton-Jones, M., Rhee, SW, Cribbs, DH, Cotman, CW & Jeon, NL A microfluidic culture platform for CNS axonal injury, regeneration and transport, Nat Methods 2, 599-605 ( 2005). [22], Paul, D., Saias, L., Pedinotti, J. C, Chabert, M., Magnifico, S., Pallandre, A., De Lambert, B., Houdayer, C, Brugg, B., Peyrin, JM & Viovy, JL A "dry and wet hybrid" lithography technique for multilevel replication templates: Biomicrofluidics 5, 24102 (201 1) [23]). This system is marketed by the company Millipore (AXIS device, ref AX15010). An improvement of this initial system with a central perpendicular microfluidic channel allows stimulations with chemical agents capable of generating a physiological response of the neurons (Taylor, AM & Jeon, NL Micro-scale and microfluidic devices for neurobiology.) Curr Opin Neurobiol 20, 640-7 (2010). [24]).

Toutefois, ces procédés sont délicats à mettre en œuvre et ne permettent pas de créer des contacts adhésifs localisés dans l'espace induits par des protéines d'adhérence spécifiquement neuronales, par exemple les molécules d'adhérence de type immunoglobulines (IgCAM) et la N-cadhérine qui jouent un rôle critique dans la migration du cône de croissance et le guidage axonal (Bard, L, Boscher, C, Lambert, M., Mege, R. M., Choquet, D. & Thoumine, O. A molecular clutch between the actin flow and N-cadherin adhésions drives growth cone migration. J Neurosci 28, 5879-90 (2008). [25], Falk, J., Thoumine, O., Dequidt, C, Choquet, D. & Faivre-Sarrailh, C. NrCAM coupling to the cytoskeleton dépends on multiple protein domains and partitioning into lipid rafts. Mol Biol Cell 15, 4695-709 (2004). [26]). Ceci est une limitation d'autant plus forte en ce qui concerne l'étude de la formation de contacts spécialisés permettant la communication entre neurones, les « synapses », ce qui constitue une question fondamentale de neurobiologie. La synaptogénèse est un processus complexe et multi-étapes au niveau des contacts axone/dendrite, initié par des protéines d'adhésion et suivi par le recrutement de molécules d'échafaudage et de récepteurs canaux fonctionnels (Bresler, T., Ramati, Y., Zamorano, P. L., Zhai, R., Garner, C. C. & Ziv, N. E. The dynamics of SAP90/PSD-95 recruitment to new synaptic junctions. Mol Cell Neurosci 18, 149-67 (2001 ). [27], Bresler, T., Shapira, M., Boeckers, T., Dresbach, T., Futter, M., Garner, C. C, Rosenblum, K., Gundelfinger, E. D. & Ziv, N. E. Postsynaptic density assembly is fundamentally différent from presynaptic active zone assembly. J Neurosci 24, 1507-20 (2004). [28], Friedman, H. V., Bresler, T., Garner, C. C. & Ziv, N. E. Assembly of new individual excitatory synapses: time course and temporal order of synaptic molécule recruitment. Neuron 27, 57-69 (2000). [29], Zito, K., Scheuss, V., Knott, G., Hill, T. & Svoboda, K. Rapid functional maturation of nascent dendritic spines. Neuron 61 , 247-58 (2009). [30]). Des études récentes ont notamment montré que le complexe d'adhérence neurexine/neuroligine ainsi que les protéines LRRTMs jouaient un rôle dans l'assemblage synaptique (Gerrow, K., Romorini, S., Nabi, S. M., Colicos, M. A., Sala, C. & El-Husseini, A. A preformed complex of postsynaptic proteins is involved in excitatory synapse development. Neuron 49, 547-62 (2006). [31 ], Graf, E. R., Kang, Y., Hauner, A. M. & Craig, A. M. Structure function and splice site analysis of the synaptogenic activity of the neurexin-1 beta LNS domain. J Neurosci 26, 4256-65 (2006). [32], Graf, E. R., Zhang, X., Jin, S. X., Linhoff, M. W. & Craig, A. M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 1 19, 1013- 26 (2004). [33], Heine, M., Thoumine, O., Mondin, M., Tessier, B., Giannone, G. & Choquet, D. Activity-independent and subunit-specific recruitment of functional AMPA receptors at neurexin/neuroligin contacts. Proc Natl Acad Sci U S A 105, 20947-52 (2008). [34], Scheiffele, P., Fan, J., Choih, J., Fetter, R. & Serafini, T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101 , 657- 69. (2000). [35], Sudhof, T. C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903-1 1 (2008). [36], Ko, J., Zhang, C, Arac, D., Boucard, A. A., Brunger, A. T. & Sudhof, T. C. Neuroligin-1 performs neurexin-dependent and neurexin-independent functions in synapse validation. Embo J 28, 3244-55 (2009). [37]) Linhoff, M. W., Lauren, J., Cassidy, R. M., Dobie, F. A., Takahashi, H., Nygaard, H. B., Airaksinen, M. S., Strittmatter, S. M. & Craig, A. M. An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron 61 , 734-49 (2009). [38], Ko, J., Fuccillo, M. V., Malenka, R. C. & Sudhof, T. C. LRRTM2 Functions as a Neurexin Ligand in Promoting Excitatory Synapse Formation. Neuron 64, 791 -798 (2009). [39], de Wit, J., Sylwestrak, E., O'Sullivan, M., Otto, S., Tiglio, K., Savas, J. N., Yates, J. R., Comoletti, D., Taylor, P. & Ghosh, A. LRRTM2 Interacts with Neurexin 1 and Régulâtes Excitatory SynapseHowever, these methods are difficult to implement and do not make it possible to create localized adhesive contacts induced by specifically neuronal adhesion proteins, for example immunoglobulin-like adhesion molecules (IgCAM) and N-cadherin, which plays a critical role in growth cone migration and axon guidance (Bard, L, Boscher, C, Lambert, M., Mege, RM, Choquet, D. & Thoumine, O. A molecular clutch between the actin flow and N-cadherin adhesion drives growth cone migration.J Neurosci 28, 5879-90 (2008). [25], Falk, J., Thoumine, O., Dequidt, C, Choquet, D. & Faivre- Sarrailh, C. NrCAM coupling to the cytoskeleton is dependent on multiple protein domains and partitioning into lipid rafts, Mol Biol Cell 15, 4695-709 (2004) [26]). This is a limitation all the stronger as regards the study of the formation of specialized contacts allowing the communication between neurons, the "synapses", which constitutes a fundamental question of neurobiology. Synaptogenesis is a complex and multi-stage process at the level of axon / dendrite contacts, initiated by adhesion proteins and followed by recruitment of scaffold molecules and functional channel receptors (Bresler, T., Ramati, Y. , Zamorano, PL, Zhai, R., Garner, CC & Ziv, NE The Dynamics of SAP90 / PSD-95 Recruitment to New Synaptic Junctions Mol Cell Neurosci 18, 149-67 (2001). [27], Bresler, T. ., Shapira, M., Boeckers, T., Dresbach, T., Futter, M., Garner, C., Rosenblum, K., Gundelfinger, ED & Ziv, NE Postsynaptic density assembly is fundamentally different from presynaptic active zone J Neurosci 24, 1507-20 (2004). [28], Friedman, HV, Bresler, T., Garner, CC & Ziv, NE Assembly of new individual excitatory synapses: time course and temporal order of synaptic molecule recruitment. Neuron 27, 57-69 (2000) [29], Zito, K., Scheuss, V., Knott, G., Hill, T. & Svoboda, K. Rapid functional maturation of nascent dendritic spines Neuron 61, 247 -58 (2009) [30]). Recent studies have shown that the neurexin / neuroligin adhesion complex and the LRRTM proteins play a role in synaptic assembly (Gerrow, K., Romorini, S., Nabi, SM, Colicos, MA, Sala, C & El-Husseini, A. Neuron 49, 547-62 (2006). [31], Graf, A preformed complex of postsynaptic proteins is involved in excitatory synapse development. ER, Kang, Y., Hauner, AM & Craig, AM Functional and structural analysis of the synaptogenic activity of the neurexin-1 beta LNS domain. J Neurosci 26, 4256-65 (2006). [32], Graf, ER, Zhang, X., Jin, SX, Linhoff, MW & Craig, AM Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 19, 1013-26 (2004). [33], Heine, M., Thoumine, O., Mondin, M., Tessier, B., Giannone, G. & Choquet, D. Activity-independent and subunit-specific recruitment of functional AMPA receptors at neurexin / neuroligin contacts . Proc Natl Acad Sci USA 105, 20947-52 (2008). [34], Scheiffele, P., Fan, J., Choih, J., Fetter, R. & Serafini, T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101, 657-69 (2000). [35], Sudhof, TC Neuroligins and Neural Link Synaptic Function to Cognitive Disease. Nature 455, 903-1 (2008). [36], Ko, J., Zhang, C, Arac, D., Boucard, AA, Brunger, AT & Sudhof, TC Neuroligin-1 performs neurexin-dependent and neurexin-independent functions in synapse validation. Embo J 28, 3244-55 (2009). [37]) Linhoff, MW, Lauren, J., Cassidy, RM, Dobie, FA, Takahashi, H., Nygaard, HB, Airaksinen, MS, Strittmatter, SM & Craig, AM An unbiased expression screen for synaptogenic proteins identified LRRTM protein family as synaptic organizers. Neuron 61, 734-49 (2009). [38], Ko, J., Fuccillo, MV, Malenka, RC & Sudhof, TC LRRTM2 Functions as a Neurexin Ligand in Promoting Excitatory Synapse Training. Neuron 64, 791-798 (2009). [39], Wit, J., Sylwestrak, E., O'Sullivan, M., Otto, S., Tiglio, K., Savas, JN, Yates, JR, Comoletti, D., Taylor, P. & Ghosh, A. LRRTM2 Interacts with Neurexin 1 and Regulatory Excitatory Synapse

Formation. Neuron 64, 799-806 (2009). [40]). Training. Neuron 64, 799-806 (2009). [40]).

En outre, ces études ainsi que d'autres études utilisant notamment des systèmes de co-cultures entre neurones primaires et cellules hetérologues exprimant des protéines d'adhérence neuronales, ainsi que la sur- expression ou la sous-expression de ces protéines dans les neurones, ont montré que les complexes d'adhérence héterophiles neurexine/neuroligine et neurexine/LRRTMs, ainsi que les complexes d'adhérence homophiles entre molécules synCAMs jouaient un rôle important dans l'assemblage synaptique (Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D., Liu, X., Kavalali, E. T., Sudhof, T. C. SynCAM, a synaptic adhésion molécule that drives synapse assembly, Science 297 1525-31 (2002) [68]; Sara, Y., Biederer, T., Atasoy, D., Chubykin, A., Mozhayeva, M. G., Sudhof, T. C, Kavalali, E. T. Sélective capability of SynCAM and neuroligin for functional synapse assembly. J Neuroscience 25 260-270 (2005) [69]. In addition, these and other studies using co-culture systems between primary neurons and heterologous cells expressing neuronal adhesion proteins as well as over-expression or under-expression of these proteins in neurons , have shown that neuroexin / neuroligin heterophilic adhesion and neurexin / LRRTMs, as well as homophilic adhesion complexes between synCAMs played an important role in synaptic assembly (Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D., Liu, X. , Kavalali, ET, Sudhof, TC SynCAM, synaptic adhesion molecule that drives synapse assembly, Science 297 1525-31 (2002) [68]; Sara, Y., Biederer, T., Atasoy, D., Chubykin, A. , Mozhayeva, MG, Sudhof, T. C, Kavalali, and Selective Capability of SynCAM and neuroligin for functional synapse assembly, J Neuroscience 25 260-270 (2005) [69].

Toutefois, s'ils permettent d'identifier les molécules synaptogènes importantes, ces systèmes de co-cultures ne permettent pas un contrôle spatial précis de la formation des synapses.  However, if they make it possible to identify the important synaptogenic molecules, these co-culture systems do not allow a precise spatial control of the formation of synapses.

Par ailleurs, une technique utilisant des cellules non-neuronales exprimant la neuroligine-1 isolées dans des micro-puits a été utilisée pour stimuler la différentiation pré-synaptique dans des axones formant des contacts avec elles (Shi, P., Scott M.A., Ghosh B., Wan D., Wissner-Gross Z., Mazitschek R., Haggarty S.J., Fatih M. Synapse microarray identification of small molécules that enhance synaptogenesis. Nat Commun 2, 510 (201 1 ) [70]), mais ces micro-puits ont des diamètres de 30 μιτι, loin de la taille physiologique de synapses réelles, de l'ordre de 1 μιτι, et les hémi-synapses se forment toujours de façon aléatoire à l'intérieur de ces puits.  Furthermore, a technique using non-neuronal neuroligin-1-expressing cells isolated in micro-wells was used to stimulate pre-synaptic differentiation in contact-forming axons (Shi, P., Scott MA, Ghosh B., Wan D., Wissner-Gross Z., Mazitschek R., Haggarty SJ, Fatih M. Synapse microarray identification of small molecules that enhance synaptogenesis Nat Nat 2, 510 (201 1) [70]), but these micro -wells have diameters of 30 μιτι, far from the physiological size of real synapses, of the order of 1 μιτι, and the hemi-synapses are always randomly formed inside these wells.

Du fait que les contacts spontanés entre neurones se forment d'une manière très imprévisible dans le temps et l'espace, et impliquent de nombreuses molécules d'adhésion dans des quantités stœchiométriques inconnues, l'étude de la synaptogénèse est une tache difficile. Ces limitations nécessitent le développement de nouveaux systèmes permettant une induction robuste, ciblée et sélective de la formation des synapses, accompagnée d'une importante production de données statistiques. La culture de neurones sur des substrats micro-structurés recouverts de molécules d'adhésion neuronales permettrait de répondre à l'ensemble de ces questions. Toutefois, une difficulté est que les neurones, cellules fortement polarisés par nature, peuvent avoir des réactions très diverses à des schémas de polarisation, en fonction de la géométrie des zones d'adhérence et de non-adhérence ainsi qu'en fonction des molécules utilisées pour l'adhérence et la non-adhérence. Par exemple, les neurones peuvent ne pas se différencier correctement en réponse à de fortes limitations géométriques imposées par le micro-environnement adhésif, en n'étant pas capables d'étendre leur arborisation d'axones et de dendrites. D'où la nécessité de trouver les conditions de géométrie et de revêtement optimales pour cultiver des neurones primaires sur ces substrats, en essayant de rester le plus proche possible de leur environnement physiologique. Because spontaneous neuronal contacts are formed in a very unpredictable way in time and space, and involve many adhesion molecules in unknown stoichiometric quantities, the study of synaptogenesis is a difficult task. These limitations require the development of new systems that allow robust, targeted and selective induction of synapse formation, accompanied by significant statistical data production. The culturing of neurons on micro-structured substrates covered with neuronal adhesion molecules could answer all these questions. However, one difficulty is that neurons, strongly polarized cells by nature, can have very different reactions to polarization patterns, depending on the geometry of the zones of adhesion and non-adhesion as well as depending on the molecules used. for adhesion and non-adhesion. For example, neurons may not differentiate properly in response to strong geometric limitations imposed by the adhesive microenvironment, not being able to extend their arborization of axons and dendrites. Hence the need to find the optimal geometry and coating conditions to grow primary neurons on these substrates, trying to stay as close as possible to their physiological environment.

Il existe donc un réel besoin de trouver un dispositif, un procédé palliant ces défauts, inconvénients et obstacles de l'art antérieur, en particulier un dispositif permettant de cultiver les cellules neuronales tout en conservant l'ensemble de leurs propriétés, un dispositif permettant de cultiver les cellules neuronales par exemple pour analyser les propriétés physiologiques des cellules neuronales, notamment leur développement axonal et dendritique ainsi que la formation de synapses, et de tester l'effet de composés sur ces processus. En outre, il existe un réel besoin de trouver un dispositif simple, pouvant être facilement mis en œuvre et permettant ainsi de réduire les coûts et d'améliorer la culture des cellules neuronales et leurs utilisations. Description de l'invention  There is therefore a real need to find a device, a method to overcome these defects, disadvantages and obstacles of the prior art, in particular a device for culturing neuronal cells while retaining all of their properties, a device for For example, neuronal cells can be cultured to analyze the physiological properties of neuronal cells, including their axonal and dendritic development as well as the formation of synapses, and to test the effect of compounds on these processes. In addition, there is a real need to find a simple device that can be easily implemented and thus reducing costs and improve the culture of neuronal cells and their uses. Description of the invention

La présente invention a précisément pour but de répondre à ces besoins en fournissant un support (1 ) de culture de cellules neuronales (c) comprenant un substrat (3) sur une surface (5) duquel sont disposés des îlots (7) de protéines d'adhésion desdites cellules neuronales, lesdits îlots (7) ayant un diamètre de 100 nm à 3 microns et étant espacés entre eux de 1 à 10 microns. La présente invention se rapporte également à l'utilisation du support (1 ) pour la culture de cellules neuronales, dans une méthode d'analyse quantitative et/ou qualitative de cellules neuronales et dans une méthode de criblage. The present invention is specifically intended to meet these needs by providing a support (1) for culturing neuronal cells (c) comprising a substrate (3) on a surface (5) of which islet islands (7) of adhesion of said neuronal cells, said islands (7) having a diameter of 100 nm to 3 microns and being spaced between them from 1 to 10 microns. The present invention also relates to the use of the support (1) for culturing neuronal cells, in a method of quantitative and / or qualitative analysis of neuronal cells and in a screening method.

Dans la présente par cellules neuronales (c) on entend toutes cellules issues du système nerveux d'un mammifère, oiseau, batracien, ou mollusque, et/ou toute cellule issue d'une lignée cellulaire neuronale. Il peut s'agir par exemple de cellules neuronales isolées du système nerveux, par exemple de cerveau ou moelle épinière, de rongeurs par exemple de rats ou souris, de poulets, de batraciens, par exemple de Xénope, de mollusques tels l'Aplysie, aux stades embryonnaires ou nouveau-nés, pouvant être situés dans l'hippocampe, le cortex, le striatum, les ganglions de la racine dorsale (DRG). Il peut également s'agir de cellules choisies parmi la lignée neuroblastome SH-SY5Y, la lignée PC12, la lignée de cellules neuronales corticales (HCN-1 ), ou la lignée de neuroblastomes B104.  In the present invention, neuronal cells (c) are understood to mean any cells originating from the nervous system of a mammal, bird, batrachian, or mollusc, and / or any cell derived from a neuronal cell line. It may be, for example, neuronal cells isolated from the nervous system, for example from the brain or spinal cord, rodents, for example from rats or mice, chickens, amphibians, for example Xenopus, molluscs such as Aplysia, embryonic or newborn stages, which may be located in the hippocampus, cortex, striatum, dorsal root ganglia (DRG). They may also be cells selected from the SH-SY5Y neuroblastoma line, the PC12 line, the cortical neuronal cell line (HCN-1), or the B104 neuroblastoma line.

Selon l'invention, le support (1 ) peut être de toute forme connue de l'homme du métier, il peut être par exemple carré, rectangulaire ou circulaire.  According to the invention, the support (1) can be of any form known to those skilled in the art, it can be for example square, rectangular or circular.

Selon l'invention, le substrat (3) peut être tout substrat solide connu de l'homme du métier. Il peut s'agir par exemple d'un substrat transparent ou opaque. Il peut s'agir d'un substrat en verre, quartz, silicium, ou en matériau du type polymère, par exemple les plastiques par exemple du polycarbonate, polystyrène, polyéthylène ou PTFE, recouvert ou non d'une couche mince d'un autre matériau polymère, métallique, par exemple l'or ou des oxydes métalliques comme le S1O2, le ΤΊΟ2, NTO « oxyde d'indium- étain », ou de gels réticulés, par exemple le polydiméthylsiloxane (PDMS) ou le polyacrylamide.  According to the invention, the substrate (3) can be any solid substrate known to those skilled in the art. It may be for example a transparent or opaque substrate. It may be a substrate made of glass, quartz, silicon or a material of the polymer type, for example plastics, for example polycarbonate, polystyrene, polyethylene or PTFE, covered or not with a thin layer of another polymeric metal material, for example gold or metal oxides such as S102, ΤΊΟ2, NTO "indium tin oxide", or crosslinked gels, for example polydimethylsiloxane (PDMS) or polyacrylamide.

Selon l'invention l'épaisseur du substrat (3) peut être comprise de 0,1 mm à 3 mm, de 0,1 10 mm à 0,290 mm, de 0,120 mm à 0,250 mm, de 0,150 mm à 0,170 mm. Avantageusement, lorsque l'épaisseur du substrat est comprise entre 150 μιτι et 170 μιτι, il peut être utilisé directement dans un dispositif de lecture optique, par exemple un microscope à épifluorescence utilisant un objectif à immersion d'huile de grande ouverture numérique, permettant l'illumination en réflexion totale interne (ondes évanescentes) et ainsi la visualisation du contact adhésif avec une profondeur de champ d'une centaine de nanomètres. According to the invention, the thickness of the substrate (3) may be from 0.1 mm to 3 mm, from 0.1 mm to 0.290 mm, from 0.120 mm to 0.250 mm, from 0.150 mm to 0.170 mm. Advantageously, when the thickness of the substrate is between 150 μιτι and 170 μιτι, it can be used directly in an optical reading device, for example an epifluorescence microscope using a high numerical aperture oil immersion objective, allowing the illumination in total internal reflection (evanescent waves) and thus the visualization of the adhesive contact with a depth of field of a hundred nanometers.

Selon l'invention la surface (5) peut être toute surface connue de l'homme du métier sur laquelle des molécules, par exemple des substances chimiques et/ou des protéines peuvent être disposées. Il peut s'agir par exemple d'une surface plane, d'une surface rugueuse, d'une surface comprenant des creux, par exemple des puits ou des canaux.  According to the invention the surface (5) can be any surface known to those skilled in the art on which molecules, for example chemical substances and / or proteins can be arranged. This may be for example a flat surface, a rough surface, a surface comprising depressions, for example wells or channels.

Selon l'invention, les îlots (7) peuvent être disposés sur la surface de telle manière qu'ils forment un réseau, par exemple un réseau hexagonal ou carré. Selon l'invention, les îlots peuvent être situés à équidistance les uns des autres ou dans des intervalles variables.  According to the invention, the islands (7) can be arranged on the surface in such a way that they form a network, for example a hexagonal or square network. According to the invention, the islands can be located equidistant from each other or in variable intervals.

Selon l'invention, la surface entre les îlots (7) peut être une surface cytophobe (9). Selon l'invention, la surface peut être rendue cytophobe du fait de la présence d'un composé choisi parmi le polyéthylène glycol, le polyéthylène oxyde, le poly(acétate de vinyle), le poly(2-hydroxyéthyl métacrylate, le polyacrylamide, le poly(N-vinyl-2-pyrrolidone), le poly(N- isopropyl acrylamide), les silicones par exemple le polydimethylsiloxane (PDMS), les silanes, par exemple les silanes perfluorés, les polymères anioniques, les polymères phosphoryl choline, l'albumine, la caséine, l'acide hyaluronique, les liposchaccarides, les glycoprotéines, les phospholipides ou une combinaison de ceux-ci.  According to the invention, the surface between the islands (7) can be a cytophobic surface (9). According to the invention, the surface can be made cytophobic because of the presence of a compound chosen from polyethylene glycol, polyethylene oxide, polyvinyl acetate, poly (2-hydroxyethyl methacrylate, polyacrylamide, poly (N-vinyl-2-pyrrolidone), poly (N-isopropyl acrylamide), silicones, for example polydimethylsiloxane (PDMS), silanes, for example perfluorinated silanes, anionic polymers, phosphoryl choline polymers, albumin, casein, hyaluronic acid, liposaccharides, glycoproteins, phospholipids or a combination thereof.

Selon l'invention, l'application des composés cytophobes peut être réalisée par tout procédé connu de l'homme du métier, par exemple par dépôt en phase liquide, par tournette, trempage, aspersion, ou dépôt chimique en phase vapeur, par exemple par plasma ou sous atmosphère contrôlée ou une combinaison des deux. Il peut s'agir par exemple du procédé décrit dans le document suivant Bhushan, Bharat Hansford, Derek Lee, Kang Kug « Surface modification of silicon and polydimethylsiloxane surfaces with vapor-phase-deposited ultrathin fluorosilane films for biomédical nanodevices », Journal of Vacuum Science & Technology A: Vacuum, Surfaces, and Films, Jul 2006, 24 (4), 1 197 - 1202 [63]. According to the invention, the application of the cytophobic compounds can be carried out by any method known to those skilled in the art, for example by liquid phase deposition, spin coating, dipping, spraying, or chemical vapor deposition, for example by plasma or controlled atmosphere or a combination of both. For example, it may be The method described in the following document Bhushan, Bharat Hansford, Derek Lee, Kang Kug "Surface modification of silicon and polydimethylsiloxane surfaces with vapor-phase-deposited ultrathin fluorosilane films for biomedical nanodevices", Journal of Vacuum Science & Technology A: Vacuum, Surfaces, and Films, Jul 2006, 24 (4), 1 197 - 1202 [63].

Selon l'invention, par « protéines d'adhésion », on entend une protéine d'adhésion issue d'une membrane de cellules neuronales ou d'une membrane physiologique supportant une cellule neuronale issue de cellules non-neuronales, par exemple de cellules non-neuronales choisies parmi les cellules gliales, les astrocytes, les oligodendrocytes, les épendymocytes, les cellules satellites, les cellules de Schwann, cellules microgliales, ou les cellules souches embryonnaires desdites cellules. Il peut s'agir par exemple d'une protéine d'adhésion membranaire de cellules neuronales, par exemple les molécules d'adhérences de type immunoglobuline (IgCAM), par exemple les molécules L1 , les molécules d'adhérence de type neural (NrCAM) ou la glycoprotéine transaxonale 1 (TAG-1 ), les cadhérines par exemple la N-cadhérine, et les proto- cadhérines, les neurexines par exemple les neurexines 1 , 2, ou 3, les neurexines de formes a ou β, les neurexines avec ou sans sites d'épissage alternatif en position 4, les neuroligines par exemple les neuroligines 1 , 2, 3, ou 4, avec ou sans site d'épissage alternatif en positions A ou B, et les protéines transmembranaires à domaines riches en leucine (« Leucine- Rich Repeat Transmembrane protein ») par exemple les LRRTM 1 , 2, 3 ou 4.  According to the invention, "adhesion proteins" means an adhesion protein derived from a neuronal cell membrane or a physiological membrane supporting a neuronal cell derived from non-neuronal cells, for example non-neuronal cells. neurons selected from glial cells, astrocytes, oligodendrocytes, ependymocytes, satellite cells, Schwann cells, microglial cells, or embryonic stem cells of said cells. It may be, for example, a membrane adhesion protein of neuronal cells, for example immunoglobulin-like adhesion molecules (IgCAM), for example L1 molecules, neural-type adhesion molecules (NrCAM). or transaxonal glycoprotein 1 (TAG-1), cadherins, for example N-cadherin, and proto-cadherins, neurexins, for example neurexins 1, 2 or 3, neurexins of the α or β forms, neurexins with or without alternative splicing sites in position 4, neuroligins, for example neuroligins 1, 2, 3, or 4, with or without an alternative splicing site at the A or B positions, and the leucine-rich domain transmembrane proteins ( "Leucine-Rich Repeat Transmembrane Protein") eg LRRTM 1, 2, 3 or 4.

Les protéines d'adhésion peuvent être également, par exemple, les molécules d'adhésions cellulaires synaptiques (« Synaptic Cell Adhésion Molécule » (SynCAM)) 1 , 2, 3, ou 4.  The adhesion proteins may also be, for example, Synaptic Cell Adhesion Molecule (SynCAM) adhesion molecules 1, 2, 3, or 4.

Il peut s'agir d'une protéine recombinante, par exemple une protéine constituée d'un domaine extracellulaire N-terminal de protéines d'adhésion membranaires de cellules neuronales, par exemple les protéines précitées, fusionné, par exemple, en sa partie C-terminale à une étiquette. It may be a recombinant protein, for example a protein consisting of an N-terminal extracellular domain of adhesion proteins Membranes of neuronal cells, for example the aforementioned proteins, fused, for example, in its C-terminal part to a label.

Selon l'invention, lorsque la protéine d'adhésion est une protéine recombinante comprenant une étiquette C-terminale, l'étiquette peut être choisie parmi les étiquettes suivantes : la protéine fluorescente verte (« green fluorescent protein (EGFP) »), la protéine fluorescente rouge (« red fluorescent protein (RFP) »), les séquences polyhistidines (6-10 His), l'étiquette hémaglutinine (HA), l'étiquette myc, la Glutathione S- transférase (GST), ou un fragment constant des anticorps (Fc).  According to the invention, when the adhesion protein is a recombinant protein comprising a C-terminal label, the label may be chosen from the following labels: the green fluorescent protein ("green fluorescent protein" (EGFP)), the protein red fluorescent protein (RFP), polyhistidine sequences (6-10 His), haemagglutinin label (HA), myc tag, Glutathione S-transferase (GST), or a constant fragment of antibody (Fc).

Les protéines recombinantes peuvent être obtenues par tout procédé connu de l'homme du métier. Il peut s'agir par exemple des procédés décrits dans le document Isabelle Collin cvc, Le génie génétique, « les animaux transgéniques », édition les Essentiels milans, 1999 [64], le Handbook of Biochemistry and Molecular Biology, Fourth Edition 201 1 - Editor(s): Roger L. Lundblad, Lundblad Biotechnology, Chapel Hill, North Carolina, USA ; Fiona Macdonald, CRC Press, Boca Raton, Florida, USA [65], ou le Practical handbook of biochemistry and molecular biology Gerald D. Fasman CRC Press, 1989 - 601 pages [66]; ou le Recombinant DNA Principles andMethodologies, Editor(s): James Greene, Catholic University, Washington D.C., USA CRC Press, 1998 [67].  The recombinant proteins can be obtained by any method known to those skilled in the art. It may be, for example, the methods described in the document Isabelle Collin cvc, Genetic engineering, "transgenic animals", edition Essentials milans, 1999 [64], the Handbook of Biochemistry and Molecular Biology, Fourth Edition 201 1 - Editor (s): Roger L. Lundblad, Lundblad Biotechnology, Chapel Hill, North Carolina, USA; Fiona Macdonald, CRC Press, Boca Raton, Florida, USA [65], or the Practical Handbook of Biochemistry and Molecular Biology Gerald D. Fasman CRC Press, 1989 - 601 pages [66]; or the Recombinant DNA Principles and Methodologies, Editor (s): James Greene, Catholic University, Washington DC, USA CRC Press, 1998 [67].

De préférence, la protéine d'adhésion est choisie parmi les neurexines, les neuroligines, les IgCAMs, la N-cadhérine, les synCAMs, les protéines transmembranaires à domaines riche en Leucine (« Leucine- Rich Repeat Transmembrane » (LRRTM)) ou un mélange de celles-ci. De préférence, la protéine d'adhésion est choisie parmi les neurexines, les neuroligines, la N-cadhérine et/ou ou un mélange de celles-ci.  Preferably, the adhesion protein is chosen from neurexins, neuroligins, IgCAMs, N-cadherin, synCAMs, Leucine-rich domain transmembrane proteins ("Leucine-Rich Repeat Transmembrane" (LRRTM)) or a mixture of these. Preferably, the adhesion protein is selected from neurexins, neuroligins, N-cadherin and / or a mixture thereof.

Avantageusement, selon l'invention la protéine d'adhésion utilisée dans le dispositif de l'invention induit une croissance des axones et/ou des dendrites et/ou la synaptogénèse.  Advantageously, according to the invention, the adhesion protein used in the device of the invention induces growth of axons and / or dendrites and / or synaptogenesis.

Selon l'invention, la protéine d'adhésion peut être fixée directement sur la surface (5) ou via un liant intermédiaire fixé sur ladite surface (5). Selon l'invention, la fixation directe de la protéine d'adhésion sur la surface (5) peut être réalisée par tout procédé connu de l'homme du métier, par exemple par adsorption, par greffage chimique, électrochimique ou thermique. According to the invention, the adhesion protein can be attached directly to the surface (5) or via an intermediate binder attached to said surface (5). According to the invention, the direct attachment of the adhesion protein on the surface (5) can be carried out by any method known to those skilled in the art, for example by adsorption, by chemical, electrochemical or thermal grafting.

Selon l'invention, le liant intermédiaire peut être choisi parmi une espèce chimique réactive permettant d'établir une liaison covalente, par exemple la benzophénone, une fonction acide, aminé ou thiol, les silanes, par exemple les alkyls trichlorosilanes, et/ou une liaison non covalente, par exemple le nickel-acide nitrîlotriacétique (NTA), une protéine, par exemple la biotine, la streptavidine, le glutathion, un anticorps par exemple anti-Fc, anti-GFP, anti-RFP, anti-HA, anti-myc, anti-His, anti-GST, une espèce chargée par exemple la poly-D-lysine ou la poly-ornithine, un polysaccharide.  According to the invention, the intermediate binder may be chosen from a reactive chemical species which makes it possible to establish a covalent bond, for example benzophenone, an acidic, amine or thiol function, silanes, for example trichlorosilane alkyls, and / or non-covalent bond, for example nickel-nitrile triacetic acid (NTA), a protein, for example biotin, streptavidin, glutathione, an antibody for example anti-Fc, anti-GFP, anti-RFP, anti-HA, anti -myc, anti-His, anti-GST, a charged species for example poly-D-lysine or poly-ornithine, a polysaccharide.

Selon l'invention, la fixation du liant sur la surface (5) peut être réalisée par tout procédé connu de l'homme du métier, par exemple par trempage de la surface dans une solution comprenant ledit liant. Par exemple lorsque le liant est un anticorps, le procédé de fixation peut être par exemple un procédé comprenant une étape de trempage de la surface (5) dans une solution d'anticorps et rinçage en milieu liquide.  According to the invention, the fixing of the binder on the surface (5) can be carried out by any method known to those skilled in the art, for example by soaking the surface in a solution comprising said binder. For example, when the binder is an antibody, the fixing method may be for example a method comprising a step of soaking the surface (5) in an antibody solution and rinsing in a liquid medium.

Selon l'invention, l'application des composés cytophobes peut être réalisée par tout procédé connu de l'homme du métier, par exemple par dépôt en phase liquide, par exemple par tournette, trempage, aspersion, ou dépôt chimique en phase vapeur, par exemple par plasma ou sous atmosphère contrôlée) ou une combinaison des deux.  According to the invention, the application of the cytophobic compounds can be carried out by any method known to those skilled in the art, for example by deposition in the liquid phase, for example by spinning, dipping, spraying, or chemical vapor deposition, by example by plasma or controlled atmosphere) or a combination of both.

Avantageusement lorsque le liant est la polylysine, celle-ci permet un attachement optimal des neurones et l'extension des neurites.  Advantageously, when the binder is polylysine, it allows optimal attachment of neurons and extension of neurites.

Avantageusement, lorsque la protéine d'adhésion est une protéine recombinante, celle-ci peut interagir avec la surface (5) et/ou avec un liant fixé sur la surface (5) permettant ainsi d'augmenter la quantité de protéines d'adhésion fixées. Par exemple, lorsque le liant est un anticorps, celui-ci peut être spécifique de la protéine d'adhésion. Par exemple, lorsque la protéine est une protéine recombinante telle que définie précédemment, l'anticorps peut être spécifique de l'étiquette de ladite protéine recombinante. Advantageously, when the adhesion protein is a recombinant protein, it can interact with the surface (5) and / or with a binder fixed on the surface (5) thus making it possible to increase the amount of adhesion proteins fixed . For example, when the binder is an antibody, it may be specific for the adhesion protein. For example, when the protein is a recombinant protein as defined above, the antibody may be specific for the label of said recombinant protein.

Avantageusement, lorsque le liant est un anticorps, son site d'interaction avec la protéine adhésive peut être tel qu'il puisse permettre d'orienter l'ectodomaine de la protéine adhésive de telle façon que la partie réactive soit disponible pour l'adhésion cellulaire.  Advantageously, when the binder is an antibody, its site of interaction with the adhesive protein may be such as to allow the ectodomain of the adhesive protein to be oriented in such a way that the reactive part is available for cell adhesion. .

Selon l'invention, les îlots (7) peuvent être déposés sur la surface (5) par une méthode choisie parmi la photolithographie, la dip-pen nanolithographie, la lithographie par faisceau, l'impression par jet d'encre, l'impression par microcontact.  According to the invention, the islands (7) can be deposited on the surface (5) by a method chosen from photolithography, dip-pen nanolithography, beam lithography, ink jet printing, printing. by microswitch.

Selon l'invention, les îlots (7) ont un diamètre de 0,2 à 2,5 μιτι, de 0,2 à 2 μηη, de 0,3 à 150 μηη.  According to the invention, the islands (7) have a diameter of 0.2 to 2.5 μιτι, of 0.2 to 2 μηη, of 0.3 to 150 μηη.

Selon l'invention, l'espacement entre les îlots est de 0,5 à 10 μιτι, 1 à 9 μιτι, 3 à 7 μιτι.  According to the invention, the spacing between the islands is 0.5 to 10 μιτι, 1 to 9 μιτι, 3 to 7 μιτι.

Avantageusement, le diamètre des îlots permet la fixation des cellules neuronales et permet de former des points d'attachement entre, par exemple le corps cellulaire, les axones ou les dendrites et la protéine d'adhésion immobilisée sur les îlots.  Advantageously, the diameter of the islets makes it possible to fix the neuronal cells and makes it possible to form points of attachment between, for example, the cell body, the axons or the dendrites and the immobilized adhesion protein on the islets.

La présente invention a également pour objet un procédé de fabrication d'un support (1 ) de culture de cellules neuronales comprenant une étape de dépôt sur une surface (5) d'un substrat d'îlots (7) d'adhésion de cellules neuronales, lesdits îlots (7) ayant un diamètre 0,2 à 2,5 μιτι, de 0,2 à 2 μιτι, de 0,3 à 150 μιτι et étant espacés entre eux de 0,5 à 10 μιτι, 1 à 9 μιτι, 3 à 7 μιτι.  The subject of the present invention is also a process for producing a neuronal cell culture support (1) comprising a step of depositing on a surface (5) an islet substrate (7) of neuronal cell adhesion. , said islands (7) having a diameter of 0.2 to 2.5 μιτι, 0.2 to 2 μιτι, of 0.3 to 150 μιτι and being spaced between them from 0.5 to 10 μιτι, 1 to 9 μιτι , 3 to 7 μιτι.

Les cellules neuronales sont telles que définies précédemment. The neuronal cells are as defined above.

Le substrat utilisé dans le procédé de l'invention correspond au substrat défini précédemment. The substrate used in the process of the invention corresponds to the substrate defined above.

Les protéines d'adhésion utilisées dans le procédé de l'invention correspondent aux protéines définies précédemment. Selon l'invention, le procédé peut comprendre en outre une étape de revêtement d'un composé cytophobe. The adhesion proteins used in the method of the invention correspond to the proteins defined above. According to the invention, the method may further comprise a step of coating a cytophobic compound.

Selon l'invention, l'étape de revêtement du composé cytophobe peut être réalisée préalablement à l'étape de dépôt des îlots d'adhésion.  According to the invention, the step of coating the cytophobic compound can be carried out prior to the deposition step of the adhesion islands.

Selon l'invention, le composé cytophobe utilisé dans le procédé est tel que défini précédemment.  According to the invention, the cytophobic compound used in the process is as defined above.

Selon l'invention, le procédé peut comprendre une étape de revêtement de la surface (5) avec un liant. L'étape de revêtement de la surface (5) avec un liant peut être réalisée préalablement à l'étape de dépôt des îlots d'adhésion.  According to the invention, the method may comprise a step of coating the surface (5) with a binder. The step of coating the surface (5) with a binder may be carried out prior to the step of depositing the adhesion islands.

Selon l'invention, le liant utilisé dans le procédé est tel que défini précédemment.  According to the invention, the binder used in the process is as defined above.

La présente invention a également pour objet l'utilisation du support (1 ) pour la culture de cellules neuronales.  The present invention also relates to the use of the support (1) for the culture of neuronal cells.

La présente invention a également pour objet l'utilisation du support The present invention also relates to the use of the support

(1 ) dans une méthode d'analyse quantitative et/ou qualitative de cellules neuronales. (1) in a method of quantitative and / or qualitative analysis of neuronal cells.

En particulier, le support de la présente invention peut être avantageusement utilisé afin d'analyser les effets de molécules chimiques sur la croissance des neurites, par exemple sur le nombre, la taille, la géométrie, les branchements.  In particular, the support of the present invention can be advantageously used to analyze the effects of chemical molecules on the growth of neurites, for example on the number, the size, the geometry, the connections.

Le support de la présente invention peut être avantageusement utilisé afin d'étudier les effets de molécules chimiques sur la formation, la structure, le développement et la migration du cône de croissance axonal.  The carrier of the present invention can be advantageously used to study the effects of chemical molecules on the formation, structure, development and migration of the axonal growth cone.

En particulier, le support de la présente invention peut être avantageusement utilisé pour analyser les effets de molécules chimiques sur, par exemple, la formation, le nombre, la structure et/ou la fonction des hémisynapses pré-synaptiques ou post-synaptiques.  In particular, the carrier of the present invention may be advantageously used to analyze the effects of chemical molecules on, for example, the formation, number, structure and / or function of pre-synaptic or postsynaptic hemispynapses.

La présente invention a également pour objet l'utilisation du support (1 ) dans une méthode d'analyse quantitative et/ou qualitative de la synaptogénèse de cellules neuronales. En particulier, le support de la présente invention peut être avantageusement utilisé pour étudier, par exemple, la formation, le nombre, la structure et/ou la fonction des hémisynapses pré-synaptiques ou post-synaptiques. The subject of the present invention is also the use of the support (1) in a method of quantitative and / or qualitative analysis of neuronal cell synaptogenesis. In particular, the carrier of the present invention may be advantageously used to study, for example, the formation, number, structure and / or function of pre-synaptic or postsynaptic hemispynapses.

En outre, le support de la présente invention peut être avantageusement utilisé pour analyser et quantifier les effets de molécules chimiques sur, par exemple, la synaptogénèse de cellules neuronales.  In addition, the carrier of the present invention can be advantageously used to analyze and quantify the effects of chemical molecules on, for example, synaptogenesis of neuronal cells.

La présente invention a également pour objet l'utilisation du support (1 ) dans des méthodes de criblage.  The present invention also relates to the use of the support (1) in screening methods.

Le dispositif de l'invention permet avantageusement de cultiver des cellules neuronales et de maintenir ces cellules en culture pendant un temps suffisant pour permettre leur développement. Par exemple le dispositif de l'invention permet le développement de synapses. En outre, durant la totalité du temps de culture, les protéines d'adhésion fixées sur les îlots conservent avantageusement leurs fonctions adhésives, permettant, par exemple et avantageusement l'expression des contre- récepteurs endogènes dans les neurones, par exemple la N-cadhérine endogène dans les axones et dendrites, les neuroligines endogènes dans les dendrites, et les neurexines endogènes dans les axones.  The device of the invention advantageously allows to cultivate neuronal cells and maintain these cells in culture for a time sufficient to allow their development. For example, the device of the invention allows the development of synapses. In addition, during the entire culture time, the adhesion proteins attached to the islets advantageously retain their adhesive functions, allowing, for example and advantageously the expression of endogenous counter-receptors in neurons, for example N-cadherin endogenous in axons and dendrites, endogenous neuroligins in dendrites, and endogenous neurexins in axons.

D'autres avantages pourront encore apparaître à l'homme du métier à la lecture des exemples ci-dessous, illustrés par les figures annexées, donnés à titre illustratif.  Other advantages may still appear to those skilled in the art on reading the examples below, illustrated by the appended figures, given for illustrative purposes.

Brève description des figures Brief description of the figures

- La Figure 1 représente un support de culture (1 ) comprenant un substrat (3), une surface cytophobe (5), et des îlots adhésifs (7).  - Figure 1 shows a culture medium (1) comprising a substrate (3), a cytophobic surface (5), and adhesive islands (7).

La Figure 2A représente un support de culture comprenant un réseau hexagonal de micro-îlots recouverts de neurexine-i -Fc sur une surface partout ailleurs cytophobe. Le greffage de la neurexine-1 β-Fc sur les îlots initialement recouverts de polylysine a été assuré par un anticorps anti-Fc. Les neurones exprimant la neuroligine-1 développent des compartiments post-synaptiques spécifiquement sur ces îlots. Le schéma en coupe d'une post-synapse individuelle formé sur un îlot de recouvert de neurexine est indiqué sur la droite. La figure 2 B représente un support de culture comprenant un réseau hexagonal de micro-îlots recouverts de neurexine-1 β-Fc sur une surface partout ailleurs cytophobe. La figure 2 C représente un schéma grossi 2 fois d'une partie du support de culture montrant des dendrites de neurones exprimant la neuroligine-1 développant des compartiments post-synaptiques spécifiquement sur ces îlots. La figure 2 D est un schéma en coupe grossi environ 10 fois d'une post-synapse individuelle formé sur un îlot de recouvert de neurexine. Figure 2A shows a culture medium comprising a hexagonal array of micro-islets coated with neurexin-1-Fc on a surface elsewhere cytophobe. The grafting of neurexin-1β-Fc on the islets initially coated with polylysine was provided by an anti-Fc antibody. Neurons expressing neuroligin-1 develop post-synaptic compartments specifically on these islets. The sectional diagram of an individual post-synapse formed on an island of neurexin-covered is shown on the right. FIG. 2B shows a culture support comprising a hexagonal network of micro-islets covered with neurexin-1β-Fc on a surface elsewhere cytophobe. Figure 2C is a two-fold magnified diagram of a portion of the culture medium showing dendrites of neurons expressing neuroligin-1 developing post-synaptic compartments specifically on these islands. Figure 2D is a roughly 10-fold enlarged sectional diagram of an individual post-synapse formed on a neurexin-coated island.

La Figure 3 représente des images de fluorescence de neurones hippocampiques dissociés, issus de rats embryonnaires, en culture sur des substrats à micro-îlots recouverts de neurexine-1 β-Fc. Les neurones ont été déposés sur ces substrats, transfectés au bout de 4 jours avec la neuroligine-1 -HA ou l'EGFP, et cultivés au total pendant 8 jours, (a) Image d'un neurone exprimant la neuroligine-1 -HA, immuno-marqué avec un anticorps anti-HA. (b) Image d'un neurone transfecté avec de la EGFP. Les îlots ont été revêtus d'un anticorps anti-huFc conjugué au fluorophore Cy5 (aHuFc-Cy5), pour une visualisation des îlots (images correspondantes à droite). Les images montrent clairement une arborescence géométrique régulière des neurones exprimant la neuroligine-1 et l'accumulation de neuroligine-1 sur les îlots recouverts de neurexine-1 β-Fc, et l'absence de ces réactions chez les neurones exprimant l'EGFP. (c) Images à plus fort grossissement de réseaux de dendrites issus de neurones transfectés avec la neuroligine-1 , montrant le développement de structures filopodiales indiquées par des flèches blanches ressemblant à des épines dendritiques, dont l'extrémité forme des contacts spécifiques avec les îlots recouverts de neurexine-1 β-Fc (droite).  Figure 3 shows fluorescence images of dissociated hippocampal neurons from embryonic rats in culture on micro-islet substrates coated with neurexin-1 β-Fc. The neurons were deposited on these substrates, transfected after 4 days with neuroligin-1-HA or EGFP, and cultured in total for 8 days. (A) Image of a neuron expressing neuroligin-1-HA immuno-labeled with an anti-HA antibody. (b) Image of a neuron transfected with EGFP. The islets were coated with an anti-huFc antibody conjugated to the fluorophore Cy5 (aHuFc-Cy5), for a display of the islets (corresponding images on the right). The images clearly show a regular geometric tree structure of neurons expressing neuroligin-1 and neuroligin-1 accumulation on neurexin-1 β-Fc-coated islets, and the absence of these reactions in EGFP-expressing neurons. (c) Higher magnification images of dendrite arrays from Neuroligin-1 transfected neurons, showing the development of filopodial structures indicated by white arrows resembling dendritic spines, the tip of which forms specific contacts with the islets covered with neurexin-1 β-Fc (right).

- La Figure 4 représente des images de fluorescence d'axones et dendrites en fonction du support utilisé. La figure 4 (a) représente des photographies d'un neurone exprimant la neuroligine-1 -HA, en développement sur le substrat recouvert de neurexine-1 β-Fc. Le neurone transfecté a été visualisé par immuno-coloration de l'épitope HA avec des anticorps primaires anti-HA et des anticorps secondaires conjugués au fluorophore Alexa488. En particulier, cette photographie représente la morphologie structurée des neurones hippocampiques de rat (DIV 8) cultivés sur des substrats à micro-îlots. La Figure 4 (b) représente des photographies d'un neurone exprimant l'EGFP, en développement sur un substrat recouvert de neurexine-1 β-Fc. Les panneaux de droite des figures 4 a et 4 b comprennent des agrandissements pris dans les zones axonales et dendritiques mettant en évidence la morphologie des neurites dans chaque état. La Figure 4 (c) est un diagramme en bâton représentant en ordonnée le pourcentage d'îlots occupés par les axones ou les dendrites sur-exprimant la neuroligine-1 -HA, en développement sur les substrats recouvert de neurexine-1 β-Fc (Nrx1 β-Fc + Nlgn-1 , 9 cellules, Dendrite: n = 595 îlots; axone: n = 187 îlots) et pour les neurones exprimant l'EGFP, en développement sur les substrats recouvert de ΝΓχΙ β-Fc (contrôle; 8 cellules, dendrites: n = 202 îlots; axone: n = 148 îlots). FIG. 4 represents fluorescence images of axons and dendrites as a function of the support used. Figure 4 (a) shows photographs of a neuron expressing neuroligin-1-HA, developing on the substrate coated with neurexin-1 β-Fc. The transfected neuron was visualized by immunostaining of the HA epitope with primary anti-HA antibodies and secondary antibodies conjugated to Alexa488 fluorophore. In particular, this photograph represents the structured morphology of rat hippocampal neurons (DIV 8) grown on micro-islet substrates. Figure 4 (b) shows photographs of a neuron expressing EGFP, developing on a substrate coated with neurexin-1 β-Fc. The right panels of Figures 4a and 4b include enlargements taken in the axonal and dendritic areas highlighting the morphology of the neurites in each state. Figure 4 (c) is a bar graph showing ordinarily the percentage of islets occupied by axons or dendrites overexpressing neuroligin-1-HA, developing on substrates coated with neurexin-1 β-Fc ( Nrx1 β-Fc + Nlgn-1, 9 cells, Dendrite: n = 595 islets, axon: n = 187 islets) and for neurons expressing EGFP, developing on substrates covered with ΝΓχΙ β-Fc (control; cells, dendrites: n = 202 islets, axon: n = 148 islets).

La Figure 5 représente des images de fluorescence de dendrites et explicite la méthode de quantification des facteurs d'enrichissement des protéines synaptiques Neuroligine-1 et PSD-95 au niveau des micro-patterns ou ilôts. L'image en (a) représente une région dendritique d'un neurone exprimant la neuroligine-1 -HA et la PSD- 95:EGFP cultivé sur un substrat recouvert de ΝΓχΙ β-Fc. L'image correspondante en (b) représente les îlots recouverts au préalable d'anticorps fluorescents ahuFc-Cy5. L'image en (c) représente les îlots détectés (cercles en pointillés), qui sont ensuite transférés sur l'image de PSD-95:EGFP. Les îlots qui ne sont pas recouverts avec des dendrites (cercles pleins) ont été éliminés de la quantification. L'image en (d) représente les contours des îlots restants (cercles en pointillés), transférés sur l'image PSD-95:EGFP, où le contour du neurite est déterminé par une fonction de seuil (en gris). L'indice d'enrichissement est calculé en mesurant l'intensité de fluorescence dans chaque îlot (cercles), et divisé par l'intensité moyenne mesurée à partir de zones dendritiques situées à l'extérieur des micro-patterns (gris). FIG. 5 represents fluorescence images of dendrites and explains the method for quantifying the enrichment factors of neuroligin-1 and PSD-95 synaptic proteins at the micro-pattern or islet level. The image in (a) represents a dendritic region of a neuron expressing neuroligin-1-HA and PSD-95: EGFP grown on a substrate coated with ΝΓχΙ β-Fc. The corresponding image in (b) represents the islands previously coated with ahuFc-Cy5 fluorescent antibodies. The image in (c) represents the detected islets (dashed circles), which are then transferred to the PSD-95: EGFP image. Islets that are not covered with dendrites (solid circles) have been eliminated from quantification. The image in (d) represents the outlines of the remaining islets (dashed circles), transferred to the PSD-95: EGFP image, where the neurite contour is determined by a threshold function (in gray). The enrichment index is calculated by measuring the fluorescence intensity in each island (circles), and divided by the average intensity measured from dendritic zones located outside the micro-patterns (gray).

- La Figure 6 représente les résultats de la quantification des facteurs d'enrichissement des protéines synaptiques au niveau des micro- patterns. Le panneau (a) représente des photographies de cellules montrant le recrutement de la Neuroligine-1 (haut) et de la PSD-95 : EGFP (milieu) au niveau de micro-patterns recouverts de neurexine-1 β-Fc (bas). Les panneaux (b) et (c) sont des graphiques représentant l'enrichissement de protéines post-synaptiques (neuroligines-1 -HA; PSD-95 : EGFP ou PSD-95 endogène). L'abscisse correspond à l'index d'enrichissement qui est un nombre sans dimension normalisé à 1 , en divisant par le niveau de fluorescence au niveau des îlots par un niveau de référence sur des régions témoins. L'enrichissement a été quantitativement déterminé sur les îlots en utilisant 3 cultures différentes de neurones d'hippocampe suivant la procédure décrite en Figure 5. La distribution cumulative de l'indice d'enrichissement des neuroligines-1 -HA (en b) ou des PSD-95 : EGFP et PSD-95 endogène (en c) est indiquée sur les graphiques. L'indice d'enrichissement a été calculé pour chaque protéine dans les conditions suivantes: substrats recouvert de neurexine-1 β-Fc et neurones exprimant la neuroligine-1 -HA (Nrx-Fc + Nlgn-1 (courbe trait plein); substrats recouvert de Fc humain et neurones exprimant la neuroligine-1 -HA (huFc + Nlgn-1 (courbe traits espacés) ou substrats recouvert de neurexine-1 β-Fc et neurones sur-exprimant la EGFP (Nrx-Fc + EGFP (courbe en pointillés). - Figure 6 shows the results of the quantification of synaptic protein enrichment factors at the level of micro-patterns. Panel (a) shows photographs of cells showing the recruitment of Neuroligin-1 (high) and PSD-95: EGFP (medium) at micro-patterns covered with neurexin-1 β-Fc (low). Panels (b) and (c) are graphs depicting enrichment of postsynaptic proteins (endogenous neuroligins-1-HA; PSD-95: EGFP or PSD-95). The abscissa corresponds to the enrichment index which is a dimensionless number normalized to 1, dividing by the level of fluorescence at the level of the islets by a reference level on control regions. Enrichment was quantitatively determined on the islets using 3 different cultures of hippocampal neurons following the procedure described in Figure 5. The cumulative distribution of the enrichment index of neuroligins-1-HA (in b) or PSD-95: EGFP and endogenous PSD-95 (in c) is shown on the graphs. The enrichment index was calculated for each protein under the following conditions: substrates coated with neurexin-1 β-Fc and neurons expressing neuroligin-1-HA (Nrx-Fc + Nlgn-1 (solid line curve); substrates covered with human Fc and neurons expressing neuroligin-1-HA (huFc + Nlgn-1 (curve spaced lines) or substrates covered with neurexin-1 β-Fc and over-expressing neurons EGFP (Nrx-Fc + EGFP (curve in dotted line).

Une valeur d'indice d'enrichissement de 1 indique qu'il n'y a pas de recrutement particulier de la protéine étudiée. An enrichment index value of 1 indicates that there is no particular recruitment of the protein under study.

La Figure 7 représente des photographies prises au cours du temps de cellules neuronales exprimant la neuroligine-1 et la PSD- 95:EGFP, en culture sur un substrat dont les îlots sont recouverts de neurexine-1 β-Fc. En particulier, cette figure représente les changements de forme de filopodes dendritiques, visualisés par le signal de fluorescence de PSD-95:EGFP. Ces figures montrent les contacts entre la partie périphérique des filopodes dendritiques enrichie en PSD-95 (flèches), avec des îlots recouverts de neurexine-1 β-Fc (cercles en pointillés), événements précurseurs de la formation d'hémi-post-synapses. Figure 7 shows photographs taken over time of neuronal cells expressing neuroligin-1 and PSD-95: EGFP, in culture on a substrate whose islets are covered with neurexin-1 β-Fc. In particular, this figure represents the changes of dendritic filopodia, visualized by the fluorescence signal of PSD-95: EGFP. These figures show the contacts between the peripheral part of the dendritic filopodia enriched in PSD-95 (arrows), with islets covered with neurexin-1 β-Fc (dashed circles), precursor events of the formation of hemi-post-synapses .

La Figure 8 représente des photographies des flux transitoires de calcium induits par le décageage de glutamate. Des neurones de rat hippocampiques (DIV 7) en développement sur le substrat recouvert de neurexine-1 β-Fc (a) et exprimant la neuroligine-1 -HA et la PSD- 95:mCherry (b) ont été marqués avec l'indicateur calcique Fluo-4, pour observer des changements intracellulaires de calcium (c) et ont été incubés dans une solution contenant du glutamate cagé (4-methoxy-7- nitroindolinyl-caged l-glutamate). Le faisceau laser bi-photon permettant le décageage est focalisé au voisinage d'un îlot (flèche). Il est noté que l'augmentation du signal de Fluo-4 à partir de l'emplacement du décageage se propage dans les dendrites au cours du temps (Panneau c). Le panneau (d) représente un graphique montrant différentes réponses calciques, normalisées à un niveau de référence (ordonnée) en fonction du temps en secondes (abscisse). Ces réponses ont été mesurées au niveau de l'îlot le plus proche de l'emplacement du décageage de glutamate (courbe noire), ou sur les îlots voisins (courbes en pointillés), comme indiqué sur l'image PSD-95 :mCherry (îlots notés 1 , 2, et 3 respectivement).  Figure 8 shows photographs of transient calcium fluxes induced by glutamate decapping. Hippocampal rat neurons (DIV 7) developing on the substrate coated with neurexin-1 β-Fc (a) and expressing neuroligin-1-HA and PSD-95: mCherry (b) were labeled with the indicator Calcium Fluo-4, to observe intracellular calcium changes (c) and were incubated in a solution containing caged glutamate (4-methoxy-7-nitroindolinyl-caged 1-glutamate). The bi-photon laser beam for decapping is focused in the vicinity of an island (arrow). It is noted that the increase of the Fluo-4 signal from the location of the stripping propagates through the dendrites over time (Panel c). Panel (d) represents a graph showing different calcium responses, normalized to a reference level (ordinate) versus time in seconds (abscissa). These responses were measured at the island closest to the location of glutamate decapping (black curve), or on neighboring islands (dashed lines), as shown in PSD-95: mCherry ( islands 1, 2 and 3 respectively).

La Figure 9 représente des images de fluorescence de neurones hippocampiques dissociés, issus de rats embryonnaires, en culture sur des substrats à micro-îlots recouverts de N-cadhérine-Fc (panneaux du haut : Substrat N-cadhérine-Fc) ou de la molécule témoin Fc (panneaux du bas : Substrat Hu -Fc). Les neurones ont été déposés sur ces substrats et cultivés pendant 8 jours. Les panneaux de gauche montrent des images de neurones marqués avec la molécule phalloidine- Figure 9 shows fluorescence images of dissociated hippocampal neurons from embryonic rats in culture on micro-islet substrates coated with N-cadherin-Fc (top panels: N-cadherin-Fc substrate) or the molecule witness Fc (bottom panels: Substrate Hu-Fc). The neurons were deposited on these substrates and cultured for 8 days. The left panels show images of neurons labeled with the phalloidin molecule.

Bodipy, pour colorer les filaments d'actine. Les images correspondantes à droite (anti-humain Fc Cy5) montrent les îlots revêtus d'un anticorps anti- huFc conjugué au fluorophore Cy5 (aHuFc-Cy5). En d'autres termes, les images correspondantes à droite montrent les îlots revêtus d'un anticorps anti-Fc humain conjugué au fluorophore Cy5 (anti-Human Fc Cy5). Ces images montrent clairement que la croissance des neurites et leur orientation suivent les lignes définies par les îlots recouverts de N- cadhérine-Fc, ce qui n'est pas le cas pour les neurones cultivés sur les micro-patterns recouverts de Fc, dont les neurites poussent mal et dans des directions aléatoires. La Figure 9c représente l'image à plus fort grossissement d'un cône de croissance coloré pour les filaments d'actine avec la molécule phalloidine-Bodipy, qui montre l'accumulation d'actine au niveau des adhésions avec les îlots recouverts de N-cadhérine-Fc (flèches et cercles). Le panneau de droite représente l'image correspondante des îlots de N-cadhérine-Fc. La Figure 9 d représente un support de culture comprenant un réseau hexagonal de micro-îlots recouverts de N- cadhérine-Fc sur une surface partout ailleurs cytophobe. Le greffage de la molécule N-cadhérine-Fc sur les îlots initialement recouverts de polylysine a été assuré par un anticorps anti-Fc. Le schéma central représente un schéma grossi 2 fois d'une partie du support de culture montrant les axones et dendrites de neurones se développant sur le support et formant des contacts spécifiques au niveau des îlots. Le schéma de droite représente une coupe grossie environ 10 fois d'un contact adhésif individuel formé sur un îlot de recouvert de N-cadhérine. Noter la différence entre les échelles horizontale et verticale. Ces observations montrent que dans ce système, la N-cadhérine favorise la croissance sélective et patternée, c'est-à-dire selon un schéma particulier, des axones, mais est incapable d'induire des compartiments pré- ou post- synatique. Bodipy, for coloring the actin filaments. The images corresponding to right (anti-human Fc Cy5) show the islets coated with anti-huFc antibody conjugated to fluorophore Cy5 (aHuFc-Cy5). In other words, the corresponding images on the right show the islets coated with an anti-human Fc antibody conjugated to the Cy5 fluorophore (anti-Human Fc Cy5). These images clearly show that the growth of neurites and their orientation follow the lines defined by islets covered with N-cadherin-Fc, which is not the case for neurons grown on Fc-coated micro-patterns, whose Neurites grow badly and in random directions. Figure 9c shows the higher magnification image of a colored growth cone for actin filaments with the phalloidin-Bodipy molecule, which shows the actin accumulation at the adhesions with N-coated islets. cadherin-Fc (arrows and circles). The right panel represents the corresponding image of islets of N-cadherin-Fc. 9 d represents a culture support comprising a hexagonal network of micro-islets covered with N-cadherin-Fc on a surface elsewhere cytophobe. The grafting of the N-cadherin-Fc molecule on the islets initially coated with polylysine was provided by an anti-Fc antibody. The central diagram represents a 2-fold diagram of a portion of the culture medium showing axons and dendrites of neurons developing on the support and forming specific contacts at the islet level. The diagram on the right represents a roughly 10-fold enlarged section of an individual adhesive contact formed on an island of N-cadherin coated. Note the difference between the horizontal and vertical scales. These observations show that in this system, N-cadherin promotes selective and patterned growth, that is to say according to a particular pattern, axons, but is unable to induce pre- or post-synaptic compartments.

Les Figures 10 a et b représentent des images de fluorescence de neurones hippocampiques dissociés, issus de rats embryonnaires, en culture sur des substrats à micro-îlots recouverts de N-cadhérine-Fc (Substrat N-cadhérine-Fc). Les neurones ont été déposés sur ces substrats, transfectés au bout de 4 jours avec la protéine fluorescente rouge (RFP) (a) ou la N-cadhérine-RFP (b), et cultivés au total pendant 8 jours. Les images correspondantes des îlots revêtus d'un anticorps anti- huFc conjugué au fluorophore Cy5 (aHuFc-Cy5), sont présentées dans les panneaux de droite. Ces images montrent clairement l'enrichissement de la N-cadhérine-RFP, qui est le récepteur membranaire du ligand N- cadhérine-Fc, mais pas de la RFP, sur les îlots recouverts de N-cadhérine- Fc (flèches). La Figure 10 (c) est un diagramme en bâton représentant en ordonnée l'index d'enrichissement de la RFP et de la N-cadhérine-RFP sur les îlots recouverts de N-cadhérine-Fc. Figures 10a and b show fluorescence images of dissociated hippocampal neurons from embryonic rats in culture on micro-islet substrates coated with N-cadherin-Fc (N-cadherin-Fc substrate). The neurons were deposited on these substrates, transfected after 4 days with red fluorescent protein (RFP) (a) or N-cadherin-RFP (b), and cultured in total for 8 days. The corresponding images of the islets coated with an anti-huFc antibody conjugated to the fluorophore Cy5 (αHuFc-Cy5), are presented in the right panels. These images clearly show the enrichment of N-cadherin-RFP, which is the membrane receptor of the N-cadherin-Fc ligand, but not of the RFP, on N-cadherin-Fc coated islands (arrows). Figure 10 (c) is a bar graph depicting on the ordinate the enrichment index of RFP and N-cadherin-RFP on N-cadherin-Fc coated islets.

La Figure 1 1 a représente un support de culture comprenant un réseau hexagonal de micro-îlots recouverts de 6His-neuroligine-1 sur une surface partout ailleurs cytophobe. La Figure 1 1 b représente un schéma grossi 2 fois d'une partie du support de culture montrant les axones et dendrites de neurones se développant sur le support et formant des contacts spécifiques au niveau des îlots. La Figure 1 1 c représente un schéma en coupe grossi environ 10 fois d'une pré-synapse individuelle formée sur un îlot de recouvert de neuroligine greffée sur les îlots initialement recouverts de polylysine via des anticorps anti-6Histidine. Sur cette figure, les vésicules synaptiques sont également représentées et le terme CASK signifie calcium/calmodulin-dependent serine protein kinase. La Figure 1 1 d représente une image en fluorescence d'un support de culture sur lequel les îlots sont revêtus d'un anticorps anti-6His conjugué au fluorophore Cy5 et sur lesquels de la 6His-neuroligine-1 a été fixée. La Figure 11a shows a culture medium comprising a hexagonal array of micro-islets coated with 6His-neuroligin-1 on a surface elsewhere cytophobe. Figure 11b shows a two-fold magnification diagram of a portion of the culture medium showing axons and dendrites of neurons developing on the support and forming specific island-level contacts. Figure 11 represents a roughly 10-fold enlarged sectional diagram of an individual pre-synapse formed on an island of neuroligin-coated graft onto islands initially coated with polylysine via anti-Histidine antibodies. In this figure, synaptic vesicles are also represented and the term CASK stands for calcium / calmodulin-dependent serine protein kinase. Figure 11 represents a fluorescence image of a culture support on which the islets are coated with an anti-6His antibody conjugated to the fluorophore Cy5 and on which 6His-neuroligin-1 was fixed. The

Figure 1 1 e représente une image en fluorescence de l'axone d'un neurone transfecté avec la neurexine-1 β-GFP. Sur cette image les points clairs correspondent à l'accumulation de neurexine-1 β -GFP au niveau des îlots recouverts de 6His-neuroligine-1 et montre la croissance des axones. Figure 1 1 e represents a fluorescence image of the axon of a neuron transfected with neurexin-1 β-GFP. In this image, the clear spots correspond to the accumulation of neurexin-1 β-GFP at the level of the islets covered with 6His-neuroligin-1 and show the growth of the axons.

- La Figure 12 a représente un support de culture comprenant un réseau hexagonal de micro-îlots recouverts de molécules d'adhérence synaptiques 1 fusionnées au fragment Fc (SynCAM-1 -Fc) et greffées sur les îlots initialement recouverts de polylysine via un anticorps anti-Fc sur une surface partout ailleurs cytophobe. La Figure 12 b représente un schéma grossi 2 fois d'une partie du support de culture montrant les axones et dendrites de neurones se développant sur le support et formant des contacts spécifiques au niveau des îlots, en particulier, ils forment des compartiments pré-synaptiques spécifiquement sur ces îlots. La Figure 12 c représente un schéma en coupe grossi environ 10 fois d'une présynapse formée sur un îlot de recouvert de SynCAM-1 - Fc. La Figure 12 d est une photographie en fluorescence d'un support de culture montrant les îlots revêtus d'un anticorps anti-Fc conjugué au fluorophore Cy5 sur lesquels ont été fixées des protéines SynCAM-1 - Fc (points clairs sur la photographie). La Figure 12e représente une image en fluorescence du marquage en immunofluorescence du récepteur SynCAMI endogène après dépôt et culture pendant 8 jours de neurones hippocampiques dissociés, issus de rats embryonnaires, non transfectés, sur le dispositif de culture. La Figure 12 f représente une image en fluorescence du marquage en immunofluorescence de vésicules présynaptiques (synapsine) après culture sur le dispositif de neurones hippocampiques dissociés, issus de rats embryonnaires. FIG. 12a shows a culture support comprising a hexagonal network of micro-islets coated with adhesion molecules synaptic 1 fused to the Fc fragment (SynCAM-1-Fc) and grafted onto the islets initially coated with polylysine via an anti-Fc antibody on a surface elsewhere cytophobe. Figure 12b is a two-fold magnification diagram of a portion of the culture medium showing axons and dendrites of neurons developing on the support and forming specific island-level contacts, in particular, they form pre-synaptic compartments. specifically on these islets. Figure 12c shows a roughly 10-fold enlarged sectional diagram of a presynapse formed on a SynCAM-1-Fc coated island. Figure 12d is a fluorescence photograph of a culture medium showing the islets coated with a Cy5 fluorophore-conjugated anti-Fc antibody to which SynCAM-1-Fc proteins (clear dots in the photograph) have been attached. Figure 12e shows a fluorescent image of the immunofluorescence staining of the endogenous SynCAMI receptor after deposition and culture for 8 days of dissociated hippocampal neurons from embryonic, untransfected rats on the culture device. Figure 12f shows a fluorescence image of the immunofluorescence staining of presynaptic vesicles (synapsin) after culture on the dissociated hippocampal neuron device, from embryonic rats.

EXEMPLES EXAMPLES

Exemple 1 : Fabrication du support de culture cellulaire Example 1 Manufacture of the Cell Culture Support

Les substrats à îlots Islet substrates

Les matrices d'îlots hydrophiles de 0,5 à 2 μιτι et séparés de 3 à 6 μιτι dans un environnement cytophobe ont été obtenues de CYTOO sur lamelles de verre de 2x2cm2 et de 170μηη d'épaisseur (Produits à façon, CYTOOchips Custom, référence catalogue 10-950-00). Les substrats ont été ensuite traités avec de la Poly(L-lysine) PLL (40 g/ml ; Sigma P2636- 1 G) qui a été adsorbée sur les points hydrophiles. Les substrats ont été ensuite séchés et stockés à 4°C. The matrices of hydrophilic islands of 0.5 to 2 μιτι and separated from 3 to 6 μιτι in a cytophobic environment were obtained from CYTOO on glass slides of 2x2cm 2 and 170μηη thick (custom products, CYTOOchips Custom, catalog number 10-950-00). The substrates were then treated with Poly (L-lysine) PLL (40 g / ml, Sigma P2636- 1G) which was adsorbed on the hydrophilic points. The substrates were then dried and stored at 4 ° C.

Production et purification de la neurexine-1 β-Fc Production and purification of neurexin-1 β-Fc

Le protocole de production de la neurexine-1 β-Fc a été publié précédemment (Heine, M., Thoumine, O., Mondin, M., Tessier, B., Giannone, G. & Choquet, D. Activity-independent and subunit-specific recruitment of functional AMPA receptors at neurexin/neuroligin contacts. Proc Natl Acad Sci U S A 105, 20947-52 (2008). [34]). Le plasmide pcDNA neomycin contenant le gène codant pour la protéine neurexine-1 β sans le site d'épissage alternatif S4, fusionné en C-terminal avec la séquence codant pour le fragment constant des IgG humain (Fc) (Scheiffele, P., Fan, J., Choih, J., Fetter, R. & Serafini, T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101 , 657- 69. (2000). [35]) fournit par P. Scheiffele (Biozentrum, Bâle, CH). Ce plasmide a été sous-cloné entre les sites Hindlll/Xhol dans le vecteur pcDNAhygro(+). Des cellules HEK293 (5 106 cellules) ont été électroporées (Biorad Puiser Xcell) avec 30 à 50 g de ce plasmide, puis cultivées dans du milieu DMEM High glucose (DMEMNA0500, Midimed) contenant 10% de sérum de veau fœtal (SVFBRE500, Midimed), 1 mM pyruvate de Sodium MEM (1 1360039, Fisher Scientific), 1 % de complément GlutaMAX (marque de commerce) I (35050038, Fisher Scientific) sans antibiotique pendant 36 h, puis supplémenté avec 0,5 mg/mL d'hygromycin B (10687-010, Fisher Scientific) pour sélectionner un clone stable exprimant la neurexine-1 β-Fc (10 jours). Les cellules ont été cultivées sur supports recouverts de Poly-L-lysine hydrobromide (1 mg/ml, P2636-1 G, Sigma-AIdrich) pendant 3 mois dans du Milieu AIM V (marque déposée) (31035-025, Fisher Scientific) supplémenté avec 0,5 mg/mL d'hygromycine B. 60 mL de milieu conditionné étaient prélevés 2 fois par semaine, puis congelé à -20°C. L'ensemble des milieux collectés a été mélangé, filtré (0,2 μιτι), traité avec du DTT 10 mM (DL-dithiothreitol, D9779-10G, Sigma) et le pH a été ajusté à 7. Grâce à une pompe péristatique, ce mélange est passé sur une colonne de protéine G (HiTrap Protein G HP, 17-0407-03, GE Healthcare) préalablement équilibrée avec du phosphate de sodium 20 mM pH=7. L'élution de la protéine a été effectuée avec de la Glycine (Sigma G-8898) 0,1 M pH = 2,7, et l'éluât a été collecté par fractions de 1 ml dans des tubes contenant du tampon Tris (Trizma Base, Sigma T6066) 1 M, pH = 9 ajusté avec HCI. La quantification de la concentration en protéine dans ces fractions est réalisée par un dosage BCA (W9981 L, Fisher Scientific). La protéine est conservée à -80°C en aliquotes de 20-50 μΙ. The production protocol for neurexin-1β-Fc has been published previously (Heine, M., Thoumine, O., Mondin, M., Tessier, B., Giannone, G. & Choquet, D. Activity-independent and subunit-specific recruitment of functional AMPA receptors at neurexin / neuroligin contacts Proc Natl Acad Sci USA 105, 20947-52 (2008) [34]). The pcDNA neomycin plasmid containing the gene encoding the neurexin-1 β protein without the alternative S4 splicing site, fused to the C-terminal with the sequence coding for the constant fragment of human IgG (Fc) (Scheiffele, P., Fan , J., Choih, J., Fetter, R. & Serafini, T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons Cell 101, 657-69 (2000) [35]) provided by P. Scheiffele (Biozentrum, Basel, CH). This plasmid was subcloned between the HindIII / XhoI sites in the pcDNAhygro (+) vector. HEK293 cells (5 × 10 6 cells) were electroporated (Biorad Pulser Xcell) with 30 to 50 g of this plasmid and then cultured in DMEM High glucose medium (DMEMNA0500, Midimed) containing 10% fetal calf serum (SVFBRE500, Midimed), 1 mM MEM Sodium pyruvate (1 1360039, Fisher Scientific), 1% GlutaMAX (Trade Mark) supplement I (35050038, Fisher Scientific) without antibiotic for 36 h, then supplemented with 0.5 mg / mL. hygromycin B (10687-010, Fisher Scientific) to select a stable clone expressing neurexin-1β-Fc (10 days). The cells were cultured on supports coated with Poly-L-lysine hydrobromide (1 mg / ml, P2636-1G, Sigma-Aldrich) for 3 months in Medium AIM V (registered trademark) (31035-025, Fisher Scientific) supplemented with 0.5 mg / mL of hygromycin B. 60 mL of conditioned medium was taken twice a week and then frozen at -20 ° C. All the media collected were mixed, filtered (0.2 μιτι), treated with 10 mM DTT (DL-dithiothreitol, D9779-10G, Sigma) and the pH was adjusted to 7. Using a peristatic pump, this mixture was passed on a column of protein G (HiTrap Protein G HP, 17-0407-03, GE Healthcare) previously balanced with 20 mM sodium phosphate pH = 7. Elution of the protein was performed with Glycine (Sigma G-8898) 0.1 M pH = 2.7, and the eluate was collected in 1 ml fractions in tubes containing Tris buffer (Trizma Base, Sigma T6066) 1 M, pH = 9 adjusted with HCl. Quantification of the protein concentration in these fractions is performed by a BCA assay (W9981 L, Fisher Scientific). The protein is stored at -80 ° C in 20-50 μl aliquots.

Production et purification de la protéine d'adhésion svnaptique SvnCAM-1 -Fc Production and purification of SvnCAM-1-Fc svnaptic adhesion protein

Le plasmide codant pour la protéine SynCAM-1 -Fc a été généreusement fourni par T. Biederer (Yale University, USA) et est décrit dans la référence (Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D., Liu, The plasmid encoding the SynCAM-1-Fc protein has been generously provided by T. Biederer (Yale University, USA) and is described in the reference (Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D. ., Liu,

X., Kavalali, E. T., Sudhof, T. C. SynCAM, a synaptic adhésion molécule that drives synapse assembly, Science 297 1525-31 (2002) [68]). La molécule SynCAM-1 -Fc a été produite à partir de ce gène selon le procédé décrit précédemment pour la neurexine-i -Fc, suivant le protocole décrit dans Breillat, C ., Thoumine O., Choquet, D. Characterization of SynCAM surface trafficking using a SynCAM derived ligand with high homophilic binding affinity, Biochem Biophys Res Commun, 359, 655-659 (2007) [71 ]. De façon alternative, les protéines d'adhésion recombinantes ont été achetées chez le fabricant R&D Systems : N-cadhérine-Fc (6626-NC-050), neurexine1 a-Fc (4485-NX-050), neurexine-1 β-Fc (5268-NX-050), neuroligine-1 -6His (4340-NL-050), neuroligine-2-6His (5645-NL-050), et LRRTM-1 -6His (4897-LR-050), LRRTM-3-6His (4898-LR-050), LRRTM-4- 6His (5377-LR-050), SynCAM1 -Fc (3519-S4), SynCAM2-Fc (4290-S4),X., Kavalali, E.T., Sudhof, T.C. SynCAM, synaptic adhesion molecule that drives synapse assembly, Science 297 1525-31 (2002) [68]). The SynCAM-1-Fc molecule was produced from this gene according to the method described above for neurexin-1-Fc, according to the protocol described in Breillat, C., Thoumine O., Choquet, D. Characterization of SynCAM surface SynCAM derived ligand with high homophilic binding affinity, Biochem Biophys Res Commun, 359, 655-659 (2007) [71]. Alternatively, the recombinant adhesion proteins were purchased from the manufacturer R & D Systems: N-cadherin-Fc (6626-NC-050), neurexin1-Fc (4485-NX-050), neurexin-1β-Fc (5268-NX-050), Neuroligin-1-6His (4340-NL-050), Neuroligin-2-6His (5645-NL-050), and LRRTM-1-6His (4897-LR-050), LRRTM- 3-6His (4898-LR-050), LRRTM-4-6His (5377-LR-050), SynCAM1-Fc (3519-S4), SynCAM2-Fc (4290-S4),

SynCAM3-Fc (3678-S4), SynCAM4-Fc (4164-S4). Recouyrement des substrats comprenant des îlots SynCAM3-Fc (3678-S4), SynCAM4-Fc (4164-S4). Recouyrement substrates including islets

Un jour avant de déposer les cellules, les substrats ont été traités avec des anticorps de chèvre anti-Fc humain (Jackson ImmunoResearch, réf. 109-005-098) conjugués au fluorophore Cy5 grâce à un kit de couplage (PA25001 GE Healthcare) et dilués dans du tampon borate (acide borique Merck ; 1001650500 ; 0,2 M, pH = 8,5), à une concentration finale de 0,023 mg/ml. Avant l'incubation, les anticorps dilués ont été centrifugés pendant 10 min à 14Ό00 tours par minute, à 4°C. Chaque lamelle obtenue a été retournée sur 200 μΙ de cette solution d'anticorps sur du parafilm (Dutscher, 090998) préalablement stérilisé pendant 1 h avec une lampe UV (365 nm) sous une hotte à flux laminaire (TELSTAR, AV-100), et incubée pendant 4 à 5 h à 23°C pour assurer une répartition uniforme des anticorps sur les micro-patterns.  One day before depositing the cells, the substrates were treated with goat anti-human Fc antibodies (Jackson ImmunoResearch, ref 109-005-098) conjugated to the Cy5 fluorophore through a coupling kit (PA25001 GE Healthcare) and diluted in borate buffer (Merck boric acid, 1001650500, 0.2 M, pH = 8.5), to a final concentration of 0.023 mg / ml. Prior to incubation, the diluted antibodies were centrifuged for 10 min at 1400 rpm at 4 ° C. Each coverslip obtained was inverted over 200 μl of this antibody solution on parafilm (Dutscher, 090998) previously sterilized for 1 h with a UV lamp (365 nm) under a laminar flow hood (TELSTAR, AV-100). and incubated for 4 to 5 hours at 23 ° C to ensure uniform antibody distribution on the micro-patterns.

L'exemple a été également réalisé en utilisant des anticorps de souris anti-6His (Santa Cruz, réf SC-8036) conjugués au fluorophore Cy5 grâce à un kit de couplage (PA25001 GE Healthcare) et dilués dans du tampon borate (acide borique Merck ; 1001650500 ; 0,2 M, pH = 8,5), à une concentration finale de 0,023 mg/ml.  The example was also carried out using anti-6His mouse antibodies (Santa Cruz, ref SC-8036) conjugated to the Cy5 fluorophore by means of a coupling kit (PA25001 GE Healthcare) and diluted in borate buffer (Merck boric acid). 1001650500, 0.2 M, pH = 8.5) at a final concentration of 0.023 mg / ml.

Par la suite, les substrats ont été soigneusement lavés avec du tampon borate, puis ont été incubés à 4°C pendant la nuit avec 100 μΙ de solution de neurexine-i -Fc purifiée, de N-cadhérine-Fc purifiée (R&D Systems, 1388-NC-050) ou de Fc humain (Jackson Immunoresearch, réf. 009-000-008) utilisé comme témoin, toutes les protéines étant diluées à 0,04 mg/ml dans le tampon borate. Ces solutions de protéines ont préalablement été centrifugées pendant 10 min à 14 000 tours par minute, à 4°C.  Subsequently, the substrates were thoroughly washed with borate buffer, and then incubated at 4 ° C overnight with 100 μl of purified neurexin-i-Fc, purified N-cadherin-Fc (R & D Systems, 1388-NC-050) or human Fc (Jackson Immunoresearch, P / N 009-000-008) used as a control, all the proteins being diluted to 0.04 mg / ml in the borate buffer. These protein solutions were previously centrifuged for 10 minutes at 14,000 rpm at 4 ° C.

Dans un autre mode de réalisation, les substrats ont été soigneusement lavés avec du tampon borate, puis ont été incubés à 4°C pendant la nuit, à savoir 16 heures avec 100 μΙ de solutions de SynCAM-1 - In another embodiment, the substrates were thoroughly washed with borate buffer, and then incubated at 4 ° C overnight, ie 16 hours with 100 μl of SynCAM-1 solutions.

Fc ou 6His-neuroligine-1 purifiées et diluées à 0,04 mg/ml dans le tampon borate. Ces solutions de protéines ont préalablement été centrifugées pendant 10 min à 14 000 tours par minute, à 4°C. Fc or 6His-neuroligin-1 purified and diluted to 0.04 mg / ml in buffer borate. These protein solutions were previously centrifuged for 10 minutes at 14,000 rpm at 4 ° C.

Le jour suivant, les substrats ont été placés dans une plaque de 6 puits, lavés 3 fois avec 1 ml de tampon borate et une fois avec 1 ml de milieu minimum essentiel (MEM) (21430-020, Gibco/lnvitrogen) complémenté avec 10% de sérum de cheval (16050-122, Gibco/lnvitrogen) et laissé dans 2,5 ml de MEM complémenté avec 10% de sérum de cheval pendant 1 à 2 heures dans un incubateur à 37°C et 5% de CO2 (Heraeus, HERACell 150).  The next day, the substrates were placed in a 6-well plate, washed 3 times with 1 ml of borate buffer and once with 1 ml of minimal essential medium (MEM) (21430-020, Gibco / Invitrogen) supplemented with % horse serum (16050-122, Gibco / Invitrogen) and left in 2.5 ml MEM supplemented with 10% horse serum for 1 to 2 hours in an incubator at 37 ° C and 5% CO2 (Heraeus , HERACell 150).

Exemple 2 : Culture de cellules neuronales avec le support de l'invention et étude du développement des cellules cultivées EXAMPLE 2 Culture of Neuronal Cells with the Support of the Invention and Study of the Development of Cultured Cells

Dans les exemples suivants, les procédés et matériaux utilisés sont ceux décrits ci-dessous :  In the following examples, the methods and materials used are those described below:

Culture cellulaire et transfection  Cell culture and transfection

Des neurones dissociés de l'hippocampe à partir d'embryons de rat E18 ont été étalés sur des substrats (100 000 cellules/substrat). Après 4 à 5 heures, les substrats ont été soigneusement lavés avec un milieu Neurobasal (NB) (Gibco, 12348-017) supplémenté avec du B27 (Gibco, 17504-044) et L-Glutamine (Glu200100, MidiMed) à 37°C pour éliminer les cellules non fixées, puis incubées dans 2,5 ml de ce même milieu pendant 8 à 10 jours. Au bout de trois jours Les neurones ont été transfectés avec les plasmides codant pour Neuroligine-1 -HA (fourni par P. Scheiffele), PSD-95 :EGFP (fourni par S ; Okabe) ou des vecteurs EGFP (Qiagen), en utilisant le kit Effectene (Qiagen, 301427), selon les instructions du fabricant, en utilisant un total de 2 μg d'ADN par puits. Pour les co- transfections de Neuroligine-1 -HA et EGFP ou de Neuroligine-1 -HA et PSD-95:EGFP, les plasmides ont été utilisés dans un rapport de 2:1 .  Neurons dissociated from the hippocampus from E18 rat embryos were spread on substrates (100,000 cells / substrate). After 4-5 hours, the substrates were thoroughly washed with Neurobasal (NB) medium (Gibco, 12348-017) supplemented with B27 (Gibco, 17504-044) and L-Glutamine (Glu200100, MidiMed) at 37 ° C. to remove unbound cells, then incubated in 2.5 ml of this same medium for 8 to 10 days. After 3 days the neurons were transfected with the plasmids encoding Neuroligin-1-HA (provided by P. Scheiffele), PSD-95: EGFP (provided by S. Okabe) or EGFP vectors (Qiagen), using the Effectene kit (Qiagen, 301427), according to the manufacturer's instructions, using a total of 2 μg of DNA per well. For co-transfections of Neuroligin-1-HA and EGFP or Neuroligin-1-HA and PSD-95: EGFP, the plasmids were used in a ratio of 2: 1.

Dans un autre mode de réalisation, les neurones ont été transfectés avec des plasmides codant pour la Neurexine-i -GFP (fourni par M. Missler), N-cadhérine-RFP (fourni par R.M. Mège) ou des vecteurs pour la protéine fluorescente rouge (RFP) (Qiagen). In another embodiment, the neurons were transfected with plasmids encoding Neurexin-i-GFP (provided by M. Missler), N-cadherin-RFP (provided by RM Mege) or vectors for red fluorescent protein (RFP) (Qiagen).

Immuno-marquage  Immunolabeling

Pour visualiser le recrutement de neuroligine-1 à la surface des neurones, les cultures transfectées avec la Neuroligine-1 -HA ont été fixées à 37°C dans une solution de tampon phosphate salin (PBS) (Euromedex ET330) complémenté avec 4% de paraformaldéhyde (VWR 28794.295,) et 4% de saccharose (Fluka 84097) pendant 10 min, et les sites restant actifs ont été saturés avec 1 ml d'une solution 50 mM de NH CI dans du PBS pendant 15 min. Les liaisons non spécifiques ont été bloquées avec 1 ml de PBS contenant 1 % de sérum albumine de bovin (Sigma ; A3059). Puis, les neurones ont été colorés avec un anticorps de rat anti-HA dilué 1 :400 dans du tampon phosphate salin (PBS) (Roche, 1 1867423001 ) suivi par un anticorps de chèvre anti-rat conjugué à Alexa568 (Invitrogen A1 1077 ; 2 mg/ml) dilué à 1 :800 dans le PBS pendant 30 min à 23°C. Pour marquer les protéines PSD-95 endogènes, les cellules ont été fixées et perméabilisées dans 0,1 % de Triton X 100 (T9284, Sigma) dans du PBS pendant 5 min. Les liaisons non spécifiques ont été bloquées avec 1 ml de PBS contenant 1 % de BSA. Les neurones ont été marqués avec un anticorps de souris anti-PSD-95 (Neuromab 75-028, 1 :400) suivi par des anticorps de chèvre anti-souris conjugués au fluorophore Alexa568 (2 mg/ml dilution 1 :800, Invitrogen A1 1004). Pour marquer les filaments d'actine, les cellules ont été fixées et perméabilisées dans 0,1 % de Triton X 100 (T9284, Sigma) dans du PBS pendant 5 min. Les liaisons non spécifiques ont été bloquées avec 1 ml de PBS contenant 1 % de BSA, puis les neurones ont été traités avec la phallicidine-Bodipy (marque déposée) FL (Molecular Probes, Invitrogen, B607) diluée 1 :100 dans le PBS. Les lamelles ont été ensuite montées sur des lames de verre (Waldemar Knittel, Braunschweig, Allemagne) avec une goutte de Mowiol (Calbiochem) et scellées avec du vernis (Cochon). L'immunomarquage a également été réalisé avec des anticorps de lapin anti-DsRed (Clontech 632496, 1 :800) suivis d'anticorps secondaires conjugués à Alexa568 pour visualiser la RFP et la N-cadhérine-RFP transfectées, selon le procédé décrit ci-dessus. To visualize the recruitment of neuroligin-1 on the surface of neurons, cultures transfected with Neuroligin-1-HA were fixed at 37 ° C in a solution of phosphate buffered saline (PBS) (Euromedex ET330) supplemented with 4% of paraformaldehyde (VWR 28794.295,) and 4% sucrose (Fluka 84097) for 10 min, and the remaining active sites were saturated with 1 ml of a 50 mM NH Cl solution in PBS for 15 min. Nonspecific binding was blocked with 1 ml of PBS containing 1% bovine serum albumin (Sigma, A3059). Then, the neurons were stained with anti-HA rat antibody diluted 1: 400 in phosphate buffered saline (PBS) (Roche, 11867423001) followed by Alexa568 conjugated goat anti-rat antibody (Invitrogen A1 1077; 2 mg / ml) diluted 1: 800 in PBS for 30 min at 23 ° C. To label endogenous PSD-95 proteins, the cells were fixed and permeabilized in 0.1% Triton X 100 (T9284, Sigma) in PBS for 5 min. Nonspecific binding was blocked with 1 ml of PBS containing 1% BSA. The neurons were labeled with anti-PSD-95 mouse antibody (Neuromab 75-028, 1: 400) followed by Alexa568 fluorophore-conjugated goat anti-mouse antibodies (2 mg / ml dilution 1: 800, Invitrogen A1 1004). To label the actin filaments, the cells were fixed and permeabilized in 0.1% Triton X 100 (T9284, Sigma) in PBS for 5 min. Nonspecific binding was blocked with 1 ml of PBS containing 1% BSA, and then the neurons were treated with phallicidin-Bodipy (trademark) FL (Molecular Probes, Invitrogen, B607) diluted 1: 100 in PBS. The slides were then mounted on glass slides (Waldemar Knittel, Braunschweig, Germany) with a drop of Mowiol (Calbiochem) and sealed with varnish (Pig). Immunostaining was also performed with anti-DsRed rabbit antibodies (Clontech 632496, 1: 800) followed by Alexa568-conjugated secondary antibodies to visualize the transfected RFP and N-cadherin-RFP, according to the method described above. above.

L'immunomarquage a également été réalisé avec des anticorps de souris anti-synapsine (Synaptic Systems 106001 , 1 :400), ou des anticorps de lapin anti-SynCAM-1 (Novus NB 300-186, 1 :400) suivis d'anticorps secondaires fluorescents pour marquer la synapsine ou les molécules d'adhésion SynCAM-1 endogènes selon le procédé décrit ci-dessus. Immunostaining was also performed with anti-synapsin mouse antibodies (Synaptic Systems 106001, 1: 400), or anti-SynCAM-1 rabbit antibodies (Novus NB 300-186, 1: 400) followed by antibodies. Fluorescent side effects for labeling synapsin or endogenous SynCAM-1 adhesion molecules according to the method described above.

Analyse des images Image analysis

Les immuno-marquages ont été visualisés sur un microscope à épifluorescence droit de type Leica DM R (Leica Microsystems, Wetzlar, Allemagne) équipé d'un objectif 63x/1 ,32 NA et un jeu de filtres Chroma Technology (Bellows Falls, VT, USA) pour l'EGFP: excitation : S490/20 nm, émission : S528/38 nm , dichroïque: 86100bs; le TRITC ou la RFP: excitation : S555/28 nm, émission : S617/73, dichroïque: 101848; le Cy5: excitation : S635/20, émission : S685/40 nm, dichroïque: 101848. Les images ont été acquises avec une caméra CCD (HQ Coolsnap, Roper Scientific, Evry, France), en utilisant le logiciel Metamorph (Universal Imaging Corp.)  Immunolabels were visualized on a Leica DM R-type right epifluorescence microscope (Leica Microsystems, Wetzlar, Germany) equipped with a 63x / 1, 32 NA objective and a Chroma Technology filter set (Bellows Falls, VT, USA) for EGFP: excitation: S490 / 20 nm, emission: S528 / 38 nm, dichroic: 86100bs; TRITC or RFP: excitation: S555 / 28 nm, emission: S617 / 73, dichroic: 101848; the Cy5: excitation: S635 / 20, emission: S685 / 40 nm, dichroic: 101848. The images were acquired with a CCD camera (HQ Coolsnap, Roper Scientific, Evry, France), using the software Metamorph (Universal Imaging Corp. .)

Les facteurs d'enrichissement de Neuroligine-1 et de PSD-95 ont été mesurés sur 3 régions dendritiques choisies au hasard sur chaque neurone et ont été calculés en utilisant un programme automatique écrit dans le logiciel Metamorph (Universal Imaging Corp), et une procédure explicitée dans la figure 5.  The enrichment factors of Neuroligin-1 and PSD-95 were measured on 3 dendritic regions randomly selected on each neuron and were calculated using an automatic program written in the Metamorph (Universal Imaging Corp) software, and a procedure explained in Figure 5.

Les facteurs d'enrichissement de RFP et N-cadhérine-RFP ont été mesurés sur 3 régions axonales choisies au hasard sur chaque neurone et ont été calculés selon la procédure explicitée dans la figure 5.  The RFP and N-cadherin-RFP enrichment factors were measured on 3 axonal regions randomly selected on each neuron and were calculated according to the procedure explained in Figure 5.

Décaqeaqe de glutamate Les neurones d'hippocampe dissociés transfectés avec la Neuroligine-1 -HA et la PSD-95:mCherry, et qui ont poussé pendant 7 à 8 jours sur les substrats comprenant des îlots recouverts de neurexine-ΐ β- Fc, ont été marqués avec 2,5 μΜ de Fluo-4-AM (Invitrogen ; F23917) pendant 5 min dans un milieu de culture Neurobasal (NB) (Gibco, 12348- 017) complété avec du B27 (Gibco, 17504-044) et L-Glutamine (Glu200100, MidiMed) puis placé dans 400 μΙ de Tyrode (30 mM de glucose, 120 mM NaCI, 5 mM de KCI, 0,1 mM MgCI2, 2 mM de CaCI2, 25 mM d'HEPES (Sigma; glucose : G6152, NaCI : S7653, KCI: P4504, MgCI2 : M8266, CaCI2 : C7902, HEPES: H4034) complémenté avec 5 mM de 4-méthoxy-7-nitroindolinyl-cage L-glutamate (MNI-glu) (Tocris, 1490), et 1 μΜ TTX (Ascent Scientific, ASC-055) pour éviter la génération d'éventuels potentiels d'action. Decay of glutamate The dissociated hippocampal neurons transfected with Neuroligin-1-HA and PSD-95: mCherry, which grew for 7 to 8 days on substrates comprising islets coated with neurexin-β-Fc, were labeled with 2.5 μl of Fluo-4-AM (Invitrogen; F23917) for 5 min in Neurobasal (NB) culture medium (Gibco, 12348-017) supplemented with B27 (Gibco, 17504-044) and L-Glutamine ( Glu200100, MidiMed) then placed in 400 μl of Tyrode (30 mM glucose, 120 mM NaCl, 5 mM KCl, 0.1 mM MgCl 2 , 2 mM CaCl 2 , 25 mM HEPES (Sigma, glucose: G6152 NaCl: S7653, KCI: P4504, MgCl 2: M8266, CaCl 2: C7902, HEPES: H4034) supplemented with 5 mM 4-methoxy-7-nitroindolinyl cage-L-glutamate (MNI-glu) (Tocris, 1490) , and 1 μΜ TTX (Ascent Scientific, ASC-055) to avoid the generation of potential action potentials.

La chambre d'observation a été placée sur un microscope confocal à balayage laser (TCS SP5; Leica) thermostatée à 37°C et équipé d'un laser puisé bi-photon (Mai Tai; Spectra-Physics) réglé à 750 nm. Pour les enregistrements de fluorescence, une zone de 100 x 100 m a été balayée à 700 Hz par un laser Argon à 488 nm et la fluorescence a été recueillie entre 500 et 530 nm par un photomultiplicateur, en utilisant un objectif à huile HCX PL APO CS 63X/1 .32 NA et un iris ouvert à trois fois le disque d'Airy (180 μηη).  The observation chamber was placed on a confocal scanning laser microscope (TCS SP5, Leica) thermostated at 37 ° C and equipped with a bi-photon pulsed laser (Mai Tai Spectra-Physics) set at 750 nm. For fluorescence recordings, an area of 100 x 100 m was scanned at 700 Hz by an Argon laser at 488 nm and the fluorescence was collected between 500 and 530 nm by a photomultiplier, using an HCX PL APO CS oil lens. 63X / 1 .32 NA and an iris open three times the Airy disk (180 μηη).

Après l'enregistrement d'une ligne de base, une impulsion de lumière bi-photon d'une durée de 10 ms correspondant à un balayage d'une zone restreinte de 2 μιτι de diamètre, à proximité d'un îlot, a été imposée pour décager le glutamate cagé. Les signaux de fluorescence de Fluo-4 ont alors été enregistrés pendant 1 minute.  After the recording of a baseline, a bi-photon light pulse with a duration of 10 ms corresponding to a scan of a restricted zone of 2 μιτι in diameter, near an island, was imposed to discard caged glutamate. Fluorescence signals from Fluo-4 were then recorded for 1 minute.

Pour représenter la réponse calcique obtenue lors du décageage de MNI-glu, les valeurs d'intensité de fluorescence du fluo-4 à un endroit donné ont été normalisées à l'intensité moyenne de fluorescence obtenue avant l'impulsion lumineuse bi-photon. Imagerie de cellules vivantes To represent the calcium response obtained during MNI-glu decapping, the fluorescence intensity values of fluo-4 at a given location were normalized to the average fluorescence intensity obtained before the bi-photon light pulse. Live cell imaging

Les neurones primaires hippocampiques (DIV7) cultivés sur la neurexine-1 β-Fc recouvrant les micro-motifs et exprimant Nlgn-1 WT et PSD-95:EGFP ont été placés dans une chambre ouverte contenant un mélange 1 :1 d'une solution de Tyrode et de milieu conditionné NB. Les cellules ont ensuite été observées sur un microscope inversé Leica 6000 DMI (Leica Microsystems, Wetzlar, Allemagne), équipé d'une caméra CCD (Coolsnap HQ2, Roper Scientific, Evry, France) et une boîte thermostatique (Life Imaging Services, Bâle, Suisse) fournissant 37°C et 5% de CO2. The hippocampal primary neurons (DIV7) cultured on neurexin-1 β-Fc covering the micro-motifs and expressing Nlgn-1 WT and PSD-95: EGFP were placed in an open chamber containing a 1: 1 mixture of a solution. of Tyrode and NB conditioned medium. The cells were then observed on a Leica 6000 DMI inverted microscope (Leica Microsystems, Wetzlar, Germany), equipped with a CCD camera (Coolsnap HQ2, Roper Scientific, Evry, France) and a thermostatic box (Life Imaging Services, Basel, Switzerland) providing 37 ° C and 5% CO 2 .

Des acquisitions sur des périodes de plusieurs heures ont été faites en utilisant un éclairage avec une lampe au mercure, un objectif HCX PL APO CS d'huile 63X 1 ,32 NA et des filtres interférentiels de la compagnie Chroma Technology (Bellows Falls, VT, USA), pour l'observation de la EGFP (excitation HQ 480/30 nm, dichroïque 86100bs, émission S528/38 nm) et de Cy5 (excitation HQ630/20 nm, dichroïque 101848, émission S685/40 nm). Des images de PSD-95:EGFP ont été enregistrées toutes les 10 min pendant 4 h, tandis que des images des motifs Cy5 ont été prises seulement deux fois, l'une avant et l'autre après l'acquisition.  Acquisitions over periods of several hours were made using mercury lamp illumination, an HCX PL APO CS oil objective 63X1, 32 NA and interferential filters from Chroma Technology (Bellows Falls, VT). USA), for the observation of EGFP (excitation HQ 480/30 nm, dichroic 86100bs, emission S528 / 38 nm) and Cy5 (excitation HQ630 / 20 nm, dichroic 101848, emission S685 / 40 nm). Images of PSD-95: EGFP were recorded every 10 min for 4 h, while images of the Cy5 patterns were taken only twice, one before and one after the acquisition.

Résultats et discussion Results and discussion

Les protéines d'adhésion transmembranaires, neurexines et neuroligines sont des acteurs clés dans la formation des synapses (Sudhof, T. C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903-1 1 (2008). [36]). Ces molécules forment un lien entre les membranes pré- et post-synaptiques par une reconnaissance de haute affinité entre leurs ectodomaines (Craig, A. M. & Kang, Y. Neurexin- neuroligin signaling in synapse development. Curr Opin Neurobiol 17, 43- 52 (2007). [41 ]). Lorsqu'on les présente à la surface de cellules hétérologues ou de microsphères, la neuroligine et la neurexine ont la capacité de générer respectivement des pré- et post-synapses fonctionnelles, lors de contacts avec des neurones primaires (Graf, E. R., Zhang, X., Jin, S. X., Linhoff, M. W. & Craig, A. M. Neurexins induce differentiation of GABA and glutamate postsynaptic spécial izations via neuroligins. Cell 1 19, 1013-26 (2004). [34], Heine, M., Thoumine, O., Mondin, M., Tessier, B., Giannone, G. & Choquet, D. Activity-independent and subunit-specific recruitment of functional AMPA receptors at neurexin/neuroligin contacts. Proc Natl Acad Sci U S A 105, 20947-52 (2008). [35], Scheiffele, P., Fan, J., Choih, J., Fetter, R. & Serafini, T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101 , 657-69. (2000). [35], Sudhof, T. C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903-1 1 (2008). [36], Ko, J., Zhang, C., Arac, D., Boucard, A. A., Brunger, A. T. & Sudhof, T. C. Neuroligin-1 performs neurexin- dependent and neurexin-independent functions in synapse validation. Embo J 28, 3244-55 (2009). [37]). L'importance de la neurexine et de la neuroligine dans la fonction synaptique est encore soulignée par les phénotypes anormaux des modèles de souris « knock-out » (Chubykin, A. A., Atasoy, D., Etherton, M. R., Brose, N., Kavalali, E. T., Gibson, J. R. & Sudhof, T. C. Activity-Dependent Validation of Excitatory versus Inhibitory Synapses by Neuroligin-1 versus Neuroligin-2. Neuron 54, 919-31 (2007). Transmembrane adhesion proteins, neurexins, and neuroligins are key players in synapse formation (Sudhof, TC Neuroligins and neurexins link synaptic function to cognitive disease, Nature 455, 903-1 1 (2008) [36]). These molecules form a link between the pre- and postsynaptic membranes by a high affinity recognition between their ectodomains (Craig, AM & Kang, Y. Neurexineuroligin signaling in synapse development, Curr Opin Neurobiol 17, 43-52 (2007). [41]). When present on the surface of heterologous cells or microspheres, neuroligin and neurexin have the ability to generate pre- and post-synapses, respectively. functional, in contact with primary neurons (Graf, ER, Zhang, X., Jin, SX, Linhoff, MW & Craig, AM Neurexins induce differentiation of GABA and glutamate postsynaptic special izations via neuroligins Cell 1 19, 1013-26 (2004) [34], Heine, M., Thoumine, O., Mondin, M., Tessier, B., Giannone, G. & Choquet, D. Activity-independent and subunit-specific recruitment of functional AMPA receptors. neuromycin / neuroligin contacts Proc Natl Acad Sci USA 105, 20947-52 (2008) [35], Scheiffele, P., Fan, J., Choih, J., Fetter, R. & Serafini, T. Neuroligin Nonneuronal cells triggers presynaptic development in contacting axons, Cell 101, 657-69 (2000). [35], Sudhof, TC Neuroligins and neurexins link synaptic function to cognitive disease, Nature 455, 903-1 1 (2008). ], Ko, J., Zhang, C., Arac, D., Boucard, AA, Brunger, AT & Sudhof, TC Neuroligin-1 performs neurexin-dependent and neurexin-independent functions in synapse validation. [Embo] J 28, 3244- 55 (2009). [37] ]). The importance of neurexin and neuroligin in synaptic function is further underlined by the abnormal phenotypes of knockout mouse models (Chubykin, AA, Atasoy, D., Etherton, MR, Brose, N., Kavalali). , And, Gibson, JR & Sudhof, TC Activity-Dependent Validation of Excitatory versus Inhibitory Synapses by Neuroligin-1 versus Neuroligin-2 Neuron 54, 919-31 (2007).

[42] ; Missler, M., Zhang, W., Rohlmann, A., Kattenstroth, G., Hammer, R. E., Gottmann, K. & Sudhof, T. C. Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. Nature 423, 939-48 (2003). [43] Varoqueaux, F., Aramuni, G., Rawson, R. L., Mohrmann, R., Missler, M., Gottmann, K., Zhang, W., Sudhof, T. C. & Brose, N. Neuroligins détermine synapse maturation and function. Neuron 51 , 741 -54 (2006). [44]). [42] Missler, M., Zhang, W., Rohlmann, A., Kattenstroth, G., Hammer, R.E., Gottmann, K. & Sudhof, T.C. Alpha-neurexins Ca2 + couple channels to synaptic vesicle exocytosis. Nature 423, 939-48 (2003). [43] Varoqueaux, F., Aramuni, G., Rawson, RL, Mohrmann, R., Missler, M., Gottmann, K., Zhang, W., Sudhof, TC & Brose, N. Neuroligins determines synapse maturation and function. Neuron 51, 741-54 (2006). [44]).

Ces éléments montrent bien l'importance des molécules d'adhésion dans la croissance axonale et la synaptogénèse.  These elements clearly show the importance of adhesion molecules in axonal growth and synaptogenesis.

Le présent exemple via l'utilisation du support de culture de l'invention a permis avantageusement de cultiver des cellules neuronales et un contrôle spatial de la formation de synapses à une résolution micrométrique, de part les propriétés d'adhésion du complexe synaptogène neurexine/neuroligine (Figures 1 et 2). The present example via the use of the culture support of the invention has advantageously allowed to cultivate neuronal cells and a spatial control of the formation of synapses at a resolution micrometric, due to the adhesion properties of the synaptogenic neurexin / neuroligin complex (Figures 1 and 2).

La culture de neurones hippocampiques de rat sur des substrats possédant des îlots revêtus de neurexine purifiée a été réalisée et les cellules obtenues sont représentées sur les Figures 3 et 4. Les substrats à îlots possèdent un réseau régulier d'îlots activés chimiquement (1 ,5 μιτι de diamètre, séparés par 5 μιτι), entouré d'un fond non-adhésif. Les îlots ont été revêtus d'une neurexine-1 β recombinante fusionnée avec le fragment constant des IgG humain, Fc (ΝΓχΙ β-Fc), ou de Fc pur utilisé en tant que molécule témoin. Le couplage a été fait via un anticorps secondaire anti-Fc marqué avec le fluorophore Cy5, permettant avantageusement à la fois la bonne orientation de l'ectodomaine adhésif et la visualisation de la fluorescence des micro-îlots.  The rat hippocampal neuron culture on substrates with islets coated with purified neurexin was performed and the cells obtained are shown in Figures 3 and 4. The islet substrates have a regular network of chemically activated islets (1, 5). μιτι of diameter, separated by 5 μιτι), surrounded by a non-adhesive bottom. The islets were coated with a recombinant neurexin-1 β fused with the constant fragment of human IgG, Fc (ΝΓχΙ β-Fc), or pure Fc used as a control molecule. The coupling was done via a secondary anti-Fc antibody labeled with the Cy5 fluorophore, advantageously allowing both the good orientation of the adhesive ectodomain and the visualization of the fluorescence of the micro-islets.

Des neurones d'hippocampe dissociés ont été placés sur ces substrats et ont permis leurs développements pendant 7 à 10 jours. Les neurones ont été transfectées après 4 jours avec de la neuroligine-1 (Nlgn- 1 ), ou de la protéine fluorescente verte (EGFP) comme témoin.  Dissociated hippocampal neurons were placed on these substrates and allowed their development for 7 to 10 days. The neurons were transfected after 4 days with neuroligin-1 (Nlgn-1), or green fluorescent protein (EGFP) as a control.

La reconnaissance entre la ΝΓχΙ β-Fc immobilisée et la neuroligine-1 exprimé dans les neurones à fortement affecté la morphologie cellulaire et limité la croissance en fonction de la géométrie et du positionnement des îlots tel que représenté sur la Figure 3. De façon surprenante et avantageuse, les dendrites des neurones exprimant la neuroligine-1 se sont propagés de façon préférentielle le long des lignes d'îlots recouverts de neurexine-1 β-Fc et les ont envahis à un degré beaucoup plus élevé que les axones de ces mêmes cellules (Figure 4).  Recognition between immobilized ΝΓχΙ β-Fc and neuroligin-1 expressed in neurons strongly affected cellular morphology and limited growth as a function of island geometry and positioning as shown in Figure 3. Surprisingly, Advantageously, the dendrites of the neurons expressing neuroligin-1 propagated preferentially along the islet lines covered with neurexin-1 β-Fc and invaded them to a much higher degree than the axons of these same cells ( Figure 4).

Ceci démontre bien la mise en contact des neurones avec le dispositif de l'invention.  This demonstrates the contact between the neurons and the device of the invention.

Etude de la croissance des cellules neuronales et formation d'assemblages post-svnaptiques Pour examiner la formation de post-synapses sur ces substrats, l'accumulation des protéines post-synaptiques neuroligine-1 et PSD-95, ou de la protéine témoin EFGP, sur des îlots recouverts de neurexine-1 β-Fc ou de Fc a été examinée pour chaque condition. Un indice d'enrichissement a été calculé en divisant l'intensité moyenne de fluorescence de la protéine donnée dans des zones dendritique de co- localisation avec des îlots revêtu de protéines, par l'intensité moyenne de fluorescence des zones dendritiques situé entre les îlots (Figure 5). Du fait que chaque neurone entre en contact avec des centaines de micro-îlots, les valeurs des échantillons statistiques permettant les comparaisons deviennent vite très élevées. La quantification présentée en Figure 6 montre que les deux protéines étaient significativement recrutées aux îlots recouverts de Nrx1 -Fc (Nlgn-1 : 26 cellules, n=2608 îlots; NLGN-1 + PSD- 95:EGFP: 17 cellules, n=993 îlots). Le recrutement détecté était spécifique de l'interaction neurexine/neuroligine (EGFP : 24 cellules, n = 1045 îlots; EGFP + PSD-95:mCherry : 7 cellules, n = 446 îlots) ou un revêtement des îlots avec du Fc au lieu de la ΝΓχΙ β-Fc (Nlgn-1 : 1 1 cellules, n = 608 îlots; Nlgn-1 + PSD-95:EGFP : 3 cellules, n = 158 îlots). La protéine endogène PSD-95 a également été significativement recrutée au niveau des îlots (15 cellules, n = 1482 îlots). Study of neuronal cell growth and formation of post-svnaptic assemblages To examine the formation of post-synapses on these substrates, the accumulation of post-synaptic neuroligin-1 and PSD-95 proteins, or the EFGP control protein, on islets coated with neurexin-1 β-Fc or Fc a been examined for each condition. An enrichment index was calculated by dividing the average fluorescence intensity of the given protein into co-localization dendritic zones with protein-coated islands, by the average fluorescence intensity of the dendritic zones located between the islets ( Figure 5). Since each neuron comes into contact with hundreds of micro-islands, the values of the statistical samples allowing the comparisons quickly become very high. The quantitation shown in Figure 6 shows that both proteins were significantly recruited to Nrx1-Fc coated islands (Nmin-1: 26 cells, n = 2608 islets, NLGN-1 + PSD-95: EGFP: 17 cells, n = 993 islands). The detected recruitment was specific for the neurexin / neuroligin interaction (EGFP: 24 cells, n = 1045 islets, EGFP + PSD-95: mCherry: 7 cells, n = 446 islets) or islet coating with Fc instead of ββ-Fc (Nlgn-1: 1 1 cells, n = 608 islets, Nlgn-1 + PSD-95: EGFP: 3 cells, n = 158 islets). The endogenous PSD-95 protein was also significantly recruited at the islet level (15 cells, n = 1482 islets).

Il a été observé des structures de type épines dendritiques montrant une accumulation de neuroligine-1 dans la partie périphérique des filopodes attachée au micro-pattern recouvert de neurexine-1 β-Fc (Figure 3c). Aussi, afin de mieux comprendre la dynamique de la formation des synapses, ce système a été combiné avec la vidéo-microscopie pour imager en direct la fluorescence de la PSD-95 :EGFP. L'un des avantages de l'utilisation du substrat de culture de l'invention comprenant des îlots par rapport à des observations aléatoires de la formation des synapses est que l'on contrôle la position où la formation des synapses est attendue. Un point qui n'est pas encore clair dans la littérature est de savoir si les synapses se forment entre les filopodes axonaux contactant les dendrites, ou entre les filopodes dendritiques contactant les axones. Cet exemple démontre clairement que les filopodes dendritiques, grâce un agrégat de la protéine d'échafaudage PSD-95 situé à l'extrémité du filopode, peuvent atteindre les micro-îlots de neurexine et établir un contact ferme dans les 3 heures (Figure 7). Ces complexes préformés contenant de la Neuroligine-1 et de la PSD-95, sont susceptibles de servir de précurseurs post- synaptiques prédéterminés pour l'établissement de nouvelles synapses excitatrices fonctionnelles. Dendritic spine-like structures have been observed showing an accumulation of neuroligin-1 in the peripheral part of the filopodia attached to the micro-pattern coated with neurexin-1β-Fc (Figure 3c). Also, in order to better understand the dynamics of synapse formation, this system was combined with video microscopy to live imaging the fluorescence of PSD-95: EGFP. One of the advantages of using the culture substrate of the invention comprising islets with respect to random observations of synapse formation is that the position where synapse formation is expected is controlled. One point that is not yet clear in the literature is whether the Synapses are formed between the axonal filopodia contacting the dendrites, or between the dendritic filopodia contacting the axons. This example clearly demonstrates that the dendritic filopodia, thanks to an aggregate of the PSD-95 scaffold protein located at the end of the filopodium, can reach micro-islets of neurexin and establish firm contact within 3 hours (Figure 7). . These preformed complexes containing Neuroligin-1 and PSD-95 are likely to serve as predetermined post-synaptic precursors for the establishment of new functional excitatory synapses.

Cet exemple démontre clairement que le dispositif de l'invention permet de cultiver et d'étudier les mécanismes physiologiques, par exemple du développement des synapses.  This example clearly demonstrates that the device of the invention makes it possible to cultivate and study the physiological mechanisms, for example the development of synapses.

Etude de la formation de synapses par les cellules neuronales en culture sur le substrat de l'invention Study of the formation of synapses by neuronal cells in culture on the substrate of the invention

Cette étape est également une étude de la fonction des assemblages post-synaptiques sur le dispositif de l'invention recouvert de neurexine.  This step is also a study of the function of the postsynaptic assemblies on the device of the invention covered with neurexin.

Dans un deuxième temps, il a été testé si les contacts neuronaux nouvellement formés sur les îlots de neurexine contenaient des récepteurs fonctionnels au glutamate, en utilisant la technique de décageage de glutamate et l'imagerie du calcium. Les neurones ont été transfectés avec la PSD-95:mCherry afin de visualiser les différenciations post-synaptiques et incubées avec un indicateur de calcium pénétrant dans les cellules (le Fluo-4).  In a second step, it was tested whether the newly formed neuronal contacts on the islets of neurexin contained functional glutamate receptors, using the glutamate decapping technique and calcium imaging. Neurons were transfected with PSD-95: mCherry to visualize post-synaptic differentiations and incubated with a cell-penetrating calcium indicator (Fluo-4).

Lorsque le M NI -glutamate a été photo-libéré à proximité d'îlots de neurexine montrant une accumulation de PSD-95-mcherry, des flux calciques transitoires locaux et sélectifs ont été enregistrées (Figure 8), démontrant ainsi la présence de canaux fonctionnels des récepteurs du glutamate. Dans une étude précédente, en utilisant des billes recouvertes de neurexine-1 β-Fc, il a été montré que les flux calciques transitoires sont dus à canaux calciques voltage dépendants qui s'ouvrent grâce la dépolarisation de la membrane induite par l'activation des récepteurs AMPA par le glutamate (Heine, M., Thoumine, O., Mondin, M., Tessier, B., Giannone, G. & Choquet, D. Activity-independent and subunit-specific recruitment of functional AMPA receptors at neurexin/neuroligin contacts. Proc Natl Acad Sci U S A 105, 20947-52 (2008). [34]). When M NI -glutamate was photo-released near neurexin islands showing PSD-95-mcherry accumulation, local and selective transient calcium fluxes were recorded (Figure 8), demonstrating the presence of functional channels. glutamate receptors. In a previous study, using beads coated with neurexin-1 β-Fc, it was shown that transient calcium fluxes are due to voltage-gated calcium channels that open through the Membrane depolarization induced by AMPA receptor activation by glutamate (Heine, M., Thoumine, O., Mondin, M., Tessier, B., Giannone, G. & Choquet, D. Activity-independent and subunit -specific recruitment of functional AMPA receptors at neurexin / neuroligin contacts Proc Natl Acad Sci USA 105, 20947-52 (2008) [34]).

Etude de la croissance neuritique et de la formation de pré-synapses des cellules neuronales sur le substrat de l'invention Study of the neuritic growth and the formation of pre-synapses of neuronal cells on the substrate of the invention

Cet exemple a également pour objet l'étude de la croissance des neurites et de la formation de pré-synapses par les cellules neuronales en culture sur le substrat de l'invention.  This example also relates to the study of the growth of neurites and the formation of pre-synapses by the neuronal cells in culture on the substrate of the invention.

En outre le dispositif de l'invention permet via l'utilisation de différentes protéines d'adhésion immobilisées au niveau des îlots, l'étude sélective de différents systèmes synaptiques, ou de protéines impliquées dans la croissance des axones et dendrites. Par exemple, lorsque la N- cadhérine-Fc a été déposée, une croissance importante des neurites a été observée dans des directions en relation avec la disposition des îlots, accompagnée d'une adhésion et d'une migration spécifique des cônes de croissance, ce qui n'était pas le cas pour des substrats recouverts de la molécule témoin Fc (Figure 9). De plus, les cellules transfectées avec N- cadhérine-RFP, mais pas les cellules transfectées avec la protéine témoin RFP, ont montré une accumulation locale de N-cadhérine-RFP sur les îlots recouverts de N-cadhérine-Fc (Figure 10). Cet exemple a également pour objet l'étude de la croissance axonale et de la formation de pré-synapses par les cellules neuronales en culture en utilisant le dispositif de l'invention ainsi que l'étude de la formation de pré-synapses par les cellules neuronales en contact avec le substrat de l'invention recouvert de Neuroligine-1 ou SynCAM-1 .  In addition the device of the invention allows via the use of different immobilized adhesion proteins at the islet level, the selective study of different synaptic systems, or proteins involved in the growth of axons and dendrites. For example, when N-cadherin-Fc was deposited, significant growth of neurites was observed in directions related to islet disposition, accompanied by adhesion and specific migration of growth cones. which was not the case for substrates coated with the control molecule Fc (FIG. 9). In addition, cells transfected with N-cadherin-RFP, but not cells transfected with the RFP control protein, showed local accumulation of N-cadherin-RFP on the N-cadherin-Fc coated islands (Figure 10). This example also relates to the study of axonal growth and the formation of pre-synapses by neuronal cells in culture using the device of the invention as well as the study of the formation of pre-synapses by the cells. neurons in contact with the substrate of the invention coated with Neuroligin-1 or SynCAM-1.

Le dispositif de l'invention permet également via l'utilisation de différentes protéines d'adhésion immobilisées au niveau des îlots, l'étude sélective de différents systèmes synaptiques, ou de protéines impliquées dans la croissance des axones et dendrites. Par exemple, lorsque la molécule 6His-Neuroligine-1 a été déposée sur les îlots, une croissance importante des axones a été observée dans des directions en relation avec la disposition des îlots, ainsi qu'une accumulation de neurexin-GFP dans les axones des neurones transfectés (Figure 1 1 ). De même, lorsque la molécule SynCAM-1 -Fc a été déposée sur les îlots, une croissance importante des axones a été observée dans des directions en relation avec la disposition des îlots, ainsi qu'une accumulation de récepteurs SynCAM- 1 endogènes et de vésicules pré-synaptiques marquées par la synapsine (Figure 12). The device of the invention also makes it possible, via the use of different immobilized adhesion proteins at the level of the islets, the study selective of different synaptic systems, or proteins involved in the growth of axons and dendrites. For example, when the 6His-Neuroligin-1 molecule was deposited on the islets, significant growth of axons was observed in directions related to islet disposition, as well as accumulation of neurexin-GFP in the axons of the islets. transfected neurons (Figure 1 1). Similarly, when the SynCAM-1-Fc molecule was deposited on the islets, significant growth of the axons was observed in directions related to the islet disposition, as well as an accumulation of endogenous SynCAM-1 receptors and Presynaptic vesicles labeled with synapsin (Figure 12).

Autres applications Other applications

Tel que démontré dans cet exemple, le dispositif de l'invention permet d'étudier la formation des synapses et la fonction synaptique avec une production élevée de données statistiques et reproductibles. En outre, le dispositif de l'invention peut être largement utilisé avec d'autres molécules synaptogènes, comme les neuroligines, par exemple pour induire la formation de pré-synapses et/ou avec des protéines récemment identifiées comme les LRRTMs et les TrkC (Sudhof, T. C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903-1 1 (2008). [36], Linhoff, M. W., Lauren, J., Cassidy, R. M., Dobie, F. A., Takahashi, H., Nygaard, H. B., Airaksinen, M. S., Strittmatter, S. M. & Craig, A. M. An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron 61 , As demonstrated in this example, the device of the invention makes it possible to study the formation of synapses and synaptic function with a high production of statistical and reproducible data. In addition, the device of the invention can be widely used with other synaptogenic molecules, such as neuroligins, for example to induce the formation of pre-synapses and / or with newly identified proteins such as LRRTMs and TrkCs (Sudhof , TC Neuroligins and neurexins link synaptic function to cognitive disease, Nature 455, 903-1 (2008) [36], Linhoff, MW, Lauren, J., Cassidy, RM, Dobie, FA, Takahashi, H., Nygaard. , HB, Airaksinen, MS, Strittmatter, SM & Craig, Neuron 61, Neuron 61,

734-49 (2009). [38], Ko, J., Fuccillo, M. V., Malenka, R. C. & Sudhof, T. C. LRRTM2 Functions as a Neurexin Ligand in Promoting Excitatory Synapse Formation. Neuron 64, 791 -798 (2009). [39], de Wit, J., Sylwestrak, E., O'Sullivan, M., Otto, S., Tiglio, K., Savas, J. N., Yates, J. R., Comoletti, D., Taylor, P. & Ghosh, A. LRRTM2 Interacts with Neurexinl and Régulâtes734-49 (2009). [38], Ko, J., Fuccillo, M.V., Malenka, R.C. & Sudhof, T.C. LRRTM2 Functions as a Neurexin Ligand in Promoting Excitatory Synapse Formation. Neuron 64, 791-798 (2009). [39], Wit, J., Sylwestrak, E., O'Sullivan, M., Otto, S., Tiglio, K., Savas, JN, Yates, JR, Comoletti, D., Taylor, P. & Ghosh, A. LRRTM2 Interacts with Neurexin and Regulatics

Excitatory Synapse Formation. Neuron 64, 799-806 (2009). [40], Takahashi, H., Arstikaitis, P., Prasad, T., Bartlett, T. E., Wang, Y. T., Murphy, T. H. & Craig, A. M. Postsynaptic TrkC and presynaptic PTPsigma function as a bidirectional excitatory synaptic organizing complex. Neuron 69, 287-303 (201 1 ). [45]). Excitatory Synapse Training. Neuron 64, 799-806 (2009). [40], Takahashi, H., Arstikaitis, P., Prasad, T., Bartlett, TE, Wang, YT, Murphy, TH & Craig, AM Postsynaptic TrkC and presynaptic PTPsigma function as bidirectional excitatory synaptic organizing complex. Neuron 69, 287-303 (201 1). [45]).

Ainsi, le dispositif de l'invention peut être utilisé dans des procédés dans lesquels des molécules sont criblées afin d'étudier leur effet sur la différenciation synaptique. Il permet également de dépister de nouvelles cibles thérapeutiques pour des pathologies telles que l'autisme, la schizophrénie, et le retard mental lié au chromosome X chez l'homme, pathologies dans lesquelles des mutations des gènes codant pour les neuroligines et les neurexines semblent être impliquées ( Jamain, S., Quach, H., Betancur, C, Rastam, M., Colineaux, C, Gillberg, I. C, Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C. & Bourgeron, T. Mutations of the X-linked gènes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genêt 34, 27-9 (2003). [46], Talebizadeh, Z., Lam, D. Y., Theodoro, M. F., Bittel, D. C, Lushington, G. H. & Butler, M. Thus, the device of the invention can be used in processes in which molecules are screened to study their effect on synaptic differentiation. It also allows the detection of new therapeutic targets for pathologies such as autism, schizophrenia, and X-linked mental retardation in humans, pathologies in which mutations of the genes encoding neuroligins and neurexins appear to be involved (Jamain, S., Quach, H., Betancur, C., Rastam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C. & Bourgeron, T. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.Nat Genet 34, 27-9 (2003). [46], Talebizadeh, Z., Lam, DY, Theodoro, MF, Bittel, D.C., Lushington, GH & Butler, M.

G. Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. J Med Genêt 43, e21 (2006). [47], Rujescu, D., Ingason, A., Cichon, S., Pietilainen, O. P., Barnes, M. R., Toulopoulou, T., Picchioni, M., Vassos, E., Ettinger, U., Bramon, E., Murray, R., Ruggeri, M., Tosato, S.,G. Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. J Med Genet 43, e21 (2006). [47], Rujescu, D., Ingason, A., Cichon, S., Pietilainen, OP, Barnes, MR, Toulopoulou, T., Picchioni, M., Vassos, E., Ettinger, U., Bramon, E. Murray, R., Ruggeri, M., Tosato, S.,

Bonetto, C, Steinberg, S., Sigurdsson, E., Sigmundsson, T., Petursson,Bonetto, C, Steinberg, S., Sigurdsson, E., Sigmundsson, T., Petursson,

H. , Gylfason, A., Olason, P. I., Hardarsson, G., Jonsdottir, G. A., Gustafsson, O., Fossdal, R., Giegling, I., Moller, H. J., Hartmann, A. M., Hoffmann, P., Crombie, C, Fraser, G., Walker, N., Lonnqvist, J., Suvisaari, J., Tuulio-Henriksson, A., Djurovic, S., Melle, I., Andreassen, O. A., Hansen, T., Werge, T., Kiemeney, L. A., Franke, B., Veltman, J., Buizer- Voskamp, J. E., Sabatti, C, Ophoff, R. A., Rietschel, M., Nothen, M. M., Stefansson, K., Peltonen, L., St Clair, D., Stefansson, H. & Collier, D. A. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genêt 18, 988-96 (2009). [48]). Exemple 3 : Procédé de criblage de molécule sur des cultures de cellules neuronales avec le support de l'invention H., Gylfason, A., Olason, PI, Hardarsson, G., Jonsdottir, GA, Gustafsson, O., Fossdal, R., Giegling, I., Moller, HJ, Hartmann, AM, Hoffmann, P., Crombie , C, Fraser, G., Walker, N., Lonnqvist, J., Suvisaari, J., Tuulio-Henriksson, A., Djurovic, S., Miss, I., Andreassen, OA, Hansen, T., Werge , T., Kiemeney, LA, Franke, B., Veltman, J., Buizer-Voskamp, JE, Sabatti, C, Ophoff, RA, Rietschel, M., Nothen, MM, Stefansson, K., Peltonen, L. , St Clair, D., Stefansson, H. & Collier, DA Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 18, 988-96 (2009). [48]). Example 3 Method for Screening Molecules on Neuronal Cell Cultures with the Support of the Invention

Les cellules et les substrats de culture sont obtenus selon le procédé décrit dans les exemples 1 et 2 précités.  Cells and culture substrates are obtained according to the method described in Examples 1 and 2 above.

Après 4 jours de culture, les cellules neuronales cultivées sur les substrats recouverts de N-cadhérine-Fc (BD Transduction Laboratories (marque de commerce), ref 610921 ) sont mis en présence de peptides compétiteurs des interactions cadhérines, par exemple contenant les séquences HAV (1 mM) (Williams, E. J., Williams, G., Gour, B., Blaschuk, O. & Doherty, P. INP, a novel N-cadherin antagonist targeted to the amino acids that flank the HAV motif. Mol Cell Neurosci 15, 456-64 (2000). [49], Williams, E., Williams, G., Gour, B. J., Blaschuk, O. W. & Doherty, P. A novel family of cyclic peptide antagonists suggests that N-cadherin specificity is determined by amino acids that flank the HAV motif. J Biol Chem 275, 4007-12 (2000). [50]), de fragments protéiques adhésifs issus des cadhérines, par exemple les domaines EC1 -EC2 (Perret, E., Benoliel, A. M., Nassoy, P., Pierres, A., Delmas, V., Thiery, J. P., Bongrand, P. & Feracci, H. Fast dissociation kinetics between individual E-cadherin fragments revealed by flow chamber analysis. Embo J 21 , 2537-46 (2002).  After 4 days of culture, the neuronal cells cultured on substrates coated with N-cadherin-Fc (BD Transduction Laboratories (trademark), ref. 610921) are placed in the presence of peptides competing with cadherin interactions, for example containing the HAV sequences. (1 mM) (Williams, EJ, Williams, G., Gour, B., Blaschuk, O. & Doherty, P. INP, a novel N-cadherin antagonist targeted to amino acids that flank the HAV motif.) Mol Cell Neurosci 15, 456-64 (2000) [49], Williams, E., Williams, G., Gour, BJ, Blaschuk, OW & Doherty, P. A novel family of cyclic peptide antagonists suggests that N-cadherin specificity is determined. by amino acids that flank the HAV motif, J Biol Chem 275, 4007-12 (2000). [50]), adhesive protein fragments derived from cadherins, for example the EC1-EC2 domains (Perret, E., Benoliel, AM , Nassoy, P., Stones, A., Delmas, V., Thiery, JP, Bongrand, P. & Feracci, H. Fast dissociation kinetics between individual Ec adherin fragments revealed by flow chamber analysis. Embo J 21, 2537-46 (2002).

[51 ], Perret, E., Leung, A., Feracci, H. & Evans, E. Trans-bonded pairs of E-cadherin exhibit a remarkable hierarchy of mechanical strengths. Proc Natl Acad Sci U S A 101 , 16472-7 (2004). [52]) ou transfectés avec des siRNA dirigés contre les cadhérines (Paradis, S., Harrar, D. B., Lin, Y., Koon, A. C, Hauser, J. L., Griffith, E. C, Zhu, L., Brass, L. F., Chen, C. & Greenberg, M. E. An RNAi-based approach identifies molécules required for glutamatergic and GABAergic synapse development. Neuron 53, 217- 32 (2007). [53]) ou les caténines (Bard, L., Boscher, C, Lambert, M., Mege, R. M., Choquet, D. & Thoumine, O. A molecular clutch between the actin flow and N-cadherin adhésions drives growth cone migration. J Neurosci 28, 5879-90 (2008). [25]) ou des molécules de cadhérines mutées (dans les domaines extracellulaires pour empêcher les interactions avec les contre-récepteurs cadhérines, ou dans les domaines intracellulaires pour empêcher la liaison avec les partenaires intracellulaires). L'effet de ces composés sur le développement des neurites et des synapses au bout de 8 jours de culture sera examiné et quantifié comme cela a été expliqué dans les Figures n° 5 et 6. [51], Perret, E., Leung, A., Feracci, H. & Evans, E. Trans-bonded peers of E-cadherin, a remarkable hierarchy of mechanical strengths. Proc Natl Acad Sci USA 101, 16472-7 (2004). [52]) or transfected with siRNAs directed against cadherins (Paradis, S., Harrar, DB, Lin, Y., Koon, A.C, Hauser, JL, Griffith, E.C., Zhu, L., Brass , LF, Chen, C. & Greenberg, ME An RNAi-based approach identified molecules required for glutamatergic and GABAergic synapse development Neuron 53, 217-32 (2007) [53]) or catenins (Bard, L., Boscher , C, Lambert, M., Mege, RM, Choquet, D. & Thoumine, O. A molecular clutch between the actin flow and N-cadherin adhesion drives growth cone migration J Neurosci 28, 5879-90 (2008). 25]) or mutated cadherin molecules (in the extracellular domains to prevent interactions with cadherin counter-receptors, or in intracellular domains to prevent binding with intracellular partners). The effect of these compounds on the development of neurites and synapses after 8 days of culture will be examined and quantified as explained in Figures 5 and 6.

Après 4 jours de culture, les cellules neuronales cultivés sur les substrats micro-patternés recouverts de neurexine-i -Fc sont mis en présence de protéines neurexines recombinantes (Scheiffele, P., Fan, J., Choih, J., Fetter, R. & Serafini, T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101 , 657- 69. (2000). [35], Dean, C, Scholl, F. G., Choih, J., DeMaria, S., Berger, J., Isacoff, E. & Scheiffele, P. Neurexin médiates the assembly of presynaptic terminais. Nat Neurosci 6, 708-16. (2003). [54], Levinson, J. N., Chery, N., Huang, K., Wong, T. P., Gerrow, K., Kang, R., Prange, O., Wang, Y. T. & El-Husseini, A. Neuroligins médiate excitatory and inhibitory synapse formation: involvement of PSD-95 and neurexin-1 beta in neuroligin- induced synaptic specificity. J Biol Chem 280, 17312-9 (2005). [55]), de peptides cellule-perméants compétiteurs des interactions entre protéines au niveau post-synaptique (Sainlos, M., Tigaret, C, Poujol, C, Olivier, N. B., Bard, L., Breillat, C, Thiolon, K., Choquet, D. & Imperiali, B. Biomimetic divalent ligands for the acute disruption of synaptic AMPAR stabilization. Nat Chem Biol 7, 81 -91 (2010). [56], Bard, L., Sainlos, M., Bouchet, D., Cousins, S., Mikasova, L., Breillat, C, Stephenson, F. A., Imperiali, B., Choquet, D. & Groc, L. Dynamic and spécifie interaction between synaptic NR2-NMDA receptor and PDZ proteins. Proc Natl Acad Sci U S A 107, After 4 days of culture, the neuronal cells cultured on micro-patterned substrates coated with neurexin-1-Fc are placed in the presence of recombinant neurexin proteins (Scheiffele, P., Fan, J., Choih, J., Fetter, R Serafini, T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons Cell 101, 657-69 (2000) [35], Dean, C, Scholl, FG, Choih, J., DeMaria, S. , Berger, J., Isacoff, E. & Scheiffele, P. Neurexin mediates the assembly of presynaptic terminais.N Nat Neurosci 6, 708-16 (2003). [54], Levinson, JN, Chery, N., Huang, K., Wong, TP, Gerrow, K., Kang, R., Prange, O., Wang, YT & El-Husseini, A. Neuroligins mediate excitatory and inhibitory synapse formation: involvement of PSD-95 and neurexin-1 beta in Biol Chem 280, 17312-9 (2005), [55]), competing cell-permeate peptides of post-synaptic protein interactions (Sainlos, M., Tigaret , C, Poujol, C, Olivier, N.B., Bard, L., Breillat, C, Thiolon, K., Choquet, D. & Imperiali, B. Biomimetic divalent ligands for the acute disruption of synaptic AMPAR stabilization. Nat Chem Biol 7, 81-91 (2010). [56], Bard, L., Sainlos, M., Bouchet, D., Cousins, S., Mikasova, L., Breillat, C., Stephenson, FA, Imperiali, B., Choquet, D. & Groc, L. Dynamic and specifies interaction between synaptic NR2-NMDA receptor and PDZ proteins. Proc Natl Acad Sci U S A 107,

19561 -6 (2010). [57]) ou transfectées avec des siRNA dirigés contre les neuroligines (Chih, B., Engelman, H. & Scheiffele, P. Control of excitatory and inhibitory synapse formation by neuroligins. Science 307, 1324-8 (2005). [58]) ou les LRRTMs, ou des molécules de neuroligines ou LRRTMs mutées (dans leurs domaines extracellulaires pour empêcher les interactions avec la neurexine, ou dans les domaines intracellulaires pour empêcher la liaison avec les partenaires post-synaptiques). L'effet de ces composés sur le développement des neurites, des cônes de croissance, et des synapses au bout de 8 jours de culture est examiné et quantifié comme cela est décrit dans les Figures n° 5 et 6. 19561 -6 (2010). [57]) or transfected with siRNAs directed against neuroligins (Chih, B., Engelman, H. & Scheiffele, P. Control of excitatory and inhibitory synapse formation by neuroligins, Science 307, 1324-8 (2005). ]) or LRRTMs, or mutant molecules of neuroligins or LRRTMs (in their extracellular domains to prevent interactions with neurexin, or in intracellular domains for prevent linkage with postsynaptic partners). The effect of these compounds on the development of neurites, growth cones, and synapses after 8 days of culture is examined and quantified as described in Figures 5 and 6.

Après 4 jours de culture, les cellules neuronales cultivés sur les substrats recouverts de neuroligines ou de LRRTMs sont mis en présence de protéines neuroligines ou de LRRTMs recombinantes (Scheiffele, P., Fan, J., Choih, J., Fetter, R. & Serafini, T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101 , 657-69. (2000). [35], Dean, C, Scholl, F. G., Choih, J., DeMaria, S., Berger, J., Isacoff, E. & Scheiffele, P. Neurexin médiates the assembly of presynaptic terminais. Nat Neurosci 6, 708-16. (2003). [54], Levinson, J. N., Chery, N., Huang, K., Wong, T. P., Gerrow, K., Kang, R., Prange, O., Wang, Y. T. & El-Husseini, A. Neuroligins médiate excitatory and inhibitory synapse formation: involvement of PSD-95 and neurexin-1 beta in neuroligin-induced synaptic specificity. J Biol Chem 280, 17312-9 (2005).  After 4 days of culture, neuronal cells cultured on substrates coated with neuroligins or LRRTMs are brought into contact with neuroligin proteins or recombinant LRRTMs (Scheiffele, P., Fan, J., Choih, J., Fetter, R. & Serafini, T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons Cell 101, 657-69 (2000) [35], Dean, C, Scholl, FG, Choih, J., DeMaria, S., Berger, J., Isacoff, E. & Scheiffele, P. Neurexin mediates the assembly of presynaptic terminais.N Nat Neurosci 6, 708-16 (2003). [54], Levinson, JN, Chery, N., Huang, K ., Wong, TP, Gerrow, K., Kang, R., Prange, O., Wang, YT & El-Husseini, A. Neuroligins mediate excitatory and inhibitory synapse formation: involvement of PSD-95 and neurexin-1 beta in neuroligin-induced synaptic specificity J Biol Chem 280, 17312-9 (2005).

[55]), de peptides cellule-perméants compétiteurs des interactions entre protéines au niveau pré-synaptique, ou transfectées avec des siRNA dirigés contre les neurexines ou des molécules de neurexines mutées (dans leurs domaines extracellulaires pour empêcher les interactions avec les neuroligines ou LRRTMs, ou dans les domaines intracellulaires pour empêcher la liaison avec les partenaires pré-synaptiques). L'effet de ces composés sur le développement des neurites et des synapses au bout de 8 jours de culture est examiné et quantifié comme cela est décrit dans les Figures n° 5 et 6. [55]), competing cell-permeate peptides for interactions between proteins at the pre-synaptic level, or transfected with siRNAs directed against neurexins or mutated neurexin molecules (in their extracellular domains to prevent interactions with neuroligins or LRRTMs , or in the intracellular domains to prevent binding with pre-synaptic partners). The effect of these compounds on the development of neurites and synapses after 8 days of culture is examined and quantified as described in Figures 5 and 6.

Après 4 jours de culture, les cellules neuronales cultivés sur les substrats recouverts de SynCAMs sont mis en présence de protéines SynCAMs recombinantes (Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D., Liu, X., Kavalali, E. T., Sudhof, T. C. SynCAM, a synaptic adhésion molécule that drives synapse assembly, Science 297 1525-31 (2002) [72]; After 4 days of culture, the neuronal cells cultured on substrates coated with SynCAMs are placed in the presence of recombinant SynCAM proteins (Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D., Liu, X., Kavalali, ET, Sudhof, TC SynCAM, Synaptic adhesion molecule that drives synapse assembly, Science 297 1525-31 (2002) [72];

Sara, Y., Biederer, T., Atasoy, D., Chubykin, A., Mozhayeva, M. G., Sudhof, T. C, Kavalali, E. T. Sélective capability of SynCAM and neuroligin for functional synapse assembly. J Neuroscience 25 260-270 (2005) [73]; Breillat, C ., Thoumine O., Choquet, D. Characterization of SynCAM surface trafficking using a SynCAM derived ligand with high homophilic binding affinity, Biochem Biophys Res Commun, 359, 655-659 (2007) [74], de peptides cellule-perméants compétiteurs des interactions entre protéines au niveau pré-synaptique, ou transfectées avec des siRNA dirigés contre les SynCAMs ou des molécules de SynCAM mutées (dans leurs domaines extracellulaires pour empêcher les interactions homophiles avec les récepteurs SynCAMs, ou dans les domaines intracellulaires pour empêcher la liaison avec les partenaires pré-synaptiques). L'effet de ces composés sur le développement des neurites et des synapses au bout de 8 jours de culture est examiné et quantifié comme cela est décrit dans les Figure 1 1 . Sara, Y., Biederer, T., Atasoy, D., Chubykin, A., Mozhayeva, MG, Sudhof, T. C, Kavalali, and Selective Capability of SynCAM and Neuroligin for functional synapse assembly. J Neuroscience 260-270 (2005) [73]; Breillat, C., Thoumine O., Choquet, D. Characterization of SynCAM surface trafficking using a SynCAM derived ligand with high homophilic binding affinity, Biochem Biophys Res Commun, 359, 655-659 (2007) [74], of cell-cell peptides. Competitive permeations of interactions between proteins at the pre-synaptic level, or transfected with siRNAs directed against SynCAMs or mutated SynCAM molecules (in their extracellular domains to prevent homophilic interactions with SynCAM receptors, or in intracellular domains to prevent liaison with pre-synaptic partners). The effect of these compounds on the development of neurites and synapses after 8 days of culture is examined and quantified as described in Figure 1 1.

Les peptides et protéines sont utilisés à des concentrations 10 fois supérieures aux constantes de dissociation des interactions visées, c'est à dire typiquement 1 μΜ pour les interactions cadhérines, 10 nM pour les interactions neurexines/neuroligines, et 5 μΜ pour les interactions intracellulaires au niveau des échafaudages pré- et post-synaptiques. Les siRNA sont utilisés à des concentrations de 0,5-2 g/support en utilisant l'agent de transfection Lipofectamine 2000, suivant les recommandations du fournisseur (Invitrogen).  Peptides and proteins are used at concentrations 10 times greater than the dissociation constants of the targeted interactions, ie typically 1 μΜ for cadherin interactions, 10 nM for neurexin / neuroligin interactions, and 5 μΜ for intracellular level of pre- and post-synaptic scaffolds. The siRNAs are used at concentrations of 0.5-2 g / carrier using the Lipofectamine 2000 transfection agent, as recommended by the supplier (Invitrogen).

Pour les synCAMs, les peptides et protéines ont été utilisés à des concentrations 10 fois supérieures aux constantes de dissociation des interactions visées, c'est à dire 100 nM pour les interactions entre For synCAMs, peptides and proteins were used at concentrations 10 times higher than the dissociation constants of the targeted interactions, ie 100 nM for interactions between

SynCAMs. SynCAMs.

Alternativement, les substrats sont ensemencés avec des neurones issus de souris knock-out pour certains gènes, par exemple, les neurexines (Missler, M., Zhang, W., Rohlmann, A., Kattenstroth, G., Hammer, R. E., Gottmann, K. & Sudhof, T. C. Alpha-neurexins couple Alternatively, the substrates are seeded with neurons derived from knockout mice for certain genes, for example, neurexins (Missler, M., Zhang, W., Rohlmann, A., Kattenstroth, G., Hammer, RE, Gottmann , K. & Sudhof, TC Alpha-neurexins couple

Ca2+ channels to synaptic vesicle exocytosis. Nature 423, 939-48 (2003). [43]), les neuroligines (Varoqueaux, F., Aramuni, G., Rawson, R. L, Mohrmann, R., Missler, M., Gottmann, K., Zhang, W., Sudhof, T. C. & Brose, N. Neuroligins détermine synapse maturation and function. Neuron 51 , 741 -54 (2006). [44]), les IgCAMs (Kamiguchi, H., Hlavin, M. L. & Lemmon, V. Rôle of L1 in neural development: what the knockouts tell us. Mol Cell Neurosci 12, 48-55 (1998). [59]) ou les cadhérines (Suzuki, S. C, Fume, H., Koga, K., Jiang, N., Nohmi, M., Shimazaki, Y., Katoh-Fukui, Y., Yokoyama, M., Yoshimura, M. & Takeichi, M. Cadherin-8 is required for the first relay synapses to receive functional inputs from primary sensory afférents for cold sensation. J Neurosci 27, 3466-76 (2007). [60]), ou de souris mutée (« knock-in ») exprimant des protéines d'adhérence portant des mutations impliquées dans certaines pathologies telles l'autisme, la schizophrénie, ou le retard mental (Etherton, M. R., Tabuchi, K., Sharma, M., Ko, J. & Sudhof, T. C. An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus. EMBO J 30, 2908-19. [61], Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M. & Sudhof, T. C. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71 -6 (2007). [62]), et le développement d'hémi-synapses est étudié tel que décrit dans les Figures n° 5 et 6. Ca2 + channels to synaptic vesicle exocytosis. Nature 423, 939-48 (2003). [43]), neuroligins (Varoqueaux, F., Aramuni, G., Rawson, R. L, Mohrmann, R., Missler, M., Gottmann, K., Zhang, W., Sudhof, TC & Brose, N. Neuroligins determines synapse maturation and function, Neuron 51, 741-54 (2006). [44]), IgCAMs (Kamiguchi, H., Hlavin, ML & Lemmon, V. Role of L1 in neural development: what the knockouts Mol Cell Neurosci 12, 48-55 (1998) [59]) or cadherins (Suzuki, S.C., Fume, H., Koga, K., Jiang, N., Nohmi, M., Shimazaki , Y., Katoh-Fukui, Y., Yokoyama, M., Yoshimura, M. & Takeichi, M. Cadherin-8 is required for the first relay synapses to receive functional inputs from primary sensory afferents for cold sensation. , 3466-76 (2007). [60]), or mutated ("knock-in") mice expressing adhesion proteins carrying mutations involved in certain pathologies such as autism, schizophrenia, or mental retardation ( Etherton, MR, Tabuchi, K., Sharma, M., Ko, J. & Sudhof, TC An autism-associated point mutation in the cytoplasmic cytoplasmic tail selectively odd AMPA receptor-mediated synaptic transmission in hippocampus. EMBO J 30, 2908-19. [61], Tabuchi, K., Blundell, J., Etherton, MR, Hammer, RE, Liu, X., Powell, CM & Sudhof, TC A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71-6 (2007). [62]), and the development of hemi-synapses is studied as described in Figures 5 and 6.

Listes des références List of references

1 . Folkman, J. & Moscona, A. Rôle of cell shape in growth control.  1. Folkman, J. & Moscona, A. Role of cell shape in growth control.

Nature 273, 345-9 (1978).  Nature 273, 345-9 (1978).

2. Watt, F. M., Jordan, P. W. & O'Neill, C. H. Cell shape controls terminal differentiation of human epidermal keratinocytes. Proc NatI 2. Watt, F.M., Jordan, P.W. & O'Neill, C.H. Cell shape controls terminal differentiation of human epidermal keratinocytes. Proc NatI

Acad Sci U S A 85, 5576-80 (1988). Acad Sci U S A 85, 5576-80 (1988).

3. Thery, M., Racine, V., Pépin, A., Piel, M., Chen, Y., Sibarita, J. B. & Bornens, M. The extracellular matrix guides the orientation of the cell division axis. Nat Cell Biol 7, 947-53 (2005).  3. Thery, M., Racine, V., Pepin, A., Piel, M., Chen, Y., Sibarita, J. B. & Bornens, M. The extracellular matrix guides the orientation of the cell division axis. Nat Cell Biol 7, 947-53 (2005).

4. Thery, M., Racine, V., Piel, M., Pépin, A., Dimitrov, A., Chen, Y., Sibarita, J. B. & Bornens, M. Anisotropy of cell adhesive microenvironment governs cell internai organization and orientation of polarity. Proc NatI Acad Sci U S A 103, 19771 -6 (2006). 4. Thery, M., Racine, V., Piel, M., Pepin, A., Dimitrov, A., Chen, Y., Sibarita, JB & Bornens, M. Anisotropy of cell adhesive microenvironment governs cell internai organization orientation of polarity. Proc NatI Acad Sci U S A 103, 19771 -6 (2006).

5. Ireland, G. W., Dopping-Hepenstal, P. J., Jordan, P. W. & O'Neill, C.  5. Ireland, G. W., Dopping-Hepenstal, P. J., Jordan, P. W. & O'Neill, C.

H. Limitation of substratum size alters cytoskeletal organization and behaviour of Swiss 3T3 fibroblasts. Cell Biol Int Rep 13, 781 -90 (1989).  H. Limitation of substrate size cytoskeletal alters organization and behavior of Swiss 3T3 fibroblasts. Cell Biol Int Rep 13, 781-90 (1989).

6. Sanjana, N. E. & Fuller, S. B. A fast flexible ink-jet printing method for patterning dissociated neurons in culture. J Neurosci Methods 136, 151 -63 (2004).  6. Sanjana, N. E. & Fuller, S. B. A fast flexible ink-jet printing method for dissociated neurons in culture. J Neurosci Methods 136, 151-63 (2004).

7. Yamagata, M., Weiner, J. A., Dulac, C, Roth, K. A. & Sanes, J. R.  7. Yamagata, M., Weiner, J.A., Dulac, C., Roth, K.A. & Sanes, J.R.

Labeled lines in the retinotectal System: markers for retinorecipient sublaminae and the retinal ganglion cell subsets that innervate them. Mol Cell Neurosci 33, 296-310 (2006).  Labeled lines in the retinotectal System: markers for retinorecipient sublaminae and the retinal ganglion cell subsets that innervate them. Mol Cell Neurosci 33, 296-310 (2006).

8. Chen, C. S., Mrksich, M., Huang, S., Whitesides, G. M. & Ingber, D. 8. Chen, C.S., Mrksich, M., Huang, S., Whitesides, G.M. & Ingber, D.

E. Micropatterned surfaces for control of cell shape, position, and function. Biotechnol Prog 14, 356-63 (1998).  E. Micropatterned surfaces for control of cell shape, position, and function. Biotechnol Prog 14, 356-63 (1998).

9. Rozkiewicz, D. I., Kraan, Y., Werten, M. W., de Wolf, F. A., Subramaniam, V., Ravoo, B. J. & Reinhoudt, D. N. Covalent microcontact printing of proteins for cell patterning. Chemistry 12,9. Rozkiewicz, D.I., Kraan, Y., Werten, M.W., Wolf, F.A., Subramaniam, V., Ravoo, B.J. & Reinhoudt, D.N.Covalent microcontact printing of proteins for cell patterning. Chemistry 12,

6290-7 (2006). 10. Shi, P., Shen, K. & Kam, L. C. Local présentation of L1 and N- cadherin in multicomponent, microscale patterns differentially direct neuron function in vitro. Dev Neurobiol 67 , 1765-76 (2007). 6290-7 (2006). 10. Shi, P., Shen, K. & Kam, LC Local presentation of L1 and N-cadherin in multicomponent, microscale patterns differentially direct neuron function in vitro. Dev Neurobiol 67, 1765-76 (2007).

H . Ladoux, B., Anon, E., Lambert, M., Rabodzey, A., Hersen, P., Buguin, A., Silberzan, P. & Mege, R. M. Strength dependence of cadherin-mediated adhésions. Biophys J 98, 534-42 (2010).  H. Ladoux, B., Anon, E., Lambert, M., Rabodzey, A., Hersen, P., Buguin, A., Silberzan, P. & Mege, R. M. Strength dependence of cadherin-mediated adhesions. Biophys J 98, 534-42 (2010).

12.Azioune, A., Carpi, N., Tseng, Q., Thery, M. & Piel, M. Protein micropatterns: A direct printing protocol using deep UVs. Methods CelI Biol 97, 133-46 (2010).  12.Azioune, A., Carpi, N., Tseng, Q., Thery, M. & Piel, Protein M. micropatterns: A direct printing protocol using deep UVs. Methods CelI Biol 97, 133-46 (2010).

13.Azioune, A., Carpi, N., Fink, J., Chehimi, M. M., Cuvelier, D. & Piel, M. Robust method for high-throughput surface patterning of deformable substrates. Langmuir 27, 7349-52 (2010). 13.Azioune, A., Carpi, N., Fink, J., Chehimi, M. M., Cuvelier, D. & Piel, M. Robust method for high-throughput surface patterning of deformable substrates. Langmuir 27, 7349-52 (2010).

14. Fink, J., Thery, M., Azioune, A., Dupont, R., Châtelain, F., Bornens, M. & Piel, M. Comparative study and improvement of current cell micro-patterning techniques. Lab Chip 7, 672-80 (2007).  14. Fink, J., Thery, M., Azioune, A., Dupont, R., Chatelain, F., Bornens, M. & Piel, M. Comparative study and improvement of current cell micro-patterning techniques. Lab Chip 7, 672-80 (2007).

15. Doyle, A. D., Wang, F. W., Matsumoto, K. & Yamada, K. M. One- dimensional topography underlies three-dimensional fibrillar cell migration. J Cell Biol 184, 481 -90 (2009).  15. Doyle, A.D., Wang, F.W., Matsumoto, K. & Yamada, K.M. One-dimensional topography underlies three-dimensional fibrillar cell migration. J Cell Biol 184, 481-90 (2009).

16. Allen, T. G. Préparation and maintenance of single-cell micro-island cultures of basai forebrain neurons. Nat Protoc 1 , 2543-50 (2006). 16. Allen, T. G. Preparation and maintenance of single-cell micro-island cultures of basal forebrain neurons. Nat. Protoc. 1, 2543-50 (2006).

17. Wilson, N. R., Ty, M. T., Ingber, D. E., Sur, M. & Liu, G. Synaptic reorganization in scaled networks of controlled size. J Neurosci 27, 13581 -9 (2007). 17. Wilson, N.R., Ty, M.T., Ingber, D.E., Sur, M. & Liu, G. Synaptic reorganization in scaled networks of controlled size. J Neurosci 27, 13581-9 (2007).

18. Ruardij, T. G., Goedbloed, M. H. & Rutten, W. L. Adhésion and patterning of cortical neurons on polyethylenimine- and fluorocarbon-coated surfaces. IEEE Trans Biomed Eng 47, 1593-9 (2000).  18. Ruardij, T.G., Goedbloed, M.H. & Rutten, W. L. Adhesion and patterning of cortical neurons on polyethylenimine- and fluorocarbon-coated surfaces. IEEE Trans Biomed Eng 47, 1593-9 (2000).

19. Fereol, S., Fodil, R., Barnat, M., Georget, V., Milbreta, U. & Nothias, F. Micropatterned ECM substrates reveal complementary contribution of low and high affinity ligands to neurite outgrowth. 19. Fereol, S., Fodil, R., Barnat, M., Georget, V., Milbreta, U. & Nothias, F. Micropatterned ECM substrates reveal complementary contribution of low and high affinity ligands to neurite outgrowth.

Cytoskeleton (Hoboken) (201 1 ). 20. von Philipsborn, A. C, Lang, S., Bernard, A., Loeschinger, J., David, C, Lehnert, D., Bastmeyer, M. & Bonhoeffer, F. Microcontact printing of axon guidance molécules for génération of graded patterns. Nat Protoc î , 1322-8 (2006). Cytoskeleton (Hoboken) (201 1). 20. von Philipsborn, A. C, Lang, S., Bernard, A., Loeschinger, J., David, C., Lehnert, D., Bastmeyer, M. & Bonhoeffer, F. Microcontact printing of axon guidance molecules for generation of graded patterns. Nat. Protoc, 1322-8 (2006).

21 .von Philipsborn, A. C, Lang, S., Loeschinger, J., Bernard, A., David, C, Lehnert, D., Bonhoeffer, F. & Bastmeyer, M. Growth cone navigation in substrate-bound ephrin gradients. Development 133, 2487-95 (2006). Philipsborn, A. C, Lang, S., Loeschinger, J., Bernard, A., David, C., Lehnert, D., Bonhoeffer, F. & Bastmeyer, M. Growth cone navigation in substrate-bound ephrin gradients. Development 133, 2487-95 (2006).

22. Taylor, A. M., Blurton-Jones, M., Rhee, S. W., Cribbs, D. H., Cotman, C. W. & Jeon, N. L. A microfluidic culture platform for CNS axonal injury, régénération and transport. Nat Methods 2, 599-605 (2005).  22. Taylor, A.M., Blurton-Jones, M., Rhee, S.W., Cribbs, D.H., Cotman, C.W. & Jeon, N.L. A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat Methods 2, 599-605 (2005).

23. Paul, D., Saias, L., Pedinotti, J. C, Chabert, M., Magnifico, S., Pallandre, A., De Lambert, B., Houdayer, C, Brugg, B., Peyrin, J. M. & Viovy, J. L. A "dry and wet hybrid" lithography technique for multilevel replication templates: Applications to microfluidic neuron culture and two-phase global mixing. Biomicrofluidics 5, 24102 (201 1 ).  23. Paul, D., Saias, L., Pedinotti, J.C., Chabert, M., Magnifico, S., Pallandre, A., De Lambert, B., Houdayer, C., Brugg, B., Peyrin, JM & Viovy, JL A "dry and wet hybrid" lithography technique for multilevel replication templates: Applications to microfluidic neuron culture and two-phase global mixing. Biomicrofluidics 5, 24102 (201 1).

24. Taylor, A. M. & Jeon, N. L. Micro-scale and microfluidic devices for neurobiology. Curr Opin Neurobiol 20, 640-7 (2010).  24. Taylor, A. M. & Jeon, N. L. Micro-scale and microfluidic devices for neurobiology. Curr Opin Neurobiol 20, 640-7 (2010).

25. Bard, L., Boscher, C, Lambert, M., Mege, R. M., Choquet, D. & Thoumine, O. A molecular clutch between the actin flow and N- cadherin adhésions drives growth cone migration. J Neurosci 28, 5879-90 (2008).  25. Bard, L., Boscher, C., Lambert, M., Mege, R. M., Choquet, D. & Thoumine, O. A molecular clutch between the actin flow and N-cadherin adhesions drives growth cone migration. J Neurosci 28, 5879-90 (2008).

26. Falk, J., Thoumine, O., Dequidt, C, Choquet, D. & Faivre-Sarrailh, C. NrCAM coupling to the cytoskeleton dépends on multiple protein domains and partitioning into lipid rafts. Mol Biol Cell 15, 4695-709 (2004). 26. Falk, J., Thoumine, O., Dequidt, C., Choquet, D. & Faivre-Sarrailh, C. NrCAM coupling to the cytoskeleton depend on multiple protein domains and partitioning into lipid rafts. Mol Biol Cell 15, 4695-709 (2004).

27. Bresler, T., Ramati, Y., Zamorano, P. L., Zhai, R., Garner, C. C. & Ziv, N. E. The dynamics of SAP90/PSD-95 recruitment to new synaptic junctions. Mol Cell Neurosci 18, 149-67 (2001 ). Bresler, T., Shapira, M., Boeckers, T., Dresbach, T., Futter, M., Garner, C. C, Rosenblum, K., Gundelfinger, E. D. & Ziv, N. E. Postsynaptic density assembly is fundamentally différent from presynaptic active zone assembly. J Neurosci 24, 1507-20 (2004). Fhedman, H. V., Bresler, T., Garner, C. C. & Ziv, N. E. Assembly of new individual excitatory synapses: time course and temporal order of synaptic molécule recruitment. Neuron 27, 57-69 (2000). 27. Bresler, T., Ramati, Y., Zamorano, PL, Zhai, R., Garner, CC & Ziv, The Dynamics of SAP90 / PSD-95 Recruitment to New Synaptic Junctions. Mol Cell Neurosci 18, 149-67 (2001). Bresler, T., Shapira, M., Boeckers, T., Dresbach, T., Futter, M., Garner, C., Rosenblum, K., Gundelfinger, ED & Ziv, NE Postsynaptic density assembly is fundamentally different from presynaptic active zone assembly. J Neurosci 24, 1507-20 (2004). Fhedman, HV, Bresler, T., Garner, CC & Ziv, NE Assembly of new individual excitatory synapses: time and synaptic sequence of molecule recruitment. Neuron 27, 57-69 (2000).

Zito, K., Scheuss, V., Knott, G., Hill, T. & Svoboda, K. Rapid functional maturation of nascent dendritic spines. Neuron 61 , 247-58 (2009). Zito, K., Scheuss, V., Knott, G., Hill, T. & Svoboda, K. Rapid functional maturation of nascent dendritic spines. Neuron 61, 247-58 (2009).

Gerrow, K., Romorini, S., Nabi, S. M., Colicos, M. A., Sala, C. & El- Husseini, A. A preformed complex of postsynaptic proteins is involved in excitatory synapse development. Neuron 49, 547-62 (2006). Gerrow, K., Romorini, S., Nabi, S.M., Colicos, M.A., Sala, C. & El-Husseini, A. Preformed complex of postsynaptic proteins is involved in excitatory synapse development. Neuron 49, 547-62 (2006).

Graf, E. R., Kang, Y., Hauner, A. M. & Craig, A. M. Structure function and splice site analysis of the synaptogenic activity of the neurexin-1 beta LNS domain. J Neurosci 26, 4256-65 (2006). Graf, E.R., Kang, Y., Hauner, A.M., & Craig, A.M., Functional and Splice Site Analysis of the Synaptogenic Activity of the Neurexin-1 Beta LNS domain. J Neurosci 26, 4256-65 (2006).

Graf, E. R., Zhang, X., Jin, S. X., Linhoff, M. W. & Craig, A. M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 1 19, 1013-26 (2004). Graf, E.R., Zhang, X., Jin, S.X., Linhoff, M.W. & Craig, A.M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 19, 1013-26 (2004).

Heine, M., Thoumine, O., Mondin, M., Tessier, B., Giannone, G. & Choquet, D. Activity-independent and subunit-specific recruitment of functional AMPA receptors at neurexin/neuroligin contacts. Proc Natl Acad Sci U S A 'I Oô, 20947-52 (2008).Heine, M., Thoumine, O., Mondin, M., Tessier, B., Giannone, G. & Choquet, D. Activity-independent and subunit-specific recruitment of functional AMPA receptors at neurexin / neuroligin contacts. Proc Natl Acad Sci U S A 'I OO, 20947-52 (2008).

Scheiffele, P., Fan, J., Choih, J., Fetter, R. & Serafini, T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101 , 657-69. (2000).Scheiffele, P., Fan, J., Choih, J., Fetter, R. & Serafini, T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101, 657-69. (2000).

Sudhof, T. C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903-1 1 (2008). Ko, J., Zhang, C, Arac, D., Boucard, A. A., Brunger, A. T. & Sudhof, T. C. Neuroligin-1 performs neurexin-dependent and neurexin- independent functions in synapse validation. Embo J 28, 3244-55 (2009). Sudhof, TC Neuroligins and Neuromins. Nature 455, 903-1 (2008). Ko, J., Zhang, C, Arac, D., Boucard, AA, Brunger, AT & Sudhof, TC Neuroligin-1 performs neurexin-dependent and neurexin-independent functions in synapse validation. Embo J 28, 3244-55 (2009).

Linhoff, M. W., Lauren, J., Cassidy, R. M., Dobie, F. A., Takahashi, H., Nygaard, H. B., Airaksinen, M. S., Strittmatter, S. M. & Craig, A. M. An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron 61 , 734-49 (2009). Linhoff, MW, Lauren, J., Cassidy, RM, Dobie, FA, Takahashi, H., Nygaard, HB, Airaksinen, MS, Strittmatter, SM & Craig, AM An expression expression screen for synaptogenic proteins identified the LRRTM protein family as synaptic organizers. Neuron 61, 734-49 (2009).

Ko, J., Fuccillo, M. V., Malenka, R. C. & Sudhof, T. C. LRRTM2 Functions as a Neurexin Ligand in Promoting Excitatory Synapse Formation. Neuron 64, 791 -798 (2009). Ko, J., Fuccillo, M.V., Malenka, R.C. & Sudhof, T.C. LRRTM2 Functions as a Neurexin Ligand in Promoting Excitatory Synapse Formation. Neuron 64, 791-798 (2009).

de Wit, J., Sylwestrak, E., O'Sullivan, M., Otto, S., Tiglio, K., Savas, J. N., Yates, J. R., Comoletti, D., Taylor, P. & Ghosh, A. LRRTM2 Interacts with Neurexin 1 and Régulâtes Excitatory Synapse Formation. Neuron 64, 799-806 (2009). of Wit, J., Sylwestrak, E., O'Sullivan, M., Otto, S., Tiglio, K., Savas, JN, Yates, JR, Comoletti, D., Taylor, P. & Ghosh, A. LRRTM2 Interacts with Neurexin 1 and Regulatory Excitatory Synapse Formation. Neuron 64, 799-806 (2009).

Craig, A. M. & Kang, Y. Neurexin-neuroligin signaling in synapse development. Curr Opin Neurobiol M, 43-52 (2007). Craig, A. M. & Kang, Y. Neurexin-neuroligin signaling in synapse development. Curr Opin Neurobiol M, 43-52 (2007).

Chubykin, A. A., Atasoy, D., Etherton, M. R., Brose, N., Kavalali, E. T., Gibson, J. R. & Sudhof, T. C. Activity-Dependent Validation of Excitatory versus Inhibitory Synapses by Neuroligin-1 versus Neuroligin-2. Neuron 54, 919-31 (2007). Chubykin, A.A., Atasoy, D., Etherton, M.R., Brose, N., Kavalali, E.T., Gibson, J.R. & Sudhof, T.C.Activity-Dependent Validation of Excitatory versus Inhibitory Synapses by Neuroligin-1 versus Neuroligin-2. Neuron 54, 919-31 (2007).

Missler, M., Zhang, W., Rohlmann, A., Kattenstroth, G., Hammer, R. E., Gottmann, K. & Sudhof, T. C. Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. Nature 423, 939-48 (2003). Varoqueaux, F., Aramuni, G., Rawson, R. L, Mohrmann, R., Missler, M., Gottmann, K., Zhang, W., Sudhof, T. C. & Brose, N. Neuroligins détermine synapse maturation and function. Neuron 51 , 741 -54 (2006). Missler, M., Zhang, W., Rohlmann, A., Kattenstroth, G., Hammer, R.E., Gottmann, K. & Sudhof, T.C. Alpha-neurexins Ca2 + couple channels to synaptic vesicle exocytosis. Nature 423, 939-48 (2003). Varoqueaux, F., Aramuni, G., Rawson, R. L, Mohrmann, R., Missler, M., Gottmann, K., Zhang, W., Sudhof, TC & Brose, N. Neuroligins determines synapse maturation and function . Neuron 51, 741-54 (2006).

Takahashi, H., Arstikaitis, P., Prasad, T., Bartlett, T. E., Wang, Y. T., Murphy, T. H. & Craig, A. M. Postsynaptic TrkC and presynaptic PTPsigma function as a bidirectional excitatory synaptic organizing complex. Neuron 69, 287-303 (201 1 ). Takahashi, H., Arstikaitis, P., Prasad, T., Bartlett, TE, Wang, YT, Murphy, TH & Craig, AM Postsynaptic TrkC and presynaptic PTPsigma function as a bidirectional excitatory synaptic organizing complex. Neuron 69, 287-303 (201 1).

Jamain, S., Quach, H., Betancur, C, Rastam, M., Colineaux, C, Gillberg, I. C, Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C. & Bourgeron, T. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genêt 34, 27-9 (2003). Jamain, S., Quach, H., Betancur, C., Rastam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C. & Bourgeron , T. Mutations of the X-linked Gene Encoding Neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet 34, 27-9 (2003).

Talebizadeh, Z., Lam, D. Y., Theodoro, M. F., Bittel, D. C, Lushington, G. H. & Butler, M. G. Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. J Med Genêt 43, e21 (2006). Talebizadeh, Z., Lam, D.Y., Theodoro, M.F., Bittel, D.C., Lushington, G.H. & Butler, M.G. Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. J Med Genet 43, e21 (2006).

Rujescu, D., Ingason, A., Cichon, S., Pietilainen, O. P., Barnes, M. R., Toulopoulou, T., Picchioni, M., Vassos, E., Ettinger, U., Bramon, E., Murray, R., Ruggeri, M., Tosato, S., Bonetto, C, Steinberg, S., Sigurdsson, E., Sigmundsson, T., Petursson, H., Gylfason, A., Olason, P. I., Hardarsson, G., Jonsdottir, G. A., Gustafsson, O., Fossdal, R., Giegling, I., Moller, H. J., Hartmann, A. M., Hoffmann, P., Crombie, C, Fraser, G., Walker, N., Lonnqvist, J., Suvisaari, J., Tuulio-Henriksson, A., Djurovic, S., Melle, I., Andreassen, O. A., Hansen, T., Werge, T., Kiemeney, L. A., Franke, B., Veltman, J., Buizer-Voskamp, J. E., Sabatti, C, Ophoff, R. A., Rietschel, M., Nothen, M. M., Stefansson, K., Peltonen, L., St Clair, D., Stefansson, H. & Collier, D. A. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genêt 18, 988-96 (2009). Williams, E. J., Williams, G., Gour, B., Blaschuk, O. & Doherty, P. INP, a novel N-cadherin antagonist targeted to the amino acids that flank the HAV motif. Mol Cell Neurosci 15, 456-64 (2000). Rujescu, D., Ingason, A., Cichon, S., Pietilainen, OP, Barnes, MR, Toulopoulou, T., Picchioni, M., Vassos, E., Ettinger, U., Bramon, E., Murray, R., Ruggeri, M., Tosato, S., Bonetto, C., Steinberg, S., Sigurdsson, E., Sigmundsson, T., Petursson, H., Gylfason, A., Olason, PI, Hardarsson, G. , Jonsdottir, GA, Gustafsson, O., Fossdal, R., Giegling, I., Moller, HJ, Hartmann, AM, Hoffmann, P., Crombie, C, Fraser, G., Walker, N., Lonnqvist, J ., Suvisaari, J., Tuulio-Henriksson, A., Djurovic, S., Melle, I., Andreassen, OA, Hansen, T., Werge, T., Kiemeney, LA, Franke, B., Veltman, J ., Buizer-Voskamp, JE, Sabatti, C, Ophoff, RA, Rietschel, M., Nothen, MM, Stefansson, K., Peltonen, L., St Clair, D., Stefansson, H. & Collier, DA Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 18, 988-96 (2009). Williams, E.J., Williams, G., Gour, B., Blaschuk, O. & Doherty, P. INP, has a novel N-cadherin antagonist targeted to amino acids that flank the HAV motif. Mol Cell Neurosci 15, 456-64 (2000).

Williams, E., Williams, G., Gour, B. J., Blaschuk, O. W. & Doherty, P. A novel family of cyclic peptide antagonists suggests that N- cadherin specificity is determined by amino acids that flank the HAV motif. J Biol Chem 275, 4007-12 (2000). 51 . Perret, E., Benoliel, A. M., Nassoy, P., Pierres, A., Delmas, V., Thiery, J. P., Bongrand, P. & Feracci, H. Fast dissociation kinetics between individual E-cadherin fragments revealed by flow chamber analysis. Embo J 2†, 2537-46 (2002). Williams, E., Williams, G., Gour, BJ, Blaschuk, OW & Doherty, P. A novel family of cyclic peptide antagonists suggests that N-cadherin specificity is determined by amino acids that flank the HAV motif. J Biol Chem 275, 4007-12 (2000). 51. Perret, E., Benoliel, AM, Nassoy, P., Stones, A., Delmas, V., Thiery, JP, Bongrand, P. & Feracci, H. Fast dissociation kinetics between individual E-cadherin fragments revealed by flow chamber analysis. Embo J 2 †, 2537-46 (2002).

52. Perret, E., Leung, A., Feracci, H. & Evans, E. Trans-bonded pairs of E-cadherin exhibit a remarkable hierarchy of mechanical strengths. Proc Natl Acad Sci U S A 101 , 16472-7 (2004). 52. Perret, E., Leung, A., Feracci, H. & Evans, E. Trans-bonded peers of E-cadherin, a remarkable hierarchy of mechanical strengths. Proc Natl Acad Sci U S A 101, 16472-7 (2004).

53. Paradis, S., Harrar, D. B., Lin, Y., Koon, A. C, Hauser, J. L, Griffith, E. C, Zhu, L., Brass, L. F., Chen, C. & Greenberg, M. E. An RNAi- based approach identifies molécules required for glutamatergic and 53. Paradis, S., Harrar, DB, Lin, Y., Koon, A.C, Hauser, J.L., Griffith, E.C., Zhu, L., Brass, LF, Chen, C. & Greenberg, ME An RNAi-based approach identified molecules required for glutamatergic

GABAergic synapse development. Neuron 53, 217-32 (2007). GABAergic synapse development. Neuron 53, 217-32 (2007).

54. Dean, C, Scholl, F. G., Choih, J., DeMaria, S., Berger, J., Isacoff, E.  54. Dean, C, Scholl, F.G., Choih, J., DeMaria, S., Berger, J., Isacoff, E.

& Scheiffele, P. Neurexin médiates the assembly of presynaptic terminais. Nat Neurosci 6, 708-16. (2003).  & Scheiffele, P. Neurexin medias the assembly of presynaptic terminais. Nat Neurosci 6, 708-16. (2003).

55. Levinson, J. N., Chery, N., Huang, K., Wong, T. P., Gerrow, K., Kang, R., Prange, O., Wang, Y. T. & El-Husseini, A. Neuroligins médiate excitatory and inhibitory synapse formation: involvement of PSD-95 and neurexin-1 beta in neuroligin-induced synaptic specificity. J Biol Chem 280, 17312-9 (2005). 55. Levinson, JN, Chery, N., Huang, K., Wong, TP, Gerrow, K., Kang, R., Prange, O., Wang, YT & El-Husseini, A. Neuroligins mediate excitatory and inhibitory synapse formation: involvement of PSD-95 and neurexin-1 beta in neuroligin-induced synaptic specificity. J Biol Chem 280, 17312-9 (2005).

56. Sainlos, M., Tigaret, C, Poujol, C, Olivier, N. B., Bard, L., Breillat, C, Thiolon, K., Choquet, D. & Imperiali, B. Biomimetic divalent ligands for the acute disruption of synaptic AMPAR stabilization. Nat Chem Biol 7, 81 -91 (2010). 56. Sainlos, M., Tigaret, C, Poujol, C, Olivier, NB, Bard, L., Breillat, C, Thiolon, K., Choquet, D. & Imperiali, B. Biomimetic divalent ligands for the acute disruption of synaptic AMPAR stabilization. Nat Chem Biol 7, 81-91 (2010).

57. Bard, L., Sainlos, M., Bouchet, D., Cousins, S., Mikasova, L., Breillat, C, Stephenson, F. A., Imperiali, B., Choquet, D. & Groc, L. 57. Bard, L., Sainlos, M., Bouchet, D., Cousins, S., Mikasova, L., Breillat, C., Stephenson, F. A., Imperiali, B., Choquet, D. & Groc, L.

Dynamic and spécifie interaction between synaptic NR2-NMDA receptor and PDZ proteins. Proc Natl Acad Sci U S A 107, 19561 -6 (2010). Dynamic and specifies interaction between synaptic NR2-NMDA receptor and PDZ proteins. Proc Natl Acad Sci U S A 107, 19561 -6 (2010).

58. Chih, B., Engelman, H. & Scheiffele, P. Control of excitatory and inhibitory synapse formation by neuroligins. Science 307, 1324-8 58. Chih, B., Engelman, H. & Scheiffele, P. Control of excitatory and inhibitory synapse formation by neuroligins. Science 307, 1324-8

(2005). Kamiguchi, H., Hlavin, M. L. & Lemmon, V. Rôle of L1 in neural development: what the knockouts tell us. Mol Cell Neurosci 12, 48- 55 (1998). (2005). Kamiguchi, H., Hlavin, ML & Lemmon, V. Role of L1 in neural development: what the knockouts tell us. Mol Cell Neurosci 12, 48-55 (1998).

Suzuki, S. C, Fume, H., Koga, K., Jiang, N., Nohmi, M., Shimazaki, Y., Katoh-Fukui, Y., Yokoyama, M., Yoshimura, M. & Takeichi, M. Cadherin-8 is required for the first relay synapses to receive functional inputs from primary sensory afférents for cold sensation. J Neurosci 27, 3466-76 (2007). Suzuki, S. C, Smoke, H., Koga, K., Jiang, N., Nohmi, M., Shimazaki, Y., Katoh-Fukui, Y., Yokoyama, M., Yoshimura, M. & Takeichi, M. Cadherin-8 is required for the first relay synapses to receive functional inputs from primary sensory afferents for cold sensation. J Neurosci 27, 3466-76 (2007).

Etherton, M. R., Tabuchi, K., Sharma, M., Ko, J. & Sudhof, T. C. An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus. EMBO J 30, 2908-19. Etherton, M.R., Tabuchi, K., Sharma, M., Ko, J. & Sudhof, T.C.A. autism-associated point mutation in the cytoplasmic cytoplasmic tail selectively odd AMPA receptor-mediated synaptic transmission in hippocampus. EMBO J 30, 2908-19.

Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M. & Sudhof, T. C. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71 -6 (2007). Tabuchi, K., Blundell, J., Etherton, M.R., Hammer, R.E., Liu, X., Powell, C.M. & Sudhof, T.C. Neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71-6 (2007).

Bhushan, Bharat Hansford, Derek Lee, Kang Kug « Surface modification of silicon and polydimethylsiloxane surfaces with vapor- phase-deposited ultrathin fluorosilane films for biomédical nanodevices », Journal of Vacuum Science & Technology A: Vacuum, Surfaces, and Films, Jul 2006, 24 (4), 1 197 - 1202 Bhushan, Bharat Hansford, Derek Lee, Kang Kug "Surface modification of silicon and polydimethylsiloxane surfaces with vapor-phase-deposited ultrathin fluorosilane films for biomedical nanodevices", Journal of Vacuum Science & Technology A: Vacuum, Surfaces, and Films, Jul 2006, 24 (4), 1 197 - 1202

Isabelle Collin cvc, Le génie génétique, « les animaux transgéniques », édition les Essentiels milans, 1999, Isabelle Collin cvc, Genetic engineering, "transgenic animals", edition Les Essentiels milans, 1999,

Handbook of Biochemistry and Molecular Biology, Fourth Edition 201 1 - Editor(s): Roger L. Lundblad, Lundblad Biotechnology, Chapel Hill, North Carolina, USA ; Fiona Macdonald, CRC Press, Boca Raton, Florida, USA,  Handbook of Biochemistry and Molecular Biology, Fourth Edition 201 1 - Editor (s): Roger L. Lundblad, Lundblad Biotechnology, Chapel Hill, North Carolina, USA; Fiona Macdonald, CRC Press, Boca Raton, Florida, USA,

Practical handbook of biochemistry and molecular biology Gerald D. Fasman CRC Press, 1989 - 601 pages; Recombinant DNA Principles andMethodologies, Editor(s): James Greene, Catholic University, Washington D.C., USA CRC Press, 1998. Gerald D. Fasman Practical Handbook of Biochemistry and Molecular Biology CRC Press, 1989 - 601 pages; Recombinant DNA Principles and Methodologies, Editor (s): James Greene, Catholic University, Washington, DC, USA CRC Press, 1998.

Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D., Liu, X., Kavalali, E. T., Sudhof, T. C. SynCAM, a synaptic adhésion molécule that drives synapse assembly, Science 297 1525-31 (2002) Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D., Liu, X., Kavalali, ET, Sudhof, TC SynCAM, Synaptic adhesion molecule that drives synapse assembly, Science 297 1525-31 (2002) )

Sara, Y., Biederer, T., Atasoy, D., Chubykin, A., Mozhayeva, M. G., Sudhof, T. C., Kavalali, E. T. Sélective capability of SynCAM and neuroligin for functional synapse assembly. J Neuroscience 25 260- 270 (2005).Sara, Y., Biederer, T., Atasoy, D., Chubykin, A., Mozhayeva, M.G., Sudhof, T.C., Kavalali, E. T. Selective capability of SynCAM and neuroligin for functional synapse assembly. J Neuroscience 25 260-270 (2005).

Shi P., Scott M.A., Ghosh B., Wan D., Wissner-Gross Z., Mazitschek R., Haggarty S.J., Fatih M. Synapse microarray identification of small molécules that enhance synaptogenesis. Nat Commun 2, 510 (201 1 ). Shi P., Scott M.A., Ghosh B., Wan D., Wissner-Gross Z., Mazitschek R., Haggarty S.J., Fatih M. Synapse microarray identification of small molecules that enhance synaptogenesis. Nat. Commun. 2, 510 (201 1).

Breillat, C ., Thoumine O., Choquet, D. Characterization of SynCAM surface trafficking using a SynCAM derived ligand with high homophilic binding affinity, Biochem Biophys Res Commun, 359, 655-659 (2007). Breillat, C., Thoumine O., Choquet, D. Characterization of SynCAM surface trafficking using a SynCAM derived ligand with high homophilic binding affinity, Biochem Biophys Res Commun, 359, 655-659 (2007).

Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D., Liu, X., Kavalali, E. T., Sudhof, T. C. SynCAM, a synaptic adhésion molécule that drives synapse assembly, Science 297 1525-31 (2002). Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D., Liu, X., Kavalali, ET, Sudhof, TC SynCAM, Synaptic adhesion molecule that drives synapse assembly, Science 297 1525-31 (2002) ).

Sara, Y., Biederer, T., Atasoy, D., Chubykin, A., Mozhayeva, M. G., Sudhof, T. C, Kavalali, E. T. Sélective capability of SynCAM and neuroligin for functional synapse assembly. J Neuroscience 25 260- 270 (2005). Sara, Y., Biederer, T., Atasoy, D., Chubykin, A., Mozhayeva, M.G., Sudhof, T.C, Kavalali, E. T. Selective capability of SynCAM and neuroligin for functional synapse assembly. J Neuroscience 25 260-270 (2005).

Breillat, C ., Thoumine O., Choquet, D. Characterization of SynCAM surface trafficking using a SynCAM derived ligand with high homophilic binding affinity, Biochem Biophys Res Commun, 359, 655-659 (2007). Breillat, C., Thoumine O., Choquet, D. Characterization of SynCAM surface trafficking using a SynCAM derived ligand with high homophilic binding affinity, Biochem Biophys Res Commun, 359, 655-659 (2007).

Claims

REVENDICATIONS 1 . Support (1 ) de culture de cellules neuronales (c) comprenant un substrat (3) sur une surface (5) duquel sont disposés des îlots (7) de protéines d'adhésion desdites cellules neuronales choisies parmi les molécules d'adhérences de type immunoglobuline (IgCAM), les cadhérines, les neurexines, les neuroligines, et les protéines transmembranaires à domaine riche en leucine ou un mélange de celles-ci, lesdits îlots (7) ayant un diamètre de 0,2 à 2,5 μιτι et étant espacés entre eux de 0,500 à 10 pm. 1. Support (1) for culturing neuronal cells (c) comprising a substrate (3) on a surface (5) of which islets (7) of adhesion proteins of said neuronal cells chosen from the immunoglobulin-type adhesion molecules are arranged (IgCAM), cadherins, neurexins, neuroligins, and leucine-rich domain transmembrane proteins or a mixture thereof, said islands (7) having a diameter of 0.2 to 2.5 μιτι and being spaced apart between them from 0.500 to 10 pm. 2. Support selon la revendication 1 dans lequel les protéines d'adhésion desdites cellules neuronales sont choisies parmi les molécules d'adhésion synaptiques (SynCAM) ou un mélange de celles-ci. The carrier of claim 1 wherein the adhesion proteins of said neuronal cells are selected from synaptic adhesion molecules (SynCAM) or a mixture thereof. 3. Support selon la revendication 1 ou 2, dans lequel la surface (5) entre les îlots (7) est une surface cytophobe (9). 3. Support according to claim 1 or 2, wherein the surface (5) between the islands (7) is a cytophobic surface (9). 4. Support selon l'une quelconque selon l'une quelconque des revendications 1 à 3, dans lequel lesdites protéines d'adhésions sont fixées par liaison chimique, soit directement sur la surface (5), ou via un liant intermédiaire fixé sur ladite surface (5), ledit liant étant choisi parmi une espèce chimique réactive, une protéine, un polysaccharide, un anticorps, un polymère, une espèce chargée. The carrier of any one of claims 1 to 3, wherein said adhesion proteins are chemically bonded either directly to the surface (5) or via an intermediate binder attached to said surface. (5), said binder being selected from a reactive chemical species, a protein, a polysaccharide, an antibody, a polymer, a charged species. 5. Support selon l'une quelconque selon l'une quelconque des revendications 1 à 4, dans lequel la protéine d'adhésion des cellules neuronales est une protéine d'adhésion issue d'une membrane de cellules neuronales ou d'une membrane physiologique de cellules non-neuronales supportant une cellule neuronale. The carrier of any one of claims 1 to 4, wherein the neuronal cell adhesion protein is an adhesion protein derived from a neuronal cell membrane or a physiological membrane of non-neuronal cells supporting a neuronal cell. 6. Support selon l'une quelconque selon l'une quelconque des revendications 1 à 5 dans lequel la surface (5) est rendue cytophobe du fait d'un composé choisi parmi le polyéthylène glycol, le poly(acétate de vinyle), le poly(2-hydroxyéthyl métacrylate, le polyacrylamide, le poly(N- vinyl-2-pyrrolidone), le poly(N-isopropyl acrylamide), les polymères anionique, les polymères phosphoryl choline, l'albumine, la caséine, l'acide hyaluronique, les liposchaccarides, les glycoprotéines, les phospholipides ou un mélange de ceux-ci. 6. Support according to any one of claims 1 to 5 wherein the surface (5) is made cytophobic because of a compound selected from polyethylene glycol, poly (vinyl acetate), poly (2-hydroxyethyl methacrylate, polyacrylamide, poly (N-vinyl-2-pyrrolidone), poly (N-isopropyl acrylamide), anionic polymers, phosphoryl choline polymers, albumin, casein, hyaluronic acid , liposaccharides, glycoproteins, phospholipids or a mixture thereof. 7. Support selon l'une quelconque des revendications 1 à 6, dans lequel les îlots (7) sont déposés sur la surface (5) par une méthode choisie parmi la photolithographie, la dip-pen nanolithographie, la lithographie par faisceau, l'impression par jet d'encre, l'impression par microcontact. 7. Support according to any one of claims 1 to 6, wherein the islands (7) are deposited on the surface (5) by a method selected from photolithography, dip-pen nanolithography, beam lithography, inkjet printing, microcontact printing. 8. Support selon l'une quelconque des revendications 1 à 7 comprenant des cellules neuronales sur les îlots (7). 8. Support according to any one of claims 1 to 7 comprising neuronal cells on the islands (7). 9. Support selon la revendication 8 dans lequel lesdites des cellules neuronales sont choisies dans le groupe comprenant des cellules neuronales issues du système nerveux d'un mammifère, oiseau, batracien, ou mollusque, et/ou toute cellule issue d'une lignée cellulaire neuronale. The carrier of claim 8 wherein said neuronal cells are selected from the group consisting of neuronal cells derived from the nervous system of a mammal, bird, batrachian, or mollusk, and / or any cell derived from a neuronal cell line. . 10. Support selon les revendications 8 ou 9 dans lequel les cellules neuronales sont isolées du système nerveux de rongeurs, de poulets, de batraciens, de mollusques. 10. Support according to claims 8 or 9 wherein the neuronal cells are isolated from the nervous system of rodents, chickens, amphibians, molluscs. 1 1 . Support selon l'une quelconque des revendications 8 à 10 dans lequel les cellules neuronales sont choisies parmi la lignée neuroblastome SH-SY5Y, la lignée PC12, la lignée de cellules neuronales corticales (HCN-1 ), ou la lignée de neuroblastomes B104. 1 1. A carrier according to any one of claims 8 to 10 wherein the neuronal cells are selected from the SH-SY5Y neuroblastoma line, the PC12 line, the cortical neuronal cell line (HCN-1), or the B104 neuroblastoma line. 12. Procédé de fabrication d'un support selon l'une quelconque des revendications 1 à 1 1 , comprenant une étape de dépôt sur une surface (5) d'un substrat d'îlots (7) de protéines d'adhésion de cellules neuronales choisie parmi les molécules de type immunoglobulines (IgCAM), les cadhérines, les neurexines, les neuroligines, et les protéines transmembranaires à domaines riche en leucine ou un mélange de celles- ci, lesdits d'îlots (7) ayant un diamètre de 0,2 à 2,5 μιτι et étant espacés entre eux de 0,500 à 10 μιτι. 12. A method of manufacturing a support according to any one of claims 1 to 1 1, comprising a step of depositing on a surface (5) of an islet substrate (7) of neuronal cell adhesion proteins. selected from immunoglobulin-like molecules (IgCAM), cadherins, neurexins, neuroligins, and leucine-rich domain transmembrane proteins or a mixture thereof, said islets (7) having a diameter of 0, 2 to 2.5 μιτι and being spaced between them from 0.500 to 10 μιτι. 13. Procédé selon la revendication 12, dans lequel le procédé comprend en outre une étape de revêtement un composé cytophobe choisi parmi le polyéthylène glycol, le poly(acétate de vinyle) le poly(2- hydroxyéthyl métacrylate, le polyacrylamide, le poly(N-vinyl-2-pyrrolidone), le poly(N-isopropyl acrylamide), les polymères anionique, les polymères phosphoryl choline, l'albumine, la caséine, l'acide hyaluronique, les liposchaccarides, les glycoprotéines, les phospholipides ou un mélange de ceux-ci, ladite étape de revêtement étant préalable à l'étape de dépôt des îlots de protéines d'adhésion. The method of claim 12, wherein the method further comprises a step of coating a cytophobic compound selected from polyethylene glycol, polyvinyl acetate, poly (2-hydroxyethyl methacrylate, polyacrylamide, poly (N) -vinyl-2-pyrrolidone), poly (N-isopropyl acrylamide), anionic polymers, phosphoryl choline polymers, albumin, casein, hyaluronic acid, liposaccharides, glycoproteins, phospholipids or a mixture of these, said coating step being prior to the deposition step of the islands of adhesion proteins. 14. Utilisation d'un support selon l'une quelconque des revendications 1 à 1 1 pour la culture de cellules neuronales. 14. Use of a carrier according to any one of claims 1 to 1 1 for culturing neuronal cells. 15. Utilisation d'un support selon l'une quelconque des revendications 1 à 1 1 dans une méthode d'analyse qualitative et/ou quantitative de la croissance des neurites et de la synaptogénèse desdites cellules neuronales. 15. Use of a support according to any one of claims 1 to 1 1 in a qualitative and / or quantitative analysis method of neurite growth and synaptogenesis of said neuronal cells. 16. Utilisation d'un support selon l'une quelconque des revendications 1 à 1 1 dans une méthode de criblage. 16. Use of a support according to any one of claims 1 to 1 1 in a screening method.
PCT/FR2012/051688 2011-07-29 2012-07-16 Device for culturing nerve cells, and uses thereof Ceased WO2013017770A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1156984 2011-07-29
FR1156984A FR2978455B1 (en) 2011-07-29 2011-07-29 DEVICE FOR CULTURING NEURONAL CELLS AND USES

Publications (1)

Publication Number Publication Date
WO2013017770A1 true WO2013017770A1 (en) 2013-02-07

Family

ID=46724479

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2012/051688 Ceased WO2013017770A1 (en) 2011-07-29 2012-07-16 Device for culturing nerve cells, and uses thereof

Country Status (2)

Country Link
FR (1) FR2978455B1 (en)
WO (1) WO2013017770A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11674952B2 (en) 2016-02-24 2023-06-13 The Rockefeller University Embryonic cell-based therapeutic candidate screening systems, models for Huntington's Disease and uses thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003002710A2 (en) * 2001-06-29 2003-01-09 The Board Of Trustees Of Leland Stanford Jr. University Artificial synapse chip interface for electronic prosthetic retina
US20060183222A1 (en) * 2005-02-17 2006-08-17 Kosuke Kuwabara Method for culturing neurons, neuron culture substrate, neurons, neuron system, and method for manufacturing neuron system
WO2010039933A2 (en) * 2008-10-02 2010-04-08 The Regents Of The University Of California Methods and compositions for high-resolution micropatterning for cell culture
WO2010121034A2 (en) * 2009-04-16 2010-10-21 University Of Memphis Research Foundation Cell growth apparatus and use of aerogels for directed cell growth

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003002710A2 (en) * 2001-06-29 2003-01-09 The Board Of Trustees Of Leland Stanford Jr. University Artificial synapse chip interface for electronic prosthetic retina
US20060183222A1 (en) * 2005-02-17 2006-08-17 Kosuke Kuwabara Method for culturing neurons, neuron culture substrate, neurons, neuron system, and method for manufacturing neuron system
WO2010039933A2 (en) * 2008-10-02 2010-04-08 The Regents Of The University Of California Methods and compositions for high-resolution micropatterning for cell culture
WO2010121034A2 (en) * 2009-04-16 2010-10-21 University Of Memphis Research Foundation Cell growth apparatus and use of aerogels for directed cell growth

Non-Patent Citations (99)

* Cited by examiner, † Cited by third party
Title
"Handbook of Biochemistry and Molecular Biology", 2011, CHAPEL HILL
"le Handbook of Biochemistry and Molecular Biology", 2011, CHAPEL HILL
"le Recombinant DNA Principles andMethodologies", 1998, CRC PRESS
"Recombinant DNA Principles andMethodologies", 1998, CRC PRESS
ALLEN, T. G.: "Preparation and maintenance of single-cell micro-island cultures of basal forebrain neurons", NAT PROTOC, vol. 1, 2006, pages 2543 - 50
AZIOUNE, A.; CARPI, N.; FINK, J.; CHEHIMI, M. M.; CUVELIER, D.; PIEL, M.: "Robust method for high-throughput surface patterning of deformable substrates", LANGMUIR, vol. 27, 2010, pages 7349 - 52
AZIOUNE, A.; CARPI, N.; TSENG, Q.; THERY, M.; PIEL, M.: "Protein micropatterns: A direct printing protocol using deep UVs", METHODS CELL BIOL, vol. 97, 2010, pages 133 - 46
BARD, L.; BOSCHER, C.; LAMBERT, M.; MEGE, R. M.; CHOQUET, D.; THOUMINE, O.: "A molecular clutch between the actin flow and N-cadherin adhesions drives growth cone migration", J NEUROSCI, vol. 28, 2008, pages 5879 - 90
BARD, L.; SAINLOS, M.; BOUCHET, D.; COUSINS, S.; MIKASOVA, L.; BREILLAT, C.; STEPHENSON, F. A.; IMPERIALI, B.; CHOQUET, D.; GROC,: "Dynamic and specific interaction between synaptic NR2-NMDA receptor and PDZ proteins", PROC NATL ACAD SCI USA, vol. 107, 2010, pages 19561 - 6
BHUSHAN, BHARAT HANSFORD; DEREK LEE; KANG KUG: "Surface modification of silicon and polydimethylsiloxane surfaces with vapor-phase-deposited ultrathin fluorosilane films for biomedical nanodevices", JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A: VACUUM, SURFACES, AND FILMS, vol. 24, no. 4, July 2006 (2006-07-01), pages 1197 - 1202
BHUSHAN; BHARAT HANSFORD; DEREK LEE; KANG KUG: "Surface modification of silicon and polydimethylsiloxane surfaces with vapor-phase-deposited ultrathin fluorosilane films for biomedical nanodevices", JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A: VACUUM, SURFACES, AND FILMS, vol. 24, no. 4, July 2006 (2006-07-01), pages 1197 - 1202
BIEDERER, T.; SARA, Y.; MOZHAYEVA, M.; ATASOY, D.; LIU, X.; KAVALALI, E. T.; SUDHOF, T. C.: "SynCAM, a synaptic adhesion molecule that drives synapse assembly", SCIENCE, vol. 297, 2002, pages 1525 - 31
BIEDERER, T.; SARA, Y.; MOZHAYEVA, M.; ATASOY, D.; LIU, X.; KAVALALI, E. T.; SUDHOF, T. C.: "SynCAM, a synaptic adhésion molecule that drives synapse assembly", SCIENCE, vol. 297, 2002, pages 1525 - 31
BREILLAT, C .; THOUMINE O.; CHOQUET, D.: "Characterization of SynCAM surface trafficking using a SynCAM derived ligand with high homophilic binding affinity", BIOCHEM BIOPHYS RES COMMUN, vol. 359, 2007, pages 655 - 659
BRESLER, T.; RAMATI, Y.; ZAMORANO, P. L.; ZHAI, R.; GARNER, C. C.; ZIV, N. E.: "The dynamics of SAP90/PSD-95 recruitment to new synaptic junctions", MOL CE// NEUROSCI, vol. 18, 2001, pages 149 - 67
BRESLER, T.; RAMATI, Y.; ZAMORANO, P. L.; ZHAI, R.; GARNER, C. C.; ZIV, N. E.: "The dynamics of SAP90/PSD-95 recruitment to new synaptic junctions", MOL CELL NEUROSCI, vol. 18, 2001, pages 149 - 67
BRESLER, T.; SHAPIRA, M.; BOECKERS, T.; DRESBACH, T.; FUTTER, M.; GARNER, C. C.; ROSENBLUM, K.; GUNDELFINGER, E. D.; ZIV, N. E.: "Postsynaptic density assembly is fundamentally different from presynaptic active zone assembly", J NEUROSCI, vol. 24, 2004, pages 1507 - 20
CHEN, C. S.; MRKSICH, M.; HUANG, S.; WHITESIDES, G. M.; INGBER, D. E.: "Micropatterned surfaces for control of cell shape, position, and function", BIOTECHNOL PROG, vol. 14, 1998, pages 356 - 63
CHIH, B.; ENGELMAN, H.; SCHEIFFELE, P.: "Control of excitatory and inhibitory synapse formation by neuroligins", SCIENCE, vol. 307, 2005, pages 1324 - 8
CHUBYKIN, A. A.; ATASOY, D.; ETHERTON, M. R.; BROSE, N.; KAVALALI, E. T.; GIBSON, J. R.; SUDHOF, T. C.: "Activity-Dependent Validation of Excitatory versus Inhibitory Synapses by Neuroligin-1 versus Neuroligin-2", NEURON, vol. 54, 2007, pages 919 - 31
CRAIG, A. M.; KANG, Y.: "Neurexin- neuroligin signaling in synapse development", CURR OPIN NEUROBIOL, vol. 17, 2007, pages 43 - 52
CRAIG, A. M.; KANG, Y.: "Neurexin-neuroligin signaling in synapse development", CURR OPIN NEUROBIOL, vol. 17, 2007, pages 43 - 52
DE WIT, J.; SYLWESTRAK, E.; O'SULLIVAN, M.; OTTO, S.; TIGLIO, K.; SAVAS, J. N.; YATES, J. R.; COMOLETTI, D.; TAYLOR, P.; GHOSH, A.: "LRRTM2 Interacts with Neurexin1 and Regulates Excitatory Synapse Formation", NEURON, vol. 64, 2009, pages 799 - 806
DEAN, C.; SCHOLL, F. G.; CHOIH, J.; DEMARIA, S.; BERGER, J.; ISACOFF, E.; SCHEIFFELE, P.: "Neurexin mediates the assembly of presynaptic terminals", NAT NEUROSCI, vol. 6, 2003, pages 708 - 16
DOYLE, A. D.; WANG, F. W.; MATSUMOTO, K.; YAMADA, K. M.: "One- dimensional topography underlies three-dimensional fibrillar cell migration", J CELL BIOL, vol. 184, 2009, pages 481 - 90
E. R.; KANG, Y.; HAUNER, A. M.; CRAIG, A. M.: "Structure function and splice site analysis of the synaptogenic activity of the neurexin-1 beta LNS domain", J NEUROSCI, vol. 26, 2006, pages 4256 - 65
ETHERTON, M. R.; TABUCHI, K.; SHARMA, M.; KO, J.; SUDHOF, T. C.: "An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus", EMBO J, vol. 30, pages 2908 - 19
FALK, J.; THOUMINE, O.; DEQUIDT, C.; CHOQUET, D.; FAIVRE-SARRAILH, C.: "NrCAM coupling to the cytoskeleton depends on multiple protein domains and partitioning into lipid rafts", MOL BIOL CE, vol. 15, 2004, pages 4695 - 709
FALK, J.; THOUMINE, O.; DEQUIDT, C.; CHOQUET, D.; FAIVRE-SARRAILH, C.: "NrCAM coupling to the cytoskeleton depends on multiple protein domains and partitioning into lipid rafts", MOL BIOL CELL, vol. 15, 2004, pages 4695 - 709
FEREOL, S.; FODIL, R.; BARNAT, M.; GEORGET, V.; MILBRETA, U.; NOTHIAS, F.: "Micropatterned ECM substrates reveal complementary contribution of low and high affinity ligands to neurite outgrowth", CYTOSKELETON (HOBOKEN, 2011
FINK, J.; THERY, M.; AZIOUNE, A.; DUPONT, R.; CHATELAIN, F.; BORNENS, M.; PIEL, M.: "Comparative study and improvement of current cell micro-patterning techniques", LAB CHIP, vol. 7, 2007, pages 672 - 80
FOLKMAN, J.; MOSCONA, A.: "Role of cell shape in growth control", NATURE, vol. 273, 1978, pages 345 - 9
FRIEDMAN, H. V.; BRESLER, T.; GARNER, C. C.; ZIV, N. E.: "Assembly of new individual excitatory synapses: time course and temporal order of synaptic molecule recruitment", NEURON, vol. 27, 2000, pages 57 - 69
GERALD D. FASMAN: "le Practical handbook of biochemistry and molecular biology", 1989, CRC PRESS, pages: 601
GERALD D.: "Practical handbook of biochemistry and molecular biology", 1989, FASMAN CRC PRESS, pages: 601
GERROW, K.; ROMORINI, S.; NABI, S. M.; COLICOS, M. A.; SALA, C.; EI-HUSSEINI, A.: "A preformed complex of postsynaptic proteins is involved in excitatory synapse development", NEURON, vol. 49, 2006, pages 547 - 62
GERROW, K.; ROMORINI, S.; NABI, S. M.; COLICOS, M. A.; SALA, C.; EI-HUSSEINI, A: "A preformed complex of postsynaptic proteins is involved in excitatory synapse development", NEURON, vol. 49, 2006, pages 547 - 62
GRAF, E. R.; KANG, Y.; HAUNER, A. M.; CRAIG, A. M.: "Structure function and splice site analysis of the synaptogenic activity of the neurexin-1 beta LNS domain", J NEUROSCI, vol. 26, 2006, pages 4256 - 65
GRAF, E. R.; ZHANG, X.; JIN, S. X.; LINHOFF, M. W.; CRAIG, A. M.: "Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins", CE, vol. 119, 2004, pages 1013 - 26
GRAF, E. R.; ZHANG, X.; JIN, S. X.; LINHOFF, M. W.; CRAIG, A. M.: "Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins", CELL, vol. 119, 2004, pages 1013 - 26
HAGIYAMA MAN ET AL: "Expression of a soluble isoform of cell adhesion molecule 1 in the brain and its involvement in directional neurite outgrowth.", THE AMERICAN JOURNAL OF PATHOLOGY JUN 2009 LNKD- PUBMED:19435791, vol. 174, no. 6, June 2009 (2009-06-01), pages 2278 - 2289, XP009163414, ISSN: 1525-2191 *
HANSEN S M ET AL: "Signaling mechanisms of neurite outgrowth induced by the cell adhesion molecules NCAM and N-Cadherin", CMLS CELLULAR AND MOLECULAR LIFE SCIENCES, BIRKHÄUSER-VERLAG, BA, vol. 65, no. 23, 15 September 2008 (2008-09-15), pages 3809 - 3821, XP019652134, ISSN: 1420-9071, DOI: 10.1007/S00018-008-8290-0 *
HEINE, M.; THOUMINE, O.; MONDIN, M.; TESSIER, B.; GIANNONE, G.; CHOQUET, D.: "Activity-independent and subunit-specific recruitment of functional AMPA receptors at neurexin/neuroligin contacts", PROC NATL ACAD SCI USA, vol. 105, 2008, pages 20947 - 52
IRELAND, G. W.; DOPPING-HEPENSTAL, P. J.; JORDAN, P. W.; O'NEILL, C. H.: "Limitation of substratum size alters cytoskeletal organization and behaviour of Swiss 3T3 fibroblasts", CELL BIOL INT REP, vol. 13, 1989, pages 781 - 90
ISABELLE COLLIN: "Le génie génétique", 1999, article "les animaux transgéniques"
ISABELLE COLLIN: "les animaux transgéniques", 1999, article "Le génie génétique"
JAMAIN, S.; QUACH, H.; BETANCUR, C.; RASTAM, M.; COLINEAUX, C.; GILLBERG, . C.; SODERSTROM, H.; GIROS, B.; LEBOYER, M.; GILLBERG,: "Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism", NAT GENET, vol. 34, 2003, pages 27 - 9
KAMIGUCHI, H.; HLAVIN, M. L.; LEMMON, V.: "Role of L1 in neural development: what the knockouts tell us", MOL CELL NEUROSCI, vol. 12, 1998, pages 48 - 55
KO, J.; FUCCILLO, M. V.; MALENKA, R. C.; SUDHOF, T. C.: "LRRTM2 Functions as a Neurexin Ligand in Promoting Excitatory Synapse Formation", NEURON, vol. 64, 2009, pages 791 - 798
KO, J.; ZHANG, C.; ARAC, D.; BOUCARD, A. A.; BRUNGER, A. T.; SUDHOF, T. C.: "Neuroligin-1 performs neurexin-dependent and neurexin-independent functions in synapse validation", EMBO J, vol. 28, 2009, pages 3244 - 55
LADOUX, B.; ANON, E.; LAMBERT, M.; RABODZEY, A.; HERSEN, P.; BUGUIN, A.; SILBERZAN, P.; MEGE, R. M.: "Strength dependence of cadherin-mediated adhesions", BIOPHYS J, vol. 98, 2010, pages 534 - 42
LEVINSON, J. N.; CHERY, N.; HUANG, K.; WONG, T. P.; GERROW, K.; KANG, R.; PRANGE, O.; WANG, Y. T.; EI-HUSSEINI, A.: "Neuroligins mediate excitatory and inhibitory synapse formation: involvement of PSD-95 and neurexin-1 beta in neuroligin-induced synaptic specificity", J BIOL CHEM, vol. 280, 2005, pages 17312 - 9
LINHOFF, M. W.; LAUREN, J.; CASSIDY, R. M.; DOBIE, F. A.; TAKAHASHI, H.; NYGAARD, H. B.; AIRAKSINEN, M. S.; STRITTMATTER, S. M.; C: "An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers", NEURON, vol. 61, 2009, pages 734 - 49
MISSLER, M.; ZHANG, W.; ROHLMANN, A.; KATTENSTROTH, G.; HAMMER, R. E.; GOTTMANN, K.; SUDHOF, T. C.: "Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis", NATURE, vol. 423, 2003, pages 939 - 48
PARADIS, S.; HARRAR, D. B.; LIN, Y.; KOON, A. C.; HAUSER, J. L.; GRIFFITH, E. C.; ZHU, L.; BRASS, L. F.; CHEN, C.; GREENBERG, M. E: "An RNAi-based approach identifies molecules required for glutamatergic and GABAergic synapse development", NEURON, vol. 53, 2007, pages 217 - 32
PAUL, D.; SAIAS, L.; PEDINOTTI, J. C.; CHABERT, M.; MAGNIFICO, S.; PALLANDRE, A.; DE LAMBERT, B.; HOUDAYER, C.; BRUGG, B.; PEYRIN,: "dry and wet hybrid'' lithography technique for multilevel replication templates: Applications to microfluidic neuron culture and two-phase global mixing", BIOMICROFLUIDICS, vol. 5, 2011, pages 24102
PERRET, E.; BENOLIEL, A. M.; NASSOY, P.; PIERRES, A.; DELMAS, V.; THIERY, J. P.; BONGRAND, P.; FERACCI, H.: "Fast dissociation kinetics between individual E-cadherin fragments revealed by flow chamber analysis", EMBO J, vol. 21, 2002, pages 2537 - 46
PERRET, E.; BENOLIEL, A. M.; NASSOY, P.; PIERRES, A.; DELMAS, V.; THIERY, J. P; BONGRAND, P.; FERACCI, H.: "Fast dissociation kinetics between individual E-cadherin fragments revealed by flow chamber analysis", EMBO J, vol. 21, 2002, pages 2537 - 46
PERRET, E.; LEUNG, A.; FERACCI, H.; EVANS, E.: "Trans-bonded pairs of E-cadherin exhibit a remarkable hierarchy of mechanical strengths", PROC NATL ACAD SCI USA, vol. 101, 2004, pages 16472 - 7
PINE J: "Microdevices for studies of cultured neural networks", AIP CONFERENCE PROCEEDINGS, 1 July 1999 (1999-07-01), AMERICAN INSTITUTE OF PHYSICS, NEW YORK, US, pages 203 - 218, XP003005114, ISSN: 0094-243X *
ROZKIEWICZ, D. I.; KRAAN, Y.; WERTEN, M. W.; DE WOLF, F. A.; SUBRAMANIAM, V.; RAVOO, B. J.; REINHOUDT, D. N.: "Covalent microcontact printing of proteins for cell patterning", CHEMISTRY, vol. 12, 2006, pages 6290 - 7
ROZKIEWICZ, D.; KRAAN, Y.; WERTEN, M. W.; WOLF, F. A.; SUBRAMANIAM, V.; RAVOO, B. J.; REINHOUDT, D. N.: "Covalent microcontact printing of proteins for cell patterning", CHEMISTRY, vol. 12, 2006, pages 6290 - 7
RUARDIJ, T. G.; GOEDBLOED, M. H.; RUTTEN, W. L.: "Adhesion and patterning of cortical neurons on polyethylenimine- and fluorocarbon-coated surfaces", IEEE TRANS BIOMED ENG, vol. 47, 2000, pages 1593 - 9
RUJESCU, D.; INGASON, A.; CICHON, S.; PIETILAINEN, O. P.; BARNES, M. R.; TOULOPOULOU, T.; PICCHIONI, M.; VASSOS, E.; ETTINGER, U.;: "Disruption of the neurexin 1 gene is associated with schizophrenia", HUM MOL GENET, vol. 18, 2009, pages 988 - 96
SAINLOS, M.; TIGARET, C.; POUJOL, C.; OLIVIER, N. B.; BARD, L.; BREILLAT, C.; THIOLON, K.; CHOQUET, D.; IMPERIALI, B.: "Biomimetic divalent ligands for the acute disruption of synaptic AMPAR stabilization", NAT CHEM BIOL, vol. 7, 2010, pages 81 - 91
SANJANA, N. E.; FULLER, S. B.: "A fast flexible ink-jet printing method for patterning dissociated neurons in culture", J NEUROSCI METHODS, vol. 136, 2004, pages 151 - 63
SARA, Y.; BIEDERER, T.; ATASOY, D.; CHUBYKIN, A.; MOZHAYEVA, M. G.; SUDHOF, T. C.; KAVALALI, E. T.: "Selective capability of SynCAM and neuroligin for functional synapse assembly", J NEUROSCIENCE, vol. 25, 2005, pages 260 - 270
SCHEIFFELE, P.; AN, J.; CHOIH, J.; FETTER, R.; SERAFINI, T.: "Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons", CELL, vol. 101, 2000, pages 657 - 69
SCHEIFFELE, P.; FAN, J.; CHOIH, J.; FETTER, R.; SERAFINI, T.: "Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons", CEL, vol. 1 01, 2000, pages 657 - 69
SCHEIFFELE, P.; FAN, J.; CHOIH, J.; FETTER, R.; SERAFINI, T.: "Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons", CEL/1, vol. 01, 2000, pages 657 - 69
SCHEIFFELE, P.; FAN, J.; CHOIH, J.; FETTER, R.; SERAFINI, T.: "Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons", CELL, vol. 101, 2000, pages 657 - 69
SCHWARZ VALENTIN ET AL: "IgCAMs redundantly control axon navigation in Caenorhabditis elegans", NEURAL DEVELOPMENT, BIOMED CENTRAL LTD, LO, vol. 4, no. 1, 2 April 2009 (2009-04-02), pages 13, XP021052278, ISSN: 1749-8104, DOI: 10.1186/1749-8104-4-13 *
SHI P., SCOTT M.A.; GHOSH B.; WAN D.; WISSNER-GROSS Z.; MAZITSCHEK R.; HAGGARTY S.J.: "Fatih M. Synapse microarray identification of small molecules that enhance synaptogenesis", NAT COMMUN, vol. 2, 2011, pages 510
SHI, P.; SCOTT M.A.; GHOSH B.; WAN D.; WISSNER-GROSS Z.; MAZITSCHEK R.; HAGGARTY S.J.; FATIH M.: "Synapse microarray identification of small molecules that enhance synaptogenesis", NAT COMMUN, vol. 2, 2011, pages 510
SHI, P.; SHEN, K.; KAM, L. C.: "Local presentation of L1 and N-cadherin in multicomponent, microscale patterns differentially direct neuron function in vitro", DEV NEUROBIOL, vol. 67, 2007, pages 1765 - 76
SUDHOF, T. C.: "Neuroligins and neurexins link synaptic function to cognitive disease", NATURE, vol. 455, 2008, pages 903 - 11
SUZUKI, S. C.; FURUE, H.; KOGA, K.; JIANG, N.; NOHMI, M.; SHIMAZAKI, Y.; KATOH-FUKUI, Y.; YOKOYAMA, M.; YOSHIMURA, M.; TAKEICHI, M: "Cadherin-8 is required for the first relay synapses to receive functional inputs from primary sensory afferents for cold sensation", J NEUROSCI, vol. 27, 2007, pages 3466 - 76
TABUCHI, K.; BLUNDELL, J.; ETHERTON, M. R.; HAMMER, R. E.; LIU, X.; POWELL, C. M.; SUDHOF, T. C.: "A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice", SCIENCE, vol. 318, 2007, pages 71 - 6
TAKAHASHI, H.; ARSTIKAITIS, P.; PRASAD, T.; BARTLETT, T. E.; WANG, Y. T.; MURPHY, T. H.; CRAIG, A. M.: "Postsynaptic TrkC and presynaptic PTPsigma function as a bidirectional excitatory synaptic organizing complex", NEURON, vol. 69, 2011, pages 287 - 303
TALEBIZADEH, Z.; LAM, D. Y.; THEODORO, M. F.; BITTEL, D. C.; LUSHINGTON, G. H.; BUTLER, M. G.: "Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism", J MED GENET, vol. 43, 2006, pages E21
TAYLOR, A. M.; BLURTON-JONES, M.; RHEE, S. W.; CRIBBS, D. H.; COTMAN, C. W.; JEON, N. L.: "A microfluidic culture platform for CNS axonal injury, regeneration and transport", NAT METHODS 2, 2005, pages 599 - 605
TAYLOR, A. M.; BLURTON-JONES, M.; RHEE, S. W.; CRIBBS, D. H.; COTMAN, C. W.; JEON, N. L.: "A microfluidic culture platform for CNS axonal injury, regeneration and transport", NAT METHODS, vol. 2, 2005, pages 599 - 605
TAYLOR, A. M.; JEON, N. L.: "Micro-scale and microfluidic devices for neurobiology", CURR OPIN NEUROBIOL, vol. 20, 2010, pages 640 - 7
TEUN G RUARDIJ* ET AL: "Adhesion and Patterning of Cortical Neurons on Polyethylenimine- and Fluorocarbon-Coated Surfaces", IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, vol. 47, no. 12, 1 December 2000 (2000-12-01), IEEE SERVICE CENTER, PISCATAWAY, NJ, USA, XP011007005, ISSN: 0018-9294 *
THERY, M.; RACINE, V.; PEPIN, A.; PIEL, M.; CHEN, Y.; SIBARITA, J. B.; BORNENS, M.: "The extracellular matrix guides the orientation of the cell division axis", NAT CELL BIOL, vol. 7, 2005, pages 947 - 53
THERY, M.; RACINE, V.; PIEL, M.; PEPIN, A.; DIMITROV, A.; CHEN, Y.; SIBARITA, J. B.; BORNENS, M.: "Anisotropy of cell adhesive microenvironment governs cell internal organization and orientation of polarity", PROC NATL ACAD SCI USA, vol. 103, 2006, pages 19771 - 6
VAROQUEAUX, F.; ARAMUNI, G.; RAWSON, R. L.; MOHRMANN, R.; MISSLER, M.; GOTTMANN, K.; ZHANG, W.; SUDHOF, T. C.; BROSE, N.: "Neuroligins determine synapse maturation and function", NEURON, vol. 51, 2006, pages 741 - 54
VON PHILIPSBORN, A. C.; LANG, S.; BERNARD, A.; LOESCHINGER, J.; DAVID, C.; LEHNERT, D.; BASTMEYER, M.; BONHOEFFER, F.: "Microcontact printing of axon guidance molecules for generation of graded patterns", NAT PROTOC, vol. 1, 2006, pages 1322 - 8
VON PHILIPSBORN, A. C.; LANG, S.; BERNARD, A.; LOESCHINGER, J.; DAVID, C.; LEHNERT, D.; BASTMEYER, M.; BONHOEFFER, F.: "Microcontact printing ofaxon guidance molecules for generation of graded patterns", NAT PROTOC, vol. 1, 2006, pages 1322 - 8
VON PHILIPSBORN, A. C.; LANG, S.; LOESCHINGER, J.; BERNARD, A.; DAVID, C.; LEHNERT, D.; BONHOEFFER, F.; BASTMEYER, M.: "Growth cone navigation in substrate-bound ephrin gradients", DEVELOPMENT, vol. 133, 2006, pages 2487 - 95
WATT, F. M.; JORDAN, P. W.; O'NEILL, C. H.: "Cell shape controls terminal differentiation of human epidermal keratinocytes", PROC NATL ACAD SCI USA, vol. 85, 1988, pages 5576 - 80
WILLIAMS, E. J.; WILLIAMS, G.; GOUR, B.; BLASCHUK, O.; DOHERTY, P.: "INP, a novel N-cadherin antagonist targeted to the amino acids that flank the HAV motif", MOL CELL NEUROSCI, vol. 15, 2000, pages 456 - 64
WILLIAMS, E.; WILLIAMS, G.; GOUR, B. J.; BLASCHUK, O. W.; DOHERTY, P. A: "novel family of cyclic peptide antagonists suggests that N-cadherin specificity is determined by amino acids that flank the HAV motif", J BIOL CHEM, vol. 275, 2000, pages 4007 - 12
WILLIAMS, E.; WILLIAMS, G.; GOUR, B. J.; BLASCHUK, O. W.; DOHERTY, P.: "A novel family of cyclic peptide antagonists suggests that N-cadherin specificity is determined by amino acids that flank the HAV motif", J BIOL CHEM, vol. 275, 2000, pages 4007 - 12
WILSON, N. R.; TY, M. T.; INGBER, D. E.; SUR, M.; LIU, G.: "Synaptic reorganization in scaled networks of controlled size", J NEUROSCI, vol. 27, 2007, pages 13581 - 9
WIT, J.; SYLWESTRAK, E.; O'SULLIVAN, M.; OTTO, S.; TIGLIO, K.; SAVAS, J. N.; YATES, J. R.; COMOLETTI, D.; TAYLOR, P.; GHOSH, A.: "LRRTM2 Interacts with Neurexinland Regulates Excitatory Synapse Formation", NEURON, vol. 64, 2009, pages 799 - 806
WRIGHT G J ET AL: "Neurexins, Neuroligins and LRRTMs: Synaptic adhesion getting fishy", JOURNAL OF NEUROCHEMISTRY, vol. 117, no. 5, June 2011 (2011-06-01), BLACKWELL PUBLISHING LTD GBR, pages 765 - 778, XP002667504, ISSN: 0022-3042, DOI: 10.1111/J.1471-4159.2010.07141.X *
YAMAGATA, M.; WEINER, J. A.; DULAC, C.; ROTH, K. A.; SANES, J. R.: "Labeled lines in the retinotectal system: markers for retinorecipient sublaminae and the retinal ganglion cell subsets that innervate them", MOL CELL NEUROSCI, vol. 33, 2006, pages 296 - 310
ZITO, K.; SCHEUSS, V.; KNOTT, G.; HILL, T.; SVOBODA, K.: "Rapid functional maturation of nascent dendritic spines", NEURON, vol. 61, 2009, pages 247 - 58

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11674952B2 (en) 2016-02-24 2023-06-13 The Rockefeller University Embryonic cell-based therapeutic candidate screening systems, models for Huntington's Disease and uses thereof

Also Published As

Publication number Publication date
FR2978455B1 (en) 2015-06-05
FR2978455A1 (en) 2013-02-01

Similar Documents

Publication Publication Date Title
Lucido et al. Rapid assembly of functional presynaptic boutons triggered by adhesive contacts
Papadimitriou et al. 3D culture method for Alzheimer's disease modeling reveals interleukin-4 rescues Aβ42-induced loss of human neural stem cell plasticity
Offenhäusser et al. Microcontact printing of proteins for neuronal cell guidance
Wyart et al. Constrained synaptic connectivity in functional mammalian neuronal networks grown on patterned surfaces
Yap et al. Adapting for endocytosis: roles for endocytic sorting adaptors in directing neural development
Silva et al. Transcriptome profiling of human pluripotent stem cell‐derived cerebellar organoids reveals faster commitment under dynamic conditions
Roy et al. Engineered cell culture substrates for axon guidance studies: moving beyond proof of concept
CN119101651A (en) Bi- or multi-differentiated organoids
Schulte et al. Scale invariant disordered nanotopography promotes hippocampal neuron development and maturation with involvement of mechanotransductive pathways
FR2842747A1 (en) METHOD AND DEVICE FOR SCREENING MOLECULES IN CELLS
JP7159055B2 (en) Method for forming functional networks of human neurons and glial cells
Stil et al. A simple method for poly-D-lysine coating to enhance adhesion and maturation of primary cortical neuron cultures in vitro
Karahuseyinoglu et al. Three‐dimensional neuron–astrocyte construction on matrigel enhances establishment of functional voltage‐gated sodium channels
Kumorek et al. Cellular responses modulated by FGF-2 adsorbed on albumin/heparin layer-by-layer assemblies
Batenburg et al. A 3D human co-culture to model neuron-astrocyte interactions in tauopathies
Martin et al. Peptide nanofiber substrates for long-term culturing of primary neurons
Schweingruber et al. Single-cell RNA-sequencing reveals early mitochondrial dysfunction unique to motor neurons shared across FUS-and TARDBP-ALS
Minner et al. Polymer-tethered lipid multi-bilayers: a biomembrane-mimicking cell substrate to probe cellular mechano-sensing
WO2013017770A1 (en) Device for culturing nerve cells, and uses thereof
Ashton et al. High-throughput screening of gene function in stem cells using clonal microarrays
Ehrhardt et al. Axogenesis in the antennal nervous system of the grasshopper Schistocerca gregaria revisited: the base pioneers
Terryn et al. Topographical Guidance of PSC‐Derived Cortical Neurons
Hjortø et al. Generating substrate bound functional chemokine gradients in vitro
Kao et al. Surface Viscosity‐Dependent Neurite Initiation in Cortical Neurons
Nguyen et al. Cytoneme-like protrusion formation induced by LAR is promoted by receptor dimerization

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12750413

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12750413

Country of ref document: EP

Kind code of ref document: A1